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Abstract
      The Krüppel-associated box (KRAB) zinc finger protein (ZFP) genes comprise
one of the largest gene families in the mammalian genome, encoding transcription
factors with an N-terminal KRAB domain and C-terminal zinc fingers. The KRAB
domain interacts with a co-repressor protein, KAP-1, which can recruit various
factors causing transcriptional repression of genes to which KRAB ZFPs bind. Little
is currently known about the gene targets of the ~400 human and mouse KRAB
ZFPs.
      Many KRAB ZFPs interact with factors other than KAP-1. To identify proteins
that may interact with one particular KRAB ZFP, Zfp647, I previously carried out a
yeast two-hybrid screen using the full-length Zfp647 sequence and a mouse
embryonic cDNA library. I have now tested the interactions from this screen for their
specificity for Zfp647. I show that Zfp647 can interact with itself and at least 20
other KRAB ZFPs through their zinc finger domains, and have confirmed the Zfp647
self-interaction by in vitro co-immunoprecipitation. In my yeast two-hybrid screen,
Zfp647 bound to KAP-1 as well as another related protein, ARD1/Trim23. Zfp647
also interacts with proteins that function in ubiquitylation. I have found evidence to
suggest that Zfp647 may also interact with proteins encoding jumonji domains both
by yeast two-hybrid assay and by co-immunoprecipitation from NIH/3T3 cell
extracts. We have previously found that Zfp647 localises to non-heterochromatic
nuclear foci in differentiated ES cells, which also contain KAP-1 and HP1, and
which lie adjacent to PML nuclear bodies in a high proportion of cells. I have found
that these foci are also visible in pMEFs, but not NIH/3T3 tissue culture cells.
Immunofluorescence studies with antibodies against proteins from the yeast two-
hybrid screen have not shown any significant co-localisation with Zfp647.
      KAP-1 is sumoylated ex vivo , as are  two human KRAB ZFPs. Because Zfp647
lies adjacent to PML nuclear bodies and can associate with proteins involved in post-
translational modification, I tested whether Zfp647 is also modified. I characterised a
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sheep _-Zfp647 antibody previously created in the lab and have shown that it detects
Zfp647 by western blot, but not by immunofluorescence. I show that treatment of
NIH/3T3 cells with NEM, which prevents the removal of protein modifications,
leads to the appearance of higher molecular weight forms of Zfp647. Modification of
Zfp647 is not dependent on KAP-1, which is known to function as a SUMO E3
ligase. Attempts to classify the modification as either ubiquitin, SUMO or NEDD8
have suggested that Zfp647 may be mono-ubquitylated. The larger modified forms of
Zfp647 are present in both NIH/3T3 and ES cells. Interestingly, I found that the
modification profile of the protein changes over the course of ES cell differentiation,
during which time Zfp647 relocalises to punctate nuclear foci; thus Zfp647
modification may be involved in this process.
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      In eukaryotes, packaging of the genome into the nucleus is achieved by
condensing DNA into tightly wound structures by proteins. This mixture of DNA
and proteins, roughly a 1:2 ratio by mass (Lee and Young, 2000), is known as
chromatin. At the basic level, 146bp of the DNA helix is wound around 8 highly
conserved histone proteins (a tetramer composed of two H3 and two H4 histone
dimers, flanked by two heterodimers of histones H2A and H2B) (Luger et al, 1997),
giving a structure called a nucleosome. Individual nucleosomes are held together by
the H1 linker histone proteins. The average number of H1 molecules per nucleosome
can vary from 0.5 in mouse embryonic stem (ES) cells (Fan et al, 2005) to 1.3 in
chicken erythrocytes (Bates and Thomas, 1981). The distance between each
nucleosome, the nucleosome repeat length (NRL), is also variable, ranging from
189bp in mouse ES cells (Fan et al, 2005) to 212bp in chicken erythrocytes (Bates
and Thomas, 1981). Histones themselves have a negative effect on transcription:
DNA bound by the core histones undergoes transcription at 15-30% lower levels
than naked DNA, and addition of linker histone H1 represses transcription even
further (Ura et al, 1995).
      The simplest chromatin fibre, consisting of DNA bound by nucleosomes, is
known as the 10nm fibre, or informally as ‘beads on a string’. The 10nm fibre can be
packaged up into a helix 30nm in diameter (the 30nm fibre) (Figure 1.1). The exact
structure of the 30nm fibre is still hotly debated, with some groups favouring a ‘one-
start’ helix (Robinson et al, 2006; Routh et al, 2008), and others championing a ‘two-
start’ structure (Dorigo et al, 2004). The 30nm fibre can be further condensed on
many levels to eventually form a 700nm structure. This level of packaging is not
seen throughout the cell cycle: the 700nm fibre is only visible during cell division as
the classic metaphase x-shaped chromosomes, to ensure the tangle-free separation of
sister chromatids or chromosomes.
3
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      Given its typical folded structure, some degree of remodelling of the chromatin is
required for the access of the transcription machinery and the synthesis of mRNA to
occur. Chromatin is often labelled as being either ‘open’, i.e. with a relatively loose
packaging arrangement, or ‘closed’, i.e. a tightly wound, condensed structure. Highly
condensed, late replicating chromatin is known as heterochromatin, whereas early
replicating chromatin with an open structure is known as euchromatin. The
permanent, or constitutive, heterochromatin of a cell is composed of large arrays of
tandem repeats often found at centromeric and pericentromeric regions, and therefore
contains repetitive, relatively transcriptionally inactive sequences. The more
transcriptionally active regions of the genome are euchromatic, and for this reason it
was originally thought that chromatin structure was dependent on transcriptional
activity (Felsenfeld and Groudine, 2003). However, work carried out on a more
biophysical level has shown that gene density is a greater determinant of whether a
genomic region is open or closed (Gilbert et al, 2004). The open structure of gene-
rich domains would grant the access of transcription factors to the DNA, allowing
transcription to occur relatively easily, whereas genes in a condensed, gene-poor
region would require further factors to loosen the chromatin structure before the
initiation of RNA synthesis (Sproul et al, 2005).
1.1.2. Chromatin Remodelling
      Nucleosome positioning is important in determining the efficiency of
transcription initiation and elongation. The transcription start site (TSS) of a gene is
typically depleted of nucleosomes, with nucleosome free regions of ~150bp being
found approximately 200bp upstream of start codons in yeast (Yuan et al, 2005).
However, nucleosomes can still present a physical barrier to the elongating
polymerase within the remainder of the coding sequence. The chromatin must
therefore be rearranged in such a way to remove the histones from the path of the
polymerase whilst maintaining the overall integrity of its structure. Thus it was
shown that a purified human transcription system cannot efficiently transcribe a
DNA template when chromatinised, but addition of certain proteins that can disrupt
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nucleosome positioning on a stretch of DNA allows transcription to occur
(Orphanides et al, 1998). Proteins that alter the pattern of nucleosomes are known as
chromatin or nucleosome remodellers.
      Eukaryotes possess at least 5 ATP-dependent chromatin remodeller families:
SWI/SNF, ISWI, NuRD/Mi-2/CHD, INO80 and SWRI (Saha et al, 2006). Each
chromatin remodelling complex contains at its heart an ATPase subunit, which is
homologous to the SWI/SNF2 subfamily of the DEAD/H box family of nucleic acid-
stimulated ATPases (Eisen et al, 1995). The two best studied families are the
SWI/SNF and ISWI proteins. The ATPase domains in these complexes are identical;
therefore the other components of the complex determine its overall function. The
SWI/SNF remodellers are large multisubunit complexes that can adjust nucleosome
position and the nucleosome/DNA structure, and that are capable of exchanging
histone dimers or octamers (Martens and Winston, 2003). In contrast, the smaller
ISWI complexes generate nucleosomes with altered positions but in standard
structures, and remodel the chromatin to achieve regular spacing of nucleosomes,
which promotes the organisation of the chromatin fibre into compact higher order
structures (Deuring et al, 2000; Goldmark et al, 2000; reviewed in Racki and
Narlikar, 2008).
1.1.3. Histone Modifications and their Effect on Transcription
      Histone proteins have two domains: the globular C-terminal domain, which lies
at the interior of the nucleosome; and the N-terminal (or C-terminal) ‘tail’ of the
protein, which protrudes from the nucleosome (Luger et al, 1997). The tail region
can interact with the DNA wrapped around the histone proteins, and with other
chromatin-associated factors. Many proteins can modify histone tails, adding acetyl,
methyl or ubiquitin groups for example (see Figure 1.2). In 2000, Strahl and Allis
published their theory of the histone code: that histone modifications form a code
that can be ‘read’ by proteins capable of recognising specific modifications. These
6
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proteins may add other marks to proximal histone tails, or alter the surrounding
chromatin structure, making it more or less conducive to transcription (Strahl and
Allis, 2000). Particular marks are therefore associated with certain transcriptional
states, and we would be able to tell what is happening at a gene by the modifications
present on the histones at that sequence. Antibodies highly specific for histone
modifications can be used in chromatin immunoprecipitation (ChIP) to ascertain the
modifications present at a DNA sequence, and this is now commonly combined with
genomic microarrays (ChIP-chip) or high-throughput sequencing (ChIP-seq) to
generate genome-wide maps of histone modifications in different cell types (Barski
et al, 2007; Mikkelsen et al, 2007).
1.1.3.1. Histone Acetylation
      Histones are rich in the positively charged amino acid lysine, which aids in their
interaction with negatively charged DNA. However, lysine residues are commonly
modified by the acetyl modification. The acetyl group is negatively charged, which
neutralises the lysine residues and relaxes the interaction between DNA and histones
(Hong et al, 1993). This makes the DNA more accessible to transcription factors and
RNA polymerases, increasing the rate of transcription of the acetylated sequence;
thus histone acetylation is linked to expressed genes (Hebbes et al, 1988).
Acetylation of histones H3 and H4 peaks at the TSSs of active genes in humans,
mice and yeast (Pokholok et al, 2005; Bernstein et al, 2005). Tse and colleagues
have also shown that hyperacetylation of histone tails in vitro disrupts higher-order
chromatin folding, and is accompanied by a 15-fold increase in transcription of the
template tested (Tse et al, 1998), indicating that histone acetylation may also
destabilise nucleosome-nucleosome interactions.
      Histones H2A, H2B, H3 and H4 are all acetylated on their N-terminal tails
(Figure 1.2). The addition of this modification is carried out by histone
acetyltransferase (HAT) enzymes such as the functionally related proteins p300 and
Creb binding-protein (p300/CBP), and p300/CBP-associated factor (PCAF). These
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proteins are typically found as part of large, multiprotein complexes. Histone
modifications are reversible: acetyl groups are removed from histones by histone
deacetylase (HDAC) enzymes, which, like HATs, are typically found as subunits of
large complexes. As expected, recruitment of HDAC-containing complexes to a gene
results in the downregulation of its transcription. The two major HDAC complexes
are NuRD (nucleosome remodelling and histone deacetylation) and Sin3 (reviewed
by Cunliffe, 2008). These complexes share four subunits: the histone deacetylases
HDAC1 and HDAC2, and the histone binding proteins RbAp46 and RbAp48. NuRD
additionally has ATP-dependent nucleosome remodelling activity, through the Mi-2_
and Mi-2_ proteins (Denslow and Wade, 2008), thus this complex is capable of
affecting both histone modification and nucleosome organisation.
1.1.3.2. Histone Methylation
      Histone proteins can also be modified by the addition of methyl groups onto a
lysine or arginine residue (Figure 1.2). Histones are mono-, di- or tri-methylated,
which can be recognised as distinct marks by other proteins, giving an extra layer of
complexity to this modification. The first histone methyltransferases (HMTases) to
be discovered were the suppressor of variegation (Suv39h1 and Suv39h2) proteins
(Rea et al, 2000; O’Carroll, 2000). These enzymes encode the highly conserved SET
domain, named after the proteins it was first discovered in: Suppressor of
Variegation 3-9, Enhancer of Zeste and trithorax (Jones and Gelbart, 1993;
Tschiersch et al, 1994). The SET domain was subsequently identified in a number of
other HMTases including G9a and SETDB1 (Tachibana et al, 2001; Schultz et al,
2002). Mammalian Suv39h1 and Suv39h2 tri-methylate H3K9 (Tachibana et al,
2001), and SETDB1 is also known to selectively methylate H3K9 (Schultz et al,
2002). The H3K9me mark is typically found at the TSSs of genes in repressed
chromatin: H3K9me3 is a characteristic of heterochromatin, whereas H3K9me1 and
H3K9me2 are enriched within silent euchromatic regions (Rice et al, 2003).
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      The tri-methylation of H3K27 is catalysed by the polycomb group repressive
complex 2 (PRC2) subunits Enhancer of Zeste 2 (EZH2) (Cao et al, 2002; Czermin
et al, 2002; Kuzmichev et al, 2002; Muller et al, 2002) and the recently discovered
EZH1 (Margueron et al, 2008; Shen et al, 2008). Polycomb group (PcG) proteins are
important for regulating the expression of many genes of developmental importance,
including the Hox, Pou, Pax, Fox, Sox and Tbx transcriptional regulators (Boyer et
al, 2006; Lee et al, 2006). Thus the loss of the PcG proteins is extremely detrimental
to development (Schumacher et al, 1996; O’Carroll et al, 2001; Voncken et al,
2003). The polycomb proteins show a remarkable ability to compact chromatin
(Francis et al, 2004), therefore it is not surprising that genes bound by these
complexes, and tri-methylated at H3K27, are transcriptionally silent. Like mono- and
di-methylated H3K9, H3K27me3 is found at silent genes in euchromatin, but
H3K27me3 is generally more dispersed throughout the coding region of the gene
than methylated H3K9.
      Histone methylation is not limited to repressed chromatin. Tri-methylation of
H3K4, carried out by hSet1, MLL1 and MLL2 in humans (Milne et al, 2002;
Wysocka et al, 2003; Yokoyama et al, 2004) is associated with transcriptionally
active genomic regions (Litt et al, 2001; Noma et al, 2001). H3K4me3 is found at the
TSSs of nearly all active genes (Barski et al, 2007). Interestingly, the methylation
status of H3K4 alters across the coding sequence of a gene, with di-methylated
H3K4 being found in the middle of transcribed sequences, and mono-methylated
H3K4 being enriched at the 3’ end. Tri-methylated H3K4 antagonises the binding of
Suv39h1, preventing the methylation of H3K9, and impairs the binding of the NuRD
complex (Nishioka et al, 2002; Zegerman et al, 2002).
      The arginine residues of histone proteins can also be methylated. Histone H3 is
methylated on arginines 2, 17, 26 (mediated by coactivator associated arginine
methyltransferase-1 (CARM1)) and 8 (carried out by protein arginine
methyltransferase-5 (PRMT5)), whereas histone H4 is methylated on the arginine
residue at position 3 by either PRMT1 or PRMT5 (Figure 1.2). Although CARM1 is
involved in nuclear hormone receptor-mediated transcription (An et al, 2004),
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genome-wide ChIP-chip analysis found that H3R2 methylation is not enriched in
active genes over those that are transcriptionally silent (Barski et al, 2007). Similarly,
the same study found that H4R3 methylation, which stimulates the acetylation of
histones H3 and H4 (Huang et al, 2005), was not preferentially identified at active
gene loci (Barski et al, 2007).
      Intriguingly, histones have the potential to be modified by both active and
repressive marks simultaneously. Studying the histone modifications present at
particular regions of mouse ES cell genomes that encode the Hox genes and other
developmentally important transcription factors, Bernstein et al found that three
quarters of the loci that have the H3K27me mark also contain sites of H3K4
methylation (Bernstein et al, 2006). These marks co-localise in pluripotent ES cells,
whereas upon differentiation, most histones have either one mark or the other, as
presumably the transcriptional fate of the genes has been decided. Bivalency can also
be found in non-ES cells: promoters with a high content of CpG islands in
neuroprogenitor cells and mouse embryonic fibroblasts have regions where H3K27
and H3K4 are both methylated, which is resolved to either one of the marks, or no
modification upon lineage commitment (Mikkelsen et al, 2007). Mass spectrometry
has allowed individual Tetrahymena nucleosomes to be analysed, showing that
H3K4me1 can be found on the same histone tail as H3K27me2, and to a lesser
extent, H3K27me1 (Taverna et al, 2007), entertaining the possibility that individual
histones at key developmental stages are positioned to go down one of a number of
potential expression pathways.
      Histone H3K4 methylation has been shown to have a unique relationship with
histone acetylation. Histones methylated at K4 are subjected to continuous turnover
of acetylation, whereas histones methylated on K9 do not share this characteristic
(Hazzalin and Mahadevan, 2005). Additionally, nucleosomes in the first intron and
exon of the proto-oncogenes c-fos and c-jun are simultaneously modified by H3ac,
H3K4me and H3S10p (see below) (Hazzalin and Mahadevan, 2005). Inhibition of
HDACs, which increases the amount of acetylation present at c-fos and c-jun, but
decreases the turnover of this mark, actually inhibited the induction of these genes,
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suggesting that at these sequences at least, it is not the presence of acetylated
histones that is the important for gene expression, but the dynamic turnover of
acetylation (Hazzalin and Mahadevan, 2005).
      Histone demethylation is carried out by LSD1 and the jumonji family of proteins
(reviewed in Cloos et al, 2008). LSD1 demethylates mono- or di-methylated histone
H3K4, but cannot demethylate the tri-methylated form of the protein, due to its
requirement for a protonated nitrogen molecule as a substrate, which is lost when the
histone is tri-methylated (Shi et al, 2004). The jumonji domain has no such
requirement of its substrate, therefore proteins bearing this domain can remove the
tri-methyl mark from histones. For example, the JMJD2 subfamily of proteins
(JMJD2A, JMJD2B and JMJD2C) can all demethylate the H3K9me3 mark (Cloos et
al, 2006; Fodor et al, 2006; Klose et al, 2006; Whetstine et al, 2006), whereas
JMJD1A can demethylate the H3K9me1 or H3K9me2 substrates (Yamane et al,
2006). JMJD2A and JMJD2B are also capable of demethylating H3K36 (Fodor et al,
2006; Klose et al, 2006; Whetstine et al, 2006), as is Fbxl11 (Tsukada et al, 2006).
Like LSD1, JARID1C can demethylate lysine 4 of histone H3 (Iwase et al, 2007).
The methylation of H3K27 is reversed by two proteins, Utx and JMJD3 (Agger et al,
2007; De Santa et al, 2007; Lan et al, 2007; Lee et al, 2007a). Finally, arginine
residues can also be demethylated, with H3R2 and H4R3 modification being
reversed by JMJD6 (Chang et al, 2007).
1.1.3.3. Histone Phosporylation
      Each of the core histones can be phosphorylated (Figure 1.2). Phosphorylation of
H3S10 and H3S28 by Aurora B kinase is associated with mitotic condensation
(Nowak and Corces, 2004). The same residues can be phosphorylated by MSK1/2
(mitogen- and stress-activated protein kinase 1 or 2) in an inducible manner during
interphase (Clayton and Mahadevan, 2003). Whilst phosphorylation of serine 10 is
known to occur at the immediate early genes (Clayton et al, 2000; Thomson et al,
2001), the location of the serine 28 modification is unknown, and this separation of
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targets is evident in the visibly distinct localisation of the modifications by
immunofluorescence (Dyson et al, 2005). The linker histone H1 is phosphorylated by
the cyclin dependent kinases (CDKs), and, like the phosphorylation of H3S10, this
modification is associated with chromosome condensation. Although the
phosphorylation of H1 during interphase is linked to chromatin relaxation, metaphase
chromosomes are hyperphosphorylated on histone H1, thus its exact role is still
uncertain (Contreras et al, 2003; Roque et al, 2008).
      Histone phosphorylation is also linked to the DNA double strand breaks (DSBs)
through a histone H2A variant called H2AX. The formation of DSBs triggers the
phosphorylation of H2AX at S139 in the proximity of the DSB, and this form of the
protein is known as _-H2AX. _-H2AX foci accumulate many proteins required for
DNA repair, and whilst not essential for repair to occur, cells without _-H2AX
cannot cope with DSBs as well as those with it (Thiriet and Hayes, 2005).
1.1.3.4. Histone Ubiquitylation and Sumoylation
      Unlike the other modification marks discussed so far, ubiquitylation involves the
addition of an entire protein entity to a lysine residue of a histone. Histones H2A and
H2B can be mono-ubiquitylated on lysines 119 and 120 respectively (Figure 1.2). On
H2A, the modification is catalysed by the murine polycomb proteins Ring1A and
Ring1B, members of the PRC1 complex. Following the tri-methylation of H3K27 by
the EZH2 component of PRC2, PRC1 binds to this mark and ubiquitylates histone
H2A (de Napoles et al, 2004; Wang et al, 2004a). H2AK119ub is therefore found at
transcriptionally silent chromatin. In humans, two enzymes, RNF20/hBRE1 and
UbcH6 work together to ubiquitylate H2B (Zhu et al, 2005). Although ubiquitylation
of histone H2B is generally associated with transcriptionally active regions,
knockdown of hBRE1 only affects the expression of a small number of genes
(Shema et al, 2008). Of those genes that were misregulated upon loss of hBRE1,
similar numbers were either up- or down-regulated, suggesting that H2B
ubiquitylation can function as either an active or repressive mark (Shema et al,
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2008). Like other modifications, ubiquitylation has been postulated to function as a
point of recruitment for other proteins, although due to its large size (at 76 amino
acids and 9kDa, it is almost as large as the histone proteins) it may be capable of
physically ‘wedging’ the chromatin open (Kouzarides, 2007).
      Sumoylation involves the modification of lysine residues by the addition of the
11kDa small ubiquitin-like modifier (SUMO) protein. After it was found that H4 can
be sumoylated in vitro in 293T mammalian cells (Shiio and Eisenman, 2003), it was
then shown that each of the core histone proteins can be sumoylated in
Saccharomyces cerevisiae (S. cer) (Nathan et al, 2006). Sumoylation of transcription
factors is relatively common, and is generally associated with repression (Stielow et
al, 2008); likewise, sumoylation of histones is believed to decrease transcription
levels (Shiio and Eisenman, 2003; Nathan et al, 2006).
1.1.3.5. Other Histone Modifications
      As well as those modifications outlined above, histones are the substrates of at
least three other marks. The linker histone H1 is the main recipient of the poly(ADP-
ribose) mark, the addition of which is catalysed by the poly(ADP-ribose)
polymerases (PARPs). There has been some indication that poly(ADP-ribosyl)ation
of H1 can relax chromatin structure, but this has yet to be proved in vivo (Ausió et al,
2001). Biotinylation of histones has been linked with gene silencing, cell
proliferation, DNA repair and apoptosis (Peters et al, 2002; Narang et al, 2004;
Kothapalli et al, 2005). Histones H3 and H4 are subjected to this modification, at
lysines 8 and 12 on H4 (Camporeale et al, 2004), and lysines 4, 9 and 18 on H3
(Kobza et al, 2005). Finally, carbonylation of histones has been shown to occur in
vitro and in vivo, and it appears that the linker histone H1 is the main target of this
modification (Wondrak et al, 2000).
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1.1.4. Histone Binding Proteins
      Whilst some histone modifications may directly affect the conformation of
chromatin, the link between a modification and its influence on transcription is often
not clear until the code has been interpreted by proteins that bind to specific
modifications and carry out further alterations to the chromatin. This indirect,
effector-mediated method appears to be the main link between histone modifications
and gene expression levels. Some of the important histone-binding domains are
outlined below, and in Table 1.1.
      The bromodomain of the HAT enzyme PCAF was the first histone-binding
domain to have its structure resolved, and was found to target acetylated lysine
residues (Dhalluin et al, 1999). For example, the bromodomain of the S. cerevisiae
homolog of PCAF, Gcn5p, binds H4K16ac (Owen et al, 2000). The largest subunit
of the transcription factor complex TFIID, TAFI (TBP-associated factor-1, formerly
known as TAFII250), encodes a double bromodomain at its C-terminal end, allowing
this protein to bind to two acetylated lysine residues simultaneously (Jacobsen et al,
2000), directly linking the acetylation of histones to transcription.
      The ‘Royal family’ contains proteins encoding motifs such as the chromo, Tudor
and MBT domains, each of which can bind to methylated lysine residues of histones.
One of the best characterised histone-binding proteins is heterochromatin protein 1
(HP1), of which there are three isoforms in mammals: HP1_, HP1_ and HP1_,
encoded by Cbx5, Cbx1 and Cbx3 in mouse respectively (Singh et al, 1991; Saunders
et al, 1993). The chromo (chromatin organisation modifier) domain of HP1 was
found to bind to H3K9me3 (Bannister et al, 2001; Lachner et al, 2001), whereas its
chromoshadow domain (not a member of the Royal family) facilitates HP1
dimerisation (Cowieson et al, 2000). The chromodomain of Polycomb (Pc), highly
similar to that of HP1, also binds to methylated lysines, and is selective for
H3K27me3, anchoring the PRC1 complex and allowing it to ubiquitylate H2A at the
same sites as H3K27me3 (Fischle et al, 2003). Another member of the ‘Royal’
family is the Tudor domain, two of which are found in JMJD2A. This motif allows
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Table 1.1. Histone binding domains. Table showing histone binding domains found in various
chromatin associated proteins, and the histone modifications that they bind to.
Domain Name Histone Modification Example Reference
Gcn5p Owen et al, 2000Bromodomain Acetyl-lysine
TAF1 Jacobsen et al, 2000
HP1 Bannister et al, 2001;
Lachner et al, 2001
Chromodomain Methyl-lysine
Polycomb Fischle et al, 2003
Tudor Methyl-lysine JMJD2A Huang et al, 2006;
Lee et al, 2008
BPTF Li et al, 2006;









Karras et al, 2005
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the interaction of JMJD2A with two distinct histone modifications, H3K4me3 and
H4K20me3 (Huang et al, 2006; Lee et al, 2008).
      H3K4me2 and H3K4me3 are bound by the plant homeodomain (PHD) finger
motif of two proteins, bromodomain plant homeodomain transcription factor (BPTF)
(Li et al, 2006; Wysocka et al, 2006) and inhibitor of growth 2 (ING2) (Peña et al,
2006). Finally, the macro domain, found in proteins such as the histone variant
macroH2A, and three PARPs (PARP9, PARP14 and PARP15) can bind to mono-
and poly(ADP-ribose), and it has been postulated that this domain can bind to
poly(ADP-ribosyl)ated histones (Karras et al, 2005).
      These examples show that, although it was originally thought that the
modification of histones provided a code by which the transcriptional state of a gene
could be ascertained, it now appears that it is instead the proteins that are bound to
the modifications that are required to effectively read the genome. The fact that the
same histone modifications can be bound by proteins with opposing effects on
transcription, that one nucleosome can be modified by marks that are linked to
differing expression statuses, and that an enzyme can bind to an active mark and
cause repression all suggest that the proteins that bind to histone modifications are
the determining factor as to the expression status of a sequence, and not the
modifications themselves.
1.1.5. DNA Methylation
      In addition to being packaged by histone proteins that are modified, the DNA
double helix is subjected to one major modification itself: the addition of a methyl
group at the fifth carbon of the cytosine residue in the context of CpG. In vertebrate
cells, DNA methylation is widespread: over 70% of CpG dinucleotides are
methylated (Meehan, 2003). DNA is methylated de novo by two methyltransferases,
Dnmt3a and Dnmt3b (Okano et al, 1999), and the pattern of methylation is
maintained following the synthesis of the new DNA strand by Dnmt1, thus DNA
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methylation is a heritable epigenetic mark. The vast majority of DNA methylation is
located at the constitutive heterochromatic regions of mammalian genomes: human
and mouse centromeres are composed of thousands of satellite repeat sequences,
which contain CpG dinucleotides that are heavily methylated. The majority of the
remaining CpG dinucleotides are found in the early replicating portions (R-bands) of
the genome (Craig and Bickmore, 1994), clustered into domains known as CpG
islands which are typically found within gene promoters (Bird et al, 1985). Most of
the CpG dinucleotides found as part of CpG islands are not methylated, even when
the genes they are associated with are transcripitionally silent (Meissner et al, 2008).
      DNA methylation can prevent efficient gene expression by blocking the
association of particular transcription factors with promoters or other binding sites.
Alternatively, as with histone modifications, methylated DNA may be bound by
proteins that exert a repressive effect on transcription. In mammals, four proteins
bearing the methyl binding domain (MBD) (MeCP2 (Meehan et al, 1989), MBD1,
MBD2 and MBD4 (Hendrich and Bird, 1998)) and three zinc finger proteins (Kaiso
(Prokhortchouk et al, 2001), ZBTB4 and ZBTB38 (Filion et al, 2006)) have been
shown to bind methylated DNA. Most of these proteins function as transcriptional
repressors, and it is thought that this is through their association with chromatin
remodelling complexes or histone modifying enzymes, such as the interactions
between MeCP2 and components of the Sin3 HDAC complex (Jones et al, 1998;
Nan et al, 1998), MBD1 and SETDB1 (Sarraf and Stancheva, 2004) and MBD2 and
the MeCP1 HDAC complex (Ng et al, 1999; Feng and Zhang, 2001). Although it has
yet to be proven definitively whether DNA methylation is the cause of, or occurs as a
result of histone modification, it is clear that the two modification processes are
intrinsically linked.
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1.2. Localisation of DNA Within the Nucleus
1.2.1. Organisation of Interphase Chromosomes
      At the nucleosomal level, we can see that the organisation of the genome is
highly regulated, with histone modifications, nucleosome remodellers and
chromatin-binding proteins combining to retain the open or closed nature of
euchromatin and heterochromatin, and to allow the expression of genes when
required. Looking at the genome as a whole within the nucleus, it is clear that the
actual physical localisation of genomic sequences is also regulated. In comparison
with their characteristics during metaphase, interphase chromosomes are relatively
decondensed, and cannot be distinguished by staining the DNA alone. It might have
been expected that the DNA of separate chromosomes is randomly dispersed in
interphase; however, visualising individual chromosomes with specific paints
revealed that chromosomes from humans and other vertebrates are relatively discrete
entities (Figure 1.3A and Figure 1.4). Vertebrate chromosomes were originally
thought to be completely separated by an interchromatin space, but recent work has
shown that chromosome territories actually intermingle at their peripheries (Branco
and Pombo, 2006). Moreover, analysis of the localisation of each chromosome
during interphase has shown that they have a conserved radial position, with gene
rich chromosomes in general being found at the centre of the nucleus, and gene poor
chromosomes lying towards the exterior (Croft et al, 1999; Sadoni et al, 1999; Boyle
et al, 2001; Bolzer et al, 2005) (Figure 1.3A). There also appears to be a correlation
between the radial localisation of a chromosome and its physical size in basepairs,
with small chromosomes lying more centrally, and larger chromosomes towards the
periphery in non-dividing cells (Sun et al, 2000; Bolzer et al, 2005). Inhibition of
transcription can affect both the amount of intermingling of chromosome territories




1.2.2. Relocalisation of Expressed Sequences: Looping Out
      The packaging of genes in three-dimensional space with respect to the
chromosome territory is altered in some circumstances. Housekeeping genes and
those expressed in a tissue-specific manner can be transcribed from the interior of a
chromosome territory (Mahy et al, 2002), and both active and inactive sequences are
found at the periphery of chromosome territories (Kurz et al, 1996). Despite this,
certain sequences leave their chromosome territory when expressed. For example,
the major histocompatibility complex (Volpi et al, 2000), the epidermal
differentiation complex (Williams et al, 2002) and the Hoxb locus (Chambeyron and
Bickmore, 2004) have all been demonstrated to loop out away from the main body of
the chromosome territory when transcribed, leading to the idea that they are relocated
to specialised sites containing factors required for their expression (see Figure 1.3B).
However, studies of the Hoxd locus have shown that looping out is neither necessary
nor sufficient for transcription. In ES cells and the mouse tail bud, the Hoxd locus
loops out, but in the limb bud, where genes from this locus are also activated,
decondensation and expression of the Hoxd locus is not accompanied by looping out
(Morey et al, 2007). Similarly, the looping out of a Hoxb1 transgene inserted into the
Hoxd locus is not sufficient to induce the transgene’s transcription (Morey et al,
2008). Positioning outside of the chromosomal territory does not necessarily affect
transcriptional status, either. The human _- and _-globin genes are located in regions
of contrasting gene density (_-globin in a gene-rich region, _-globin in a gene
desert). The _-globin locus often lies outside the HSA16 chromosome territory to
which it belongs, whereas the _-globin locus sits within its chromosome territory
(Mahy et al, 2002b; Brown et al, 2006), but both genes are expressed in the same
tissues, at the same rate (Brown et al, 2006). Therefore different factors affecting
localisation and expression may be at play in different tissues, and gene activation of
the same sequences may not always be accompanied by the same hallmarks.
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1.2.3. Transcription Factories
      Much research in the past few years has looked at where genes that are looping
out of their territories, or those that show a high level of expression, localise to.
Incorporation of the nucleotide analogue bromouridine (BrdU) into newly
synthesised RNA revealed that transcription appears to occur at specific foci
containing RNA polymerases and other factors, which are approximately 50nm in
diameter (Jackson et al, 1993; Iborra et al, 1996; Jackson et al, 1998). These foci are
dispersed evenly throughout the nucleus, except for the nucleolus and the very
periphery of the nucleus, agreeing with the finding that transcription can occur from
any part of a chromosome territory. Estimates of the numbers of transcription foci
are dependent on the cell type, but given that the values range from 1 200 (Brown et
al, 2008) to 8 000 (Iborra, 2002), and the fact that there could be 65 000 active RNA
polymerase II complexes present in the nucleus (Jackson et al, 1998), each focus
must contain at least 8 active polymerases on average. Therefore these foci were
named transcription factories, where multiple transcription units co-localise (Jackson
et al, 1993). Certain genes, for example the _- and _-globin genes in human
erythroblasts, show an increased frequency of co-localisation when co-expressed,
and it has been suggested that they are recruited to the same transcription factory
(Osborne et al, 2004). Contradictory work has indicated that active genes are instead
juxtaposed at nuclear speckles, and that this is dependent on the status of the
chromatin, i.e. the levels of decondensation and transcriptional activity, and its
interaction with other proteins (Brown et al, 2006; Brown et al, 2008). Nuclear
speckles are domains, approximately 0.5_m in diameter, rich in poly(A) RNA and
splicing factors (Spector, 1993), and have previously been found to be sites where
specific pairs of genes and genes on certain chromosomal bands co-localise
(Shopland et al, 2003; Moen et al, 2004). Association with speckles is not required
for transcription of these genes, as only a percentage of cells are found to do it, but it
may improve the rate of their expression.
      Globin genes have also provided much of the evidence that expressed genes
come into contact with enhancer sequences. Enhancers are generally highly
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conserved regions that can lie tens or hundreds of kilobases from a gene’s coding
sequence, which enhance transcription by coming into contact with the gene’s
promoter region. An enhancer element known as the locus control region (LCR) is
vital for high-level expression of the _-globin genes in mouse erythroid cells (Bender
et al, 2000). The LCR, situated 50kb away from the murine _-globin genes, comes
into physical contact with these genes to form an active chromatin hub (Bender et al,
2000; Tolhuis et al, 2002). Formation of the hub is tissue-specific (Palstra et al,
2003) and dependent upon certain transcription factors (Drissen et al, 2004; Vakoc et
al, 2005; Splinter et al, 2006). Further analysis of the LCR showed that this region
can also contact loci tens of megabases (Mb) away, and that the LCR in liver cells
(where the _-globin genes are expressed) associates with regions containing
transcriptionally active genes, whereas the LCR in brain cells (where the _-globin
locus is transcriptionally inactive) preferentially associates with silent genomic
regions (Simonis et al, 2006). A ubiquitously expressed gene on a different
chromosome, Rad23a, showed the same interactions in both liver and brain tissue,
and in both cases interacted with transcriptionally active loci (Simonis et al, 2006).
Although it appeared that the transcription status of the LCR was the determining
factor in the ‘choice’ of interactions that the LCR makes, transcription itself is not
required for the maintenance of these interactions (Palstra et al, 2008). This suggests
that the associations that a particular locus makes are instead dependent on the
factors bound to the interacting sequences. Certain loci appear to have a preferential
set of interactions with other regions of the genome, thus the folding of a
chromosome does not seem to be a completely random process, but one which
preserves the interactions that specific loci make.
1.2.4. Sites of Transcriptional Repression Within the Nucleus
      The constitutive heterochromatin of mammalian cells, composed of the tandemly
repeated satellite repeats, forms highly condensed structures. These AT-rich
structures are visible in mouse nuclei upon staining with 4',6-diamidino-2-
phenylindole (DAPI). The DAPI bright spots are also rich in H3K9me3 and certain
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isoforms of HP1. HP1_ is found to be highly enriched at the DAPI bright spots,
whereas HP1_ localises to both the constitutive heterochromatin and the
euchromatin, and HP1_ is primarily found at euchromatic regions (Horsley et al,
1996; Minc et al, 1999; Minc et al, 2000; Minc et al, 2001). Genes that are
physically associated with the heterochromatic bright spots are often transcriptionally
inactivated. The Ikaros protein, which is expressed in haematopoietic cells, is found
to localise to the pericentromeric heterochromatin in some lymphocyte cell lines
(Figure 1.3C-D; Brown et al, 1997; Brown et al, 1999) and to recruit genes that are
transcriptionally repressed, such as TdT and Rag (Brown et al, 1999) to these nuclear
sites (Cobb et al, 2000) (Figure 1.3E-H). The human _-globin gene is also observed
at the centromeric heterochromatin when silenced, but loses this association in cells
where it is transcriptionally active (Brown et al, 2001). Interestingly, the _-globin
locus in the same cells is never found at the centromeric heterochromatin (Brown et
al, 2001), which most likely reflects its chromosomal positioning within a cluster of
ubiquitiously expressed housekeeping genes, whose silencing would be detrimental
to the cell.
      Heterochromatin is also found at the very edge of the nucleus underlying the
nuclear membrane, and attached to the matrix surrounding the nucleolus (Figure 1.4;
reviewed in Comings, 1980). The interior surface of the nuclear periphery is made up
of a family of intermediate filament proteins called the lamins, which form a
complex called the nuclear lamina. The inner nuclear membrane (INM) is also
decorated with specific proteins. Lamins and INM proteins can bind DNA and
histones in vitro (Luderus et al, 1992; Taniura et al, 1995), and this area of the
nucleus has therefore been postulated to have a role in chromatin organisation and
gene regulation. DNA associated with lamin B1 at the nuclear periphery is enriched
in gene deserts, is predominantly transcriptionally silent, deficient for methylated
H3K4 and RNA polymerase II, and enriched in methylated H3K27 and H3K9
(Guelen et al, 2008). Proteins at the nuclear periphery are also known to interact with
repressive proteins and complexes such as HP1, N-CoR and HDACs (Kourmouli et
al, 2000; Somech et al, 2005; Holaska and Wilson, 2007). Consistent with this, some
genes localise to the edge of the nucleus when repressed. During B-lymphocyte
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development, the immunoglobulin (Ig) loci are subject to rearrangement and
transcription to form and express different Ig proteins. Murine IgH and Ig_ loci are
situated at the nuclear periphery as a default in most cell types; however, in pro-B
lymphocyte cells, these loci become positioned towards the nuclear interior prior to
their transcription, suggesting that their retention at the periphery keeps them in a
repressed state (Kosak et al, 2002). Two separate studies, analysing the human CFTR
locus (Zink et al, 2004) and the mouse Mash1 gene (Williams et al, 2006), found that
when repressed, these genes localise to the nuclear periphery, but that in an
expressed state, they move towards the interior of the nucleus (Zink et al, 2004).
However, as with looping out upon gene activation, localisation to the nuclear
periphery does not ensure transcriptional silencing of a DNA sequence. The
interferon-_ (IFN-_) gene, which is upregulated upon the differentiation of CD4 T
cells, remains at the nuclear periphery in the majority of cells tested regardless of its
transcriptional activity (Hewitt et al, 2004).
      The link between localisation to the nuclear periphery and transcriptional
repression has recently been tested more rigorously by three independent studies that
used the same tactic of artificially tethering genes to the nuclear periphery in
mammalian cells and analysing their subsequent expression (Finlan et al, 2008;
Kumaran and Spector, 2008; Reddy et al, 2008). Finlan et al showed that
transcription of an integrated reporter gene was decreased when tethered to LAP2_,
an INM protein. In the regions of chromosomes 4 and 11 surrounding the reporter,
some endogenous genes were subjected to downregulation, but many genes were
also unaffected by their relocalisation (Finlan et al, 2008). Kumaran and Spector
found that reporter gene expression was still possible upon recruitment to the
periphery in the majority of cells tested, although compared to control cells with an
untethered reporter, the number of alleles being actively transcribed was decreased
(Kumaran and Spector, 2008). Reddy et al reported that transcription of their reporter
was significantly repressed upon association with the nuclear periphery (Reddy et al,
2008). It therefore appears that localisation to the nuclear periphery is not a
generalised method of silencing, and the lamina does not provide an entirely
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transcription-free environment, although certain genes are repressed when localised
there.
1.2.5. Other Domains of the Nucleus: PML Bodies
       The nucleus is home to many other protein structures that are important for
different aspects of gene expression and the cell cycle (Figure 1.4). One such
structure is the promyelocytic leukaemia nuclear body, or PML-NB. PML (also
known as tripartite motif protein 19, or Trim19) was first identified as being
associated with acute promyelocytic leukaemia (APL) (de Thé et al, 1991). A
specific translocation between human chromosomes 15 and 17 fuses PML with the
retinoic acid receptor _ (RAR_) locus, preventing promyelocyte differentiation and
causing APL (de Thé et al, 1991). PML is a member of the tripartite motif protein
family, containing an N-terminal RING, B-boxes and coiled-coil (RBCC) domain or
tripartite motif (Figure 1.5). In the middle of the protein lies a nuclear localisation
signal (NLS), and the C-terminus harbours an exonuclease domain (Salomoni et al,
2008). There are at least seven different splice variants of the PML gene, each of
which creates a different PML isoform through variation in the length of the C-
terminal end of the protein (Salomoni et al, 2008). Each isoform contains the RBCC
domain and NLS, but only PML-I contains the exonuclease motif (Figure 1.5).
Despite their differing characteristics and functions, these variants will be hereafter
collectively referred to as PML. In the nucleus, PML is found as part of the large,
matrix-associated domains named PML-NBs, nuclear domain 10 (ND10), Kremer
(Kr) bodies or PML oncogenic domains (PODs) (Figure 1.4). The average number of
PML-NBs per cell is 10 (hence the original name, ND10 (Ascoli and Maul, 1991)),
but there can be between 5 and 30 PML bodies in the nucleus, which appears to be
cell type- and cell cycle-dependent (Dellaire and Bazett-Jones, 2004). Mutation of
each portion of the tripartite motif of PML can affect NB formation. Altering amino
acids of the RING domain increases the size, and reduces the number, of PML-NBs
in mouse cells (Boddy et al, 1997), whereas mutation of the B-box domains prevents
PML-NB formation (Borden et al, 1996).
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      PML-NBs are highly dynamic in structure and composition. They are typically
0.3-1.0_m in diameter (Ascoli and Maul, 1991; Dellaire and Bazett-Jones, 2004) and
either spherical or ring-shaped (Boisvert et al, 2000; Lallemand-Breitenbach et al,
2001; Eskiw et al, 2003). PML-NBs do not appear to have any nucleic acid at the
core of their structure (Boisvert et al, 2000), but associate with sites of transcription
(Kießlich et al, 2002), heterochromatin (Seeler et al, 1998; Luciani et al, 2006),
centromeres (Everett et al, 1999), telomeres (Yeager et al, 1999) and damaged DNA
(Xu et al, 2003; Boe et al, 2006; Dellaire et al, 2006). Through its interaction with
SATB1 (special AT-rich sequence binding protein 1), PML has been shown to
organise the higher-order chromatin structure of the major histocompatibilty complex
(MHC) class I locus, and can thus regulate the expression of the genes encoded at
this locus (Kumar et al, 2007). As well as SATB1 and other proteins involved in
gene regulation, PML-NBs contain proteins that belong to various cellular pathways,
including DNA repair, antiviral response, apoptosis and tumour suppression (Dellaire
and Bazett-Jones, 2004). Because of the diverse mixture of proteins located there,
PML bodies have been suggested to be either storage depots for nuclear proteins
(Maul et al, 2000; Negorev et al, 2001), sites allowing the post-translational
modification of proteins (D’Orazi et al, 2002), or hubs where particular events occur,
for example DNA replication or repair (Dellaire and Bazett-Jones, 2004). However,
knockout of PML is not lethal: PML-/- mice have a normal appearance, but are
deficient in their apoptotic response to DNA damage (Wang et al, 2004b).
      Whatever their exact function, it is clear that PML-NBs are intrinsically linked to
post-translational modification by SUMO. PML was one of the first proteins
identified to be modified in this manner (Boddy et al, 1996), and while sumoylation
of PML was found to be non-essential for the formation of PML-NBs, it is required
for the accumulation of other nuclear factors such as Sp100 and Daxx at PML-NBs
(Zhong et al, 2000). PML encodes a SUMO-interacting motif (SIM), which can bind
to other SUMO-modified PML moieties, and it is believed that this is how orderly
PML-NB structures are formed (Shen et al, 2006). Other proteins often present at
PML-NBs, for example Daxx, are also modified by SUMO. Like PML, Daxx too
encodes a SIM. While the localisation of Daxx to PML-NBs is independent of its
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sumoylation, a functional SIM is required for its recruitment to these sites (Lin et al,
2006).
      The formation of PML-NBs requires the presence of wild-type PML (Ishov et al,
1999). In APL patients, PML-NBs are either disrupted or dispersed (Dyck et al,
1994). Treatment of APL patients with either retinoic acid (RA) or arsenic oxide
(As2O3) can cause the destruction of the PML-RAR_ fusion protein, leading to the
differentiation and apoptosis of cells affected by APL and remission of the disease
(Zhu et al, 2002). Upon treatment of cells with As2O3, PML is targeted for
polysumoylation. Poly-sumoylated PML is then poly-ubiquitinated by the ubiquitin
E3 ligase RNF4, and the protein (either native PML in tissue culture cells or PML-
RAR_ in APL patients) is destroyed by the proteasome, again sending some APL
patients into remission (Lallemand-Breitenbach et al, 2008; Tatham et al, 2008).
      As well as their association with APL, PML bodies can be linked to cancer
through their role in the alternative lengthening of telomeres (ALT) pathway. This
occurs in cancerous cells that retain their telomere length by homologous
recombination (HR) to increase their proliferative capacity. Telomeres in these cells
are recruited to the PML-NBs, forming ALT-associated PML-NBs (APBs) (Yeager
et al, 1999). APB formation and telomeric HR depends on the structural maintenance
of chromosomes 5/6 (SMC5/6) complex, which harbours SUMO ligase activity
through its MMS21 subunit (Potts and Yu, 2007). MMS21-mediated sumoylation of
the shelterin complex, which normally protects the telomeres from homologous
recombination, is required for the recruitment of telomeres to APBs, again
highlighting the association of PML-NBs and sumoylation.
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1.3. KAP-1 and the KRAB Zinc Finger Family of Transcriptional
Repressors
1.3.1. KAP-1 and Transcriptional Repression
      Mammals encode 37 other tripartite motif proteins in addition to PML. One of
the most studied of these is KAP-1 (KRAB-associated protein-1), also known as
Trim28, Tif1_ (transcription intermediary factor 1_) or KRIP-1 (KRAB-interacting
protein-1). As well as the RBCC domain, KAP-1 encodes a PHD and a
bromodomain at its C-terminus (Figure 1.5). Three related proteins are known with
this structure: Tif1_ (aka Trim24), Tif1_ (Trim33) and Tif1_ (Trim66). When
tethered to a reporter gene, all four of these proteins can cause transcriptional
repression (Friedman et al, 1996; Kim et al, 1996; Le Douarin et al, 1996;
Moosmann et al, 1996; Venturini et al, 1999; Khetchoumian et al, 2004); however
the sequence identity between these proteins is not high, at between 30 and 50%
(Khetchoumian et al, 2004). Tif1_ is tightly associated with chromatin, is expressed
early in mouse development, where it has been implicated in the control of the first
wave of transcriptional activation (Remboutsika et al, 1999; Torres-Padilla and
Zernika-Goetz, 2006), and is also expressed in adult tissues (Le Douarin et al, 1995).
Tif1_ (KAP-1) is expressed ubiquitously throughout development (Cammas et al,
2000) and in adult tissues (Kim et al, 1996). Knockout of KAP-1 results in the
termination of development prior to gastrulation (Cammas et al, 2000),
demonstrating the essential nature of this protein. Tif1_ is also expressed in both
embryonic and adult tissues (Venturini et al, 1999; Yan et al, 2004), whereas Tif1_’s
expression is limited to the testis (Khetchoumian et al, 2004). Tif1-_, -_ and -_ can
all homodimerise; Tif1_ and Tif1_ can also heterodimerise in vitro (Peng et al, 2002;
Germain-Desprez et al, 2003).
      KAP-1 was independently identified by three groups as the co-repressor of a
family of proteins called the Krüppel-associated box (KRAB) zinc finger proteins
(Friedman et al, 1996; Kim et al, 1996; Moosmann et al, 1996). These proteins
encode a KRAB domain at their N-terminus, and most also have multiple zinc finger
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motifs at their C-terminal end. The KRAB zinc finger proteins are not capable of
repressing transcription themselves, but are believed to bind to specific gene targets
through their zinc fingers and exert a repressive effect through the recruitment of
KAP-1 by the KRAB domain. This interaction occurs through the RBCC domain of
KAP-1, which is also responsible for KAP-1 oligomerisation (Figure 1.6; Peng et al,
2000). Different portions of this N-terminal region have been implicated in the
KRAB-KAP-1 interaction; it remains unclear whether it is the entire RBCC domain
(Peng et al, 2000), the RING domain and B-boxes (Friedman et al, 1996) or the B-
boxes and coiled coil domains (Moosmann et al, 1996; Agata et al, 1999) that are
vital. The RING finger co-ordinates two zinc ions, producing a ‘cross-brace’ motif
unique to this domain (Meroni and Diez-Roux, 2005). Many E3 ubiquitin ligases,
which catalyse the transfer of a ubiquitin moiety from an E2 ligase to a substrate
protein (or commonly to itself) contain a RING domain, and the RING sequence has
been shown to be critical in this reaction (Joazeiro and Weissman, 2000). Thus any
proteins that contain a RING domain may have E3 ligase activity. The ~40 amino
acid B-boxes encoded in KAP-1 are known as B-box 1 and B-box 2. Like the RING
domain, they are thought to bind zinc (Borden et al, 1995), but no specific function
has been assigned to these structures. The coiled-coil region stretches over 126
amino acids, and is involved in KAP-1 homo-interaction (Reymond et al, 2001).
      KAP-1 causes transcriptional silencing through the proteins it interacts with. One
of the first studies to identify KAP-1 did so as a result of its ability to bind to HP1 in
a yeast two-hybrid assay (Le Douarin et al, 1996). Further experimentation showed
that this interaction occurred through the central portion of KAP-1, from amino acids
483-510, and that a KRAB domain, the DNA it is bound to, KAP-1 and HP1 could
form a quaternary complex in vitro (Figure 1.5 and Figure 1.6; Ryan et al, 1999). It
was later revealed that this section of the protein harbours an HP1-binding motif with
the sequence PRVSL, adhering to the consensus of PxVxL (Smothers and Henikoff,
2000) which binds to the HP1 chromoshadow domain (Lechner et al, 2000) (Figure
1.6). Loss of the interaction between HP1 and KAP-1 leads to a reduction in the
KRAB-KAP-1 mediated repression of both transfected and chromatinised reporter
genes (Ryan et al, 1999; Sripathy et al, 2006). In undifferentiated cell lines, KAP-1
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is diffuse throughout the nucleus, and excluded from the nucleolus. Upon
differentiation of F9 embryonic carcinoma (EC) or ES cells, however, the protein
often relocalises to the centromeric heterochromatin, showing a similar distribution
pattern to HP1_ (Cammas et al, 2002; Cammas et al, 2004). By mutating the PxVxL
consensus sequence, it was shown that the binding of KAP-1 to HP1 is required for
the protein’s relocalisation, and that this interaction is actually essential for cell
differentiation (Cammas et al, 2002; Cammas et al, 2004).
      At the carboxy terminus of KAP-1 are a PHD finger and a bromodomain. As well
as being able to bind to histones, PHD and bromodomains can bind to non-histone
chromatin proteins, for example the PHD and bromodomain of NoRC, which
interacts with HDAC1, SNF2 and two DNA methyltransferases (Zhou and Grummt,
2005). The bromodomain of Tif1_ interacts directly with nucleosomes in vitro
(Remboutsika et al, 2002); however, this property has not been shown for KAP-1 to
date. Examination of the role of the C-terminal region of KAP-1 revealed that the
PHD and bromodomain can function as transcriptional repressors when tethered to
DNA, and that the two domains in concert bind to the chromatin modifying proteins
Mi-2_ (Schultz et al, 2001) and SETDB1 (Schultz et al, 2002) (Figure 1.5 and Figure
1.6). Mi-2_ is a component of the NuRD HDAC and chromatin remodelling
complex, which is most commonly linked to transcriptional repression (Denslow and
Wade, 2007). The association of the KRAB-KAP-1 machinery with this complex
explains why treatment of cells with trichostatin A, a HDAC inhibitor, reduces KAP-
1’s repressive ability (Nielsen et al, 1999; Schultz et al, 2001). SETDB1 encodes an
MBD and a bifurcated SET domain, and is known to specifically methylate histone
H3K9 (Schultz et al, 2002).
1.3.2. Evolution of KRAB Zinc Finger Proteins
      When first identified, the 75 amino acid KRAB domain was estimated to be
present in approximately one third of all human proteins encoding Krüppel-type zinc
fingers, making it one of the largest known protein families (Bellefroid et al, 1991).
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Despite being present in ~400 human proteins (Huntley et al, 2006) and a similar
number in mouse, the KRAB domain is restricted to the vertebrate tetrapods, with a
decreased number (six) in Xenopus laevis (the most studied of these being Xfin (Ruiz
i Altaba et al, 1987; Bellefroid et al, 1991)) and 41 KRAB proteins predicted in
chicken (http://smart.embl-heidelberg.de/). This suggests that the KRAB zinc finger
proteins have undergone a relatively recent, and extremely large, evolutionary
expansion within the mammals. As might be expected from a gene family that has
recently expanded, half of the human and mouse KRAB zinc finger proteins are
found in large clusters: 11 major clusters in the human genome are home to 200
KRAB zinc finger protein loci (Shannon et al, 2003). The human ZNF91 subfamily
is one of the subgroups of the KRAB zinc finger proteins. (Human KRAB zinc finger
proteins are denoted by the three-letter acronym ZNF; murine KRAB zinc finger
proteins are denoted by Zfp). These genes can be found in two major clusters, with
49 genes on HSA19 and 27 on either side of the centromere of HSA7 (Hamilton et
al, 2006). These genes initially began duplicating approximately 40 million years
ago, have seeded new clusters on other chromosomes due to genomic
rearrangements, and have continued to expand, giving rise to a number of lineage-
specific genes (Hamilton et al, 2006). The other half of the KRAB zinc finger
proteins do not belong to gene clusters, and are thought to be less functionally
redundant than their clustered counterparts. Despite their abundance in the
mammalian genome, however, remarkably little is known about the role of the
KRAB zinc finger proteins.
      Although many KRAB zinc finger proteins are conserved between species, there
has been gain, loss and modification of KRAB zinc finger protein genes since the
generation of their clusters. For example, the same KRAB zinc finger protein cluster
was analysed in human and mice on HSA19q13.2 and MMU7, encoding 21 and 10
genes respectively (Shannon et al, 2003) (Figure 1.7). Three genes were identified
which were conserved in a 1:1 manner. One mouse gene had given rise to ten human
genes, and one human gene had six mouse counterparts, suggesting selective
pressure has lead to the retention and modification of some sequences and the loss of
others (Shannon et al, 2003). Many of the KRAB zinc finger protein genes at these
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large loci have evolved to a greater degree in the sequences encoding their zinc
finger domain compared to the KRAB domain. This will have affected the DNA
sequences to which they can bind, but not the mechanism by which they cause
transcriptional repression. Thus, although there are a great number of KRAB zinc
finger proteins, the degree of redundancy between them may be limited, as they have
separate gene targets. Therefore, as it appears that different species have a slightly
different collection of KRAB zinc finger protein genes, they might be of importance
in the emergence of species-specific gene expression, and the evolution of each
species as it is today.
      Whilst high numbers of KRAB zinc finger proteins are restricted to mammals,
other lineages appear to have undergone large-scale expansion of particular zinc
finger proteins. Drosophila, like humans, encode many C2H2 zinc finger proteins,
believed to be between 234 (Venter et al, 2001) and 352 (Rubin et al, 2000). 89 of
these proteins contain a ~70 amino acid N-terminal domain, termed the zinc finger-
associated C4DM domain, or ZAD (Lander et al, 2001; Chung et al, 2002; Lespinet
et al, 2002). Analysis of other insect, non-insect invertebrate and vertebrate genomes
showed that these ZAD-associated zinc finger proteins are restricted to five insect
species: Drosophila melanogaster, Anopheles gambiae, Aedes aegyptii, A p i s
mellifera (honey bee) and Bombyx mori (silk moth). Three mutant ZAD alleles have
been identified in Drosophila: deformed wing/zeste-white5 (dwg/zw5) (Fahmy and
Fahmy, 1959), grauzone (Schupbach and Wieschaus, 1989) and Serendipity _ (Payre
et al, 1990), and studies on the encoding proteins have suggested that they are
involved in the regulation of transcription. Like the KRAB zinc finger proteins,
ZAD-associated zinc finger proteins are not evenly dispersed throughout the genome,
with 41 genes being present in clusters. The majority of the ZAD proteins are
expressed, inferring that they have retained some function (Chung et al, 2002).
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1.3.3. Structure of KRAB Zinc Finger Proteins
      The KRAB domain was initially shown to act as a potent transcriptional
repressor when targeted to reporter gene promoters (Witzgall et al, 1993; Margolin et
al, 1994; Pengue et al, 1994). This repression was still observed when the KRAB
domain was bound 700bp upstream of the promoter sequence (Pengue et al, 1994).
The KRAB motif is always situated at the amino terminus of a protein. There are
four sub-types of KRAB domain, depending on which of four subdomains are
present (Figure 1.8). All KRAB domains contain a KRAB-A box. This can be paired
with a KRAB-B (Bellefroid et al, 1991) or KRAB-b box (Mark et al, 1999), or with
the more recently discovered KRAB-C subunit (Looman et al, 2004). Alternatively,
some KRAB zinc finger proteins only encode the KRAB-A domain. Each of the
KRAB subdomains is encoded by a separate exon, and alternative splicing may lead
to the removal of the KRAB-B, –b or -C boxes from the protein, increasing the
number of distinct KRAB zinc finger proteins that can be expressed (Bellefroid et al,
1993). For most KRAB zinc finger proteins, the entire zinc finger domain is encoded
by one exon, which, given that the domain may contain 30 zinc finger motifs
spanning over one kilobase, is highly unusual, and may suggest that this part of the
KRAB zinc finger protein genes evolved through retroposition.
      The KRAB-A and KRAB-B motifs both reduce transcription levels, and it has
been suggested that the KRAB-B subdomain has a stronger repression activity than
the KRAB-A domain (Vissing et al, 1995), despite the KRAB-A box being the only
indispensable portion of the KRAB motif (Margolin et al, 1994). The presence of the
highly divergent KRAB-b subdomain does not appear to enhance the overall
repression activity of the KRAB domain (Abrink et al, 2001). While the exact
functions of the KRAB-B and KRAB-b subdomains are unknown, the mechanism of
transcription repression has been determined for the KRAB-A motif: it is this domain
that binds to KAP-1 (Friedman et al, 1996; Kim et al, 1996; Moosmann et al, 1996).
The KRAB-C subdomain enhances the interaction between the KRAB domain and
KAP-1, but this apparently does not increase the KRAB zinc finger protein’s ability
to repress transcription (Abrink et al, 2001; Looman et al, 2004). In addition, KRAB
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zinc finger proteins occasionally contain a leucine-rich (LeR), or SCAN (SRE-ZBP,
CTfin51, AW-1 and Number 18 cDNA) domain (Figure 1.8). This ~90 amino acid
structure is normally located beside the KRAB domain, and allows homo- and
hetero-dimerisation with other SCAN domain-containing proteins (Honer et al,
2001).
1.3.4. Mechanism of KRAB Zinc Finger Protein-Mediated Repression
      The mechanism by which KRAB zinc finger proteins cause transcriptional
repression is outlined in Figure 1.6. The KRAB zinc finger protein is thought to bind
to its target through an unspecified number of zinc finger motifs. This may not
require the full complement of zinc fingers, given the large numbers of motifs in
some proteins, and the fact that each zinc finger can bind to 3 nucleotides. The
KRAB domain interacts with the KAP-1 co-repressor, which acts as a scaffold
protein: it can recruit the NuRD HDAC and chromatin remodelling complex, the
SETDB1 HMTase, or HP1 proteins. These proteins can cause the
heterochromatinisation of the gene target (Sripathy et al, 2006), and can bring in
factors such as DNA methyltransferases and histone modifying enzymes which could
maintain a heterochromatic state at the target locus, keeping it stably repressed.
      It is unknown whether KRAB zinc finger proteins cause heterochromatinisation
of their targets in situ in the cell, or whether they are relocated to a repressive
environment within the nucleus to cause gene silencing, for example to the
heterochromatin or the nuclear periphery. In support of the idea that KAP-1-
mediated repression may occur at sites of constitutive heterochromatin, it has been
reported that two KRAB zinc finger proteins, KRAZ1 and KRAZ2, co-localise with
HP1_ at the pericentromeric heterochromatin, and that this interaction is dependent
on the binding of the KRAB zinc finger proteins to KAP-1 (Matsuda et al, 2001).
KAP-1 also appears to concentrate at the constitutive heterochromatin during
differentiation (Cammas et al, 2002), and the tethering of a KRAB-KAP-1 complex
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to a reporter plasmid can cause its relocalisation to the DAPI bright spots
(Ayyanathan et al, 2003).
      Evidence against the localisation of KRAB zinc finger protein targets to
heterochromatin comes from the fact that SETDB1 predominantly localises to the
euchromatic regions of the nucleus, and colocalises with HP1 at non-pericentromeric
regions of chromatin (Schultz et al, 2002). It was also demonstrated that Mi-2_ can
be recruited to a euchromatic gene through its interaction with KAP-1, and thus it
was proposed that KAP-1 initiates the formation of a heterochromatin scaffold
around the gene, rather than taking the gene to a pre-formed repressive complex
(Schultz et al, 2001). KAP-1 localises to both heterochromatic and euchromatic
regions of the nucleus, which does not aid in deciphering how and where it functions
in KRAB-mediated silencing.
1.3.5. Post-Translational Modification of KAP-1 and KRAB Zinc Finger
Proteins
      KAP-1 is subjected to various post-translational modifications, which are
believed to alter its function (Figure 1.5). Firstly, as has been found for many
transcription factors, KAP-1 can be modified by SUMO. Out of 42 lysines present, 6
are targets for sumoylation, all of which lie in and around the PHD and
bromodomains in the protein’s carboxy terminus (Lee et al, 2007b; Mascle et al,
2007) (Figure 1.5). Three of these sites, K554, K779 and K804, are the major
recipient of the mark, and the three other lysines, at positions 575, 676 and 750, are
not modified in vivo to the same degree (Lee et al, 2007b; Mascle et al, 2007).
Prevention of sumoylation leads to a loss of KAP-1-mediated transcriptional
repression at the KRAB zinc finger protein ZBRK1 target gene p21, which is
accompanied by an increase in lysine acetylation and a decrease in H3K9
methylation at this sequence (Lee et al, 2007b). Oligomerisation was also shown to
be important for KAP-1 sumoylation, as the removal of the RBCC domain, which
co-ordinates KAP-1-KAP-1 interactions, reduces the sumoylation of the protein, but
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replacing this domain with another capable of self-interaction restores KAP-1
modification (Mascle et al, 2007). Following these two reports, it was shown that
KAP-1’s PHD-finger (which shows strong similarity to a RING domain) and
bromodomain are required for KAP-1 sumoylation, and in fact bind to the SUMO E2
ligase Ubc9, directing modification to KAP-1’s bromodomain, thus acting as the
protein’s E3 ligase (Ivanov et al, 2007, Zeng et al, 2008). Sumoylation of KAP-1
was also shown to be critical for KRAB-mediated repression, as SETDB1 and Mi-2_
bind to the sumoylated form of the protein in vivo (Ivanov et al, 2007).
      One paper that has surveyed the sumoylation of human proteins in tissue culture
cells has suggested that the KRAB zinc finger proteins may also be sumoylated in
vivo. Vertegaal et al isolated proteins that had been modified by exogenously
expressed His6-tagged-SUMO-1 or -SUMO-2, and identified the sumoylated proteins
by mass spectrometry (Vertegaal et al, 2006). Of the 25 SUMO-1 targets, 14
encoded zinc finger motifs, and two of these proteins were in fact KRAB zinc finger
proteins (retinoblastoma (RB)-associated KRAB repressor (RBAK) and ZNF317).
KAP-1 was not identified in this screen. Given its close association with the SUMO
ligase KAP-1, it is tempting to speculate that KRAB zinc finger protein sumoylation
may also play a part in KRAB-mediated transcriptional repression.
      KAP-1 is also phosphorylated at two points within its structure, on serines 473
and 824 (Figure 1.5). Phosphorylation of S824 occurs after UV-irradiation of cells or
induction of DSBs, and is dependent on the ataxia-telangiectasia mutated (ATM)
protein kinase (White et al, 2006; Ziv et al, 2006). The chromatin of cells treated to
induce DSBs is decondensed, an effect that is exacerbated when wild-type KAP-1 is
swapped for a phosphorylation mimetic S824D isoform. This suggested that KAP-1
is involved in global chromatin condensation, which is over-ridden by S824
phosphorylation to allow the relaxation of the chromatin (Ziv et al, 2006). KAP-1
phosphorylation at this amino acid, and the protein’s sumoylation, have been shown
to have a negative effect on each other, whereby sumoylation leads to a decrease in
phosphorylation of KAP-1, and vice versa, and active removal of SUMO leads to an
increase in phosphorylated KAP-1 levels (Li et al, 2007). If KAP-1-mediated
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chromatin decondensation plays an important part in the DSB repair pathway, this
phosphorylation mark would allow the conversion of KAP-1 involved in KRAB-
mediated gene silencing to the DSB repair isoform without having to remove the
protein from the cell.
      KAP-1 that is phosphorylated on S473 seems to be present during S and M
phases of the cell cycle (Chang et al, 2008). This modification is carried out by
member of the protein kinase C (PKC) pathway. A S473A mutation, which cannot be
phosphorylated, generates a KAP-1 protein that can interact more robustly with HP1,
and so it has been postulated that this modification may regulate gene repression
carried out by KAP-1 by altering its binding relationship with the heterochromatin
proteins (Chang et al, 2008).
1.3.6. Regulation of KRAB Zinc Finger Protein Genes by KAP-1 and HP1
      Two recent studies have suggested that some of the major targets of KRAB zinc
finger proteins and KAP-1 are the genes encoding the KRAB zinc finger proteins
themselves. Using ChIP on chip, O’Geen et al looked for the location of KAP-1
binding within the human genome (O’Geen et al, 2007). By high resolution mapping,
the group found that KAP-1 binding sites are enriched for zinc finger transcription
factors, and in particular, the KRAB zinc finger protein genes: 212 of the 355 genes
were in the list of KAP-1 targets in Ntera2 cells. The length of DNA sequence bound
by KAP-1 moieties was 820bp on average, and these sites were concentrated at the 3’
ends of the KRAB zinc finger protein genes. Interestingly, this report correlated with
another paper, which used the DamID method to map where in the genome HP1_
localises to. HP1_ is also found at the KRAB zinc finger protein genes, and, like
KAP-1, was enriched towards the 3’ end of the coding sequence, and absent from the
5’ end (Vogel et al, 2006). HP1_ was found in 20 large domains of up to 4Mb,
thousands of times the size of the KAP-1 domains. The majority of the HP1 binding
sites coincided with the KRAB zinc finger protein gene clusters. Using the
mechanism outlined above, it would appear that KAP-1 binds to the zinc finger gene
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clusters, recruits HP1 and the HMTase SETDB1, causing the methylation of H3K9.
This would allow the binding of more HP1 moieties, which could in turn facilitate
the spreading of H3K9me3 and HP1 to regions outwith that of KAP-1 binding.
      These papers suggested two reasons for why the KRAB zinc finger protein genes
are themselves subjected to KAP-1/HP1-mediated heterochromatinisation. Firstly,
Vogel et al argued that HP1 binding and the subsequent condensed chromatin
structure protected the KRAB zinc finger protein genes from HR-driven gene
removal, therefore these gene clusters were allowed to flourish where they might
have otherwise been removed (Vogel et al, 2006). O’Geen et al analysed the
expression of the KRAB zinc finger protein genes, and saw that those bound by
KAP-1 were reduced in their expression when compared to all other genes (O’Geen
et al, 2007). Additionally, they reported that an unspecified number of KRAB zinc
finger protein genes were expressed at a high level in Ntera2 cells. Using this
evidence, they put forward the idea that the KRAB zinc finger protein genes may be
regulated by the KRAB-KAP-1 mechanism. They argued that certain KRAB zinc
finger proteins are expressed in particular cell lines, tissues or developmental stages
to control the transcription of the remaining KRAB genes. Because little is known
about the targets of the KRAB zinc finger proteins, we are unable at this point to
ascertain whether proteins with similar functions are released from KRAB-mediated
transcriptional repression and expressed simultaneously, although it is easy to
imagine that this might be the case.
1.3.7. Gene Targets of KRAB Zinc Finger Proteins
      Bona fide gene targets of KRAB zinc finger proteins have not been forthcoming.
Most of the work that has shown that KRAB zinc finger proteins and KAP-1
function as transcriptional repressors has measured the expression of reporter genes
rather than an endogenous target sequence. The first genuine targets of KRAB zinc
finger proteins to be identified were the major urinary protein (Mup) genes (Johnson
et al, 1995); Cyp2d9, a cytochrome P450 gene (Sueyoshi et al, 1999); and the gene
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encoding sex-limited protein (Slp) (Georgatsou et al, 1993; Tullis et al, 2003), which
are all typically only expressed in male mice. The activity that represses these genes
in female mice (Regulator of sex-limitation, or Rsl) localises to mouse chromosome
13 (Jiang et al, 1996), and was mapped to a 23-gene cluster encoding KRAB zinc
finger proteins (Krebs et al, 2003). Two of the genes from this cluster, renamed Rsl1
and Rsl2, are required for repression of the male-specific genes in females. The
restoration of function of these proteins in mice mutant for both Rsl1 and Rsl2
showed that Rsl1 represses Slp and Cyp2d9, whereas Rsl2 inhibits the expression of
the Mup genes (Krebs et al, 2003).
      More recently, it was discovered that the KRAB zinc finger proteins are linked to
the restriction of retroviral replication in ES and EC cells. Restriction is thought to
happen only in these cells in order to prevent germ-line insertional mutagenesis.
KAP-1 binds to the primer binding site of an integrated murine leukaemia virus,
inhibiting transcription of the viral genes, and thus stopping viral replication (Wolf
and Goff, 2007, Wolf et al, 2008a). Mutation of the HP1 binding site found in KAP-
1 prevented restriction, showing that HP1 is essential for the transcriptional
repression of the integrated virus (Wolf et al, 2008b). Finally, purification and
analysis of the repressive complex showed that a single KRAB zinc finger protein,
Zfp809, was responsible for recognising the primer binding site and recruiting KAP-
1 (Wolf and Goff, 2009). It is therefore possible that other KRAB zinc finger
proteins have evolved to bind to and silence other retroviral sequences. If so, this
function may help to explain the expansive evolution of KRAB zinc finger proteins
in mammals, as these animals are targeted by a wide range of retroviruses.
1.3.8. Protein-Protein Interactions of KRAB Zinc Finger Proteins
      As well as binding to KAP-1, KRAB zinc finger proteins are able to interact with
other proteins, which has given some clue as to the range of roles that they play
within the cell. Protein-protein interactions can be mediated through the KRAB,
linker and zinc finger regions, indicating that each domain may be multi-functional.
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The murine protein NRIF (neurotrophin receptor interacting factor), which encodes
two KRAB domains, a SCAN domain and five zinc fingers, binds to the
neurotrophin receptor p75NTR through its linker region (Casademunt et al, 1999), and
to another p75NTR-interacting protein, TRAF6 (tumour necrosis factor (TNF)
receptor-associated factor 6) through its most amino-terminal KRAB domain (Gentry
et al, 2004). p75NTR promotes programmed cell death in embryonic tissues; loss of
NRIF in these cells leads to a significant reduction in cell death (Casademunt et al,
1999). Moreover, the interaction between NRIF and TRAF6 which is required for the
nuclear localisation of NRIF, is also necessary for the TRAF6-mediated activation of
c-Jun NH2-terminal kinase (JNK). Another protein that forms interactions through its
linker region is RBAK. RB is known to repress the expression of genes normally
under the control of the E2F transcription factor family (Hamel et al, 1992; Hiebert
et al, 1992). By uncovering its interaction with RB, Skapek et al were able to show
that RBAK also represses the activation of an E2F-dependent promoter, although the
repression activities of RB and RBAK were not in this case co-operative (Skapek et
al, 2000). Thus it is possible to discover genes that are repressed (or activated) by
KRAB zinc finger proteins by analysis of their protein binding partners, rather than
trying to directly identify the sequences that they bind to.
      KRAB zinc finger proteins can also bind to other factors through their zinc finger
domains. KRIM-1 (KRAB box interacting with Myc-1) interacts with c-myc, a
transcriptional transactivator, through one of its zinc fingers, which negatively
regulates c-myc function (Hennemann et al, 2003). Another protein, Zkscan17, binds
to the SET domain-containing histone methyltransferase NSD1 through a unique
zinc finger derivative called the C2HR motif (Nielsen et al, 2004). Zkscan17 can also
interact with the jumonji domain-containing protein JARID2, which is critical for
cardiovascular development (Mysliwiec et al, 2007), indicating that KRAB zinc
finger proteins are capable of binding to chromatin remodelling machinery directly.
These two reports produced conflicting results as to whether Zkscan17 assists or
antagonises transcription. In the case of NSD1, Zkscan17 repressed the reporter
construct it was targeted to, and mutation of the C2HR motif suppressed this
repression (Nielsen et al, 2004). Conflictingly, the paper reporting on Zkscan17’s
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interaction with JARID2 found that the KRAB zinc finger protein increased
transcriptional activity of a reporter construct, which was reduced upon over
expression of the jumonji protein (Mysliwiec et al, 2007).
      Another protein that was shown to form protein-protein interactions through its
C-terminus is ZBRK1 (zinc finger and BRCA1-interacting protein with a KRAB
domain-1). This protein was identified as a binding partner of BRCA1 (breast
cancer-1, early onset), a tumour suppressor that has a role in DNA damage repair.
Binding to BRCA1 occurs through the last 4 of the protein’s 8 zinc fingers and its
extended C-terminal region, which is present in only three other KRAB zinc finger
proteins (ZNF577, ZNF613, and FLJ12644) (Zheng et al, 2000; Tan et al, 2004).
ZBRK1 can bind to DNA sequences with the consensus GGGxxxCAGxxxTTT
(Zheng et al, 2000). One of BRCA1’s targets, GADD45a, encodes a sequence similar
to the ZBRK1 consensus in its third intron, and it has been shown that ZBRK1 can
repress the transcription of GADD45a through BRCA1, independent of its KRAB
domain (Zheng et al, 2000). Furthermore, ZBRK1’s C-terminal domain can also
mediate its homo-tetramerisation, an ability that no other KRAB zinc finger protein
has been reported to possess to date. The deletion of 9 amino acids from the carboxy
terminus abolishes homo-oligimerisation, and almost completely removes ZBRK1’s
co-repressor ability, thus self-interaction seems to be of great importance to this
protein (Tan et al, 2004). Therefore, despite the dearth of verified gene targets of
KRAB zinc finger protein, elements of their functions are slowly coming to light
through identification of their non-KAP-1 binding partners.
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1.4. KRAB Zinc Finger Protein 647 (Zfp647)
1.4.1. Identification of Zfp647
      In 2001, the Bickmore lab published a gene trap screen undertaken to identify
proteins that localise to specific regions within the mouse nucleus (Sutherland et al,
2001). For this screen, a _-galactosidase-neomycin phosphotransferase (_-geo)
vector, designed to integrate into the introns of expressed genes, was transfected into
EC and ES cells. This lead to the creation of cell lines that expressed fusions of the
N-terminal portion of an endogenous protein attached to the _-geo reporter. Selection
for G418 resistance ensured that only those clones expressing a correctly integrated
and folded fusion protein would survive. X-gal staining of the gene-trapped cells
identified those clones where the fusion protein was located within the nucleus, and
immunostaining against _-galactosidase was used to determine the exact nuclear
localisation of the gene-trapped protein. Cells in which the protein was observed at a
specific nuclear compartment, such as the nucleolus, splicing speckles or
heterochromatin, were selected, and the trapped genes were identified by 5’ RACE.
As part of this screen, seven KRAB zinc finger proteins were trapped and identified.
One of these proteins, zinc finger protein 647 (Zfp647), was analysed further by Dr
Heidi Sutherland and Dr Stephanie Briers.
      The Zfp647 gene is located on mouse chromosome 15, arm q, band D3. Its 535
amino acid sequence encodes both KRAB-A and KRAB-B subdomains, and 13 zinc
finger motifs separated from the KRAB domain by a 95 amino acid linker (Figure
1.9A). The gene encoding the homologous protein in humans, ZNF250, is conserved
in its syntenic location on human chromosome 8, at HSA8q24.3 (Figure 1.9B-C).
The KRAB domain and linker region of the human and mouse proteins share 89%
and 86% identity at the amino acid level, whereas the zinc fingers are more highly
conserved, with 98% identity. This suggests that Zfp647 and ZNF250 may share
their DNA binding targets, and thus could regulate the transcription of the same
genes. Unlike some of the KRAB zinc finger protein genes, Zfp647 and ZNF250 do
not belong to a gene cluster, and do not appear to have significant homology to any
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other KRAB zinc finger proteins, suggesting that their functions are non-redundant.
A few KRAB zinc finger protein genes are found in the vicinity of Zfp647 and
ZNF250 (Figure 1.9B-C); however, the proteins encoded by these genes are less
similar to Zfp647 and ZNF250 than other KRAB zinc finger proteins encoded in the
mouse and human genomes. In the gene-trapped ES cells, instead of inserting into an
intron, the _-geo cassette inserted into the 5’ end of the final exon encoding Zfp647’s
zinc fingers (Figure 1.10A). The Zfp647-_-geo fusion protein was still expressed in
frame, however, and therefore must use a cryptic splice site. Since the gene-trap
insertion is upstream of the zinc fingers, the trapped Zfp647 has probably lost its
DNA binding capacity.
1.4.2. Localisation of Zfp647 and KAP-1 in ES Cells
      Immunofluorescence of the gene-trapped ES cells with an anti-_-gal antibody
showed that in undifferentiated cells, Zfp647 had a diffuse pattern of nuclear
staining, appearing in fine speckles throughout the nucleoplasm, but excluded from
the nucleoli and the pericentric heterochromatin (Figure 1.10A, -RA). Upon
differentiation of the cells with RA, the protein re-localised to the heterochromatic
bright spots, detected by DAPI staining, in almost half of the cells analysed.
Moreover, this localisation overlapped with that of KAP-1 suggesting that, like the
KRAZ proteins, Zfp647 may be recruited to the heterochromatin (Figure 1.10A,
+RA; Briers et al, 2009). Because the localisation of gene-trapped Zfp647 may have
been affected by the loss of its DNA binding domain, a GFP-Zfp647 fusion protein
was also generated (Figure 1.10B), and transfected into NIH/3T3 cells. Like the
gene-trapped Zfp647 protein, GFP-Zfp647 localised to the pericentric
heterochromatin in 20% of the cells analysed (Figure 1.10B, upper fluorescence
panel), and also in some cases to small non-heterochromatic foci (Figure 1.10B,
lower fluorescence panel).
      However, the sub-cellular localisation of the GFP-fusion protein may differ from
that of the endogenous protein. Thus two antibodies were raised by Dr Stephanie
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Briers against endogenous Zfp647 (one in sheep, one in rabbit) to verify the results
obtained with the Zfp647 fusion proteins. The linker region (amino acids 90-174)
was used as the antigen to immunise the animals, as this domain of the protein is the
most unique (Figure 1.11A). The rabbit _-Zfp647 antibody stained within the nucleus
of mouse cells, whereas the sheep _-Zfp647 antibody gave no signal by indirect
immunofluorescence. Therefore all cell imaging experiments were carried out with
rabbit _-Zfp647.
      Co-staining of undifferentiated OS25 ES cells with the rabbit _-Zfp647 and
mouse _-KAP-1 antibodies gave a similar fine speckled pattern of localisation for
both proteins to that observed in the undifferentiated gene-trapped cells (Figure
1.11A, -RA). Differentiation of ES cells with RA dramatically changed the
localisation of Zfp647 and KAP-1 in the nucleus. Zfp647 appeared less diffuse in the
+RA cells and, instead of associating with the pericentric heterochromatin as found
with the gene-trapped protein, the endogenous protein localised to relatively large,
distinct non-heterochromatic foci (arrowed in Figure 1.11A, +RA). The number of
cells displaying these foci increased throughout differentiation, reaching a peak of
44% of cells after 6 days of RA treatment, with between 5 and 40 foci present per
nucleus (Briers et al, 2009). In differentiated cells, KAP-1 was strongly associated
with the heterochromatic bright spots (double arrowheads in Figure 1.11), but also
co-localised with Zfp647 at the non-heterochromatic foci, with at least two-thirds of
the cells containing Zfp647 foci showing co-staining of KAP-1 (Figure 1.11A, +RA).
      At this stage, it was unknown whether the relocalisation of Zfp647 to KAP-1
associated foci upon ES cell differentiation was a trait possessed by just this protein,
or whether other KRAB zinc finger proteins could be found at these non-
heterochromatic foci as well. Therefore an antibody was obtained from Yoshihiko
Yamada which had been raised against another KRAB zinc finger protein, NT2
(Tanaka et al, 2002), and indirect immunofluorescence was carried out on
undifferentiated and differentiated ES cells. This antibody was raised in rabbit,
therefore co-staining could not be done with Zfp647. However, NT2 showed a
similar pattern of localisation to Zfp647, with a fine speckled pattern of staining
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reverting to punctate localisation at non-heterochromatic foci upon RA-mediated
differentiation, co-incident with KAP-1 (Figure 1.11B) (Briers et al, 2009). We
therefore believe that a number of KRAB zinc finger proteins may localize to these
foci, and have thus named them KAKA foci, for KRAB and KAP-1 associated foci.
 1.4.3. Co-localisation of Zfp647 with HP1 and PML
      As discussed previously, the HP1 proteins play a critical role in the KRAB zinc
finger protein transcriptional silencing mechanism, as loss of the interaction between
KAP-1 and HP1 increases the expression of a KAP-1 target gene. If the KAKA foci
formed a repressive environment within the nucleus where KRAB-mediated
repression occurred, it was therefore possible that HP1 also localized to these foci.
Incubation of differentiated OS25 cells with antibodies against HP1_ and HP1_
revealed that these proteins were often juxtaposed to the Zfp647 foci in the
nucleoplasm, as well as localising to the pericentric heterochromatin (Figure 1.12A).
The localization of another member of the KRAB repression machinery, SETDB1,
was also analysed. This protein displayed a similar pattern of staining, often lying
next to, or slightly overlapping, the KAP-1 foci (data not shown).
      The KAKA foci appeared to be relatively large, protein-rich bodies. To
determine whether there was any overlap with previously characterized nuclear
bodies, co-staining with CREST antisera, which recognises centromeric components,
was carried out with the α -Zfp647 antibody. Zfp647 did not localize to these
structures in differentiated ES cells (data not shown). The average number of KAKA
foci was similar to the number of PML bodies typically present in mammalian cells,
and a number of transcription factors are known to be recruited to these bodies.
Therefore co-staining studies were also carried out with Zfp647 and PML in RA-
treated OS25 cells. These experiments showed that the Zfp647 foci often lay side-by-
side with PML-NBs (Figure 1.12B) (Briers et al, 2009). This pattern of staining
mirrors that of a human KRAB zinc finger protein, PAROT (PML-associated
repressor of transcription), which localizes to foci within the nucleus alongside KAP-
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1, HP1_, HP1_, HP1_ and PML (Fleischer et al, 2006). However, these experiments
were undertaken using a GFP-PAROT fusion protein, rather than
immunofluorescence against the endogenous protein, thus it is possible that this
protein is mislocalised, as found when the localization of endogenous and GFP-
tagged Zfp647 were compared.
      Why the KRAB zinc finger proteins relocalise to KAKA foci is currently
unknown. We believe there are three main possibilities, which could overlap to some
degree. First, the foci could be repressive environments, to which the KRAB zinc
finger proteins and their gene targets are relocated during differentiation to cause
gene silencing. The accumulation of many KRAB zinc finger proteins and a high
concentration of KAP-1 may be beneficial to the repression process. Alternatively,
the foci may be storage sites for KRAB zinc finger proteins and other KRAB-
associated proteins, a function that has previously been suggested for the PML
bodies, near to which the KAKA foci are found. Finally, given the proximity to the
PML bodies, the KRAB zinc finger proteins may be recruited to the KAKA foci in
order to undergo some form of post-translational modification, for example
sumoylation (Vertegaal et al, 2006; Lee et al, 2007b; Mascle et al, 2007) or
phosphorylation (Chang et al, 2007; Li et al, 2007).
1.5. Proposed Work
      To discover more about Zfp647, as part of my Masters project, I undertook a
yeast two-hybrid screen with the full-length Zfp647 protein and an embryonic mouse
cDNA library. Protein-protein interactions between Zfp647 and transcriptional
regulators of specific genes may suggest genes that Zfp647 helps to control, as has
been shown with BRCA1 and ZBRK1 (Zheng et al, 2000), or potentially proteins
that are present at the KAKA foci. During my Masters project, I managed to
sequence each of the clones that I picked, however I did not verify any of these
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interactions. Therefore my first aim for my PhD project was to test these proteins for
their ability to auto-activate the nutritional markers used in the screen. It is also
possible that some of these proteins interact with Zfp647 in yeast cells, but do not
bind to Zfp647 in vivo. Thus I also wished to verify some of the interactions from the
yeast two-hybrid screen in vitro.
      One of the most interesting findings from the yeast two-hybrid screen was that
Zfp647 is capable of interacting with a number of proteins involved in the
ubiquitylation process. Given that KAP-1 has been shown to be sumoylated (Lee et
al, 2007b; Mascle et al, 2007), and two other KRAB zinc finger proteins are also
believed to be modified in this way (Vertegaal et al, 2006), I also set out to test
whether Zfp647 is post-translationally modified, possibly by ubiquitin or another of
the ubiquitin-like proteins. If this was the case, it may suggest that the KRAB zinc
finger proteins, like KAP-1, are post-translationally modified to aid the
transcriptional repression of their targets. Alternatively, modification may be
important for the localisation pattern of Zfp647 seen in ES cells.
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Chapter 2: Materials and Methods
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2.1 Microbiological Methods
2.1.1. Bacterial Culture Conditions
      All bacteria were cultured in Luria Bertani broth (LB), containing the antibiotic
selective for the desired plasmid where appropriate (Table 2.1). BL21 (DE3) pLysS
cultures were grown in the presence of chloramphenicol. Cultures were grown at
37°C unless otherwise stated.




     Table 2.1. Antibiotics used in bacterial culture.
2.1.2. Generating Competent Bacteria
       1ml of a 3ml overnight BL21 (DE3) pLysS culture was used to inoculate a
100ml culture. Cells were left to grow at 30°C until an optical density at 600nm
(OD600) of 0.5-0.6 was reached. Cells were then pelleted at 6000g, resuspended in
25ml of 0.1M CaCl2, and incubated on ice for 25 minutes. Cells were pelleted,
resuspended in 10ml freezing mix (15% glycerol, 50mM CaCl2), and divided into
200_l aliquots. Cells not to be used immediately were snap-frozen in dry ice and
stored at -80°C until required.
2.1.3. Bacterial Transformation
      Competent DH5_ (Invitrogen) or BL21 (DE3) pLysS cells were incubated with
plasmid DNA on ice for 10 minutes. Cells were then heat-shocked at 42°C for 45
seconds, and returned to ice for a further 2 minutes. 300_l of LB was added, and the
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cells were shaken at 37°C for 45 minutes. Transformed bacteria were plated on LB-
agar plates containing the appropriate antibiotic and grown at 37°C overnight.
2.1.4. Making Extracts of Bacterially-Expressed Proteins
      BL21 (DE3) pLysS cells transformed with pGEX-4T-1 carrying the protein of
interest were grown in a 3ml overnight culture. The next morning, the bacteria were
diluted into a 10ml culture to give an OD600 reading of 0.1-0.2, and the bacteria were
grown at the appropriate temperature until the culture reached an OD600 value of 0.4.
Two aliquots of 1ml were removed from the culture, and the remaining culture was
induced to express the protein encoded on the transfected vector by the addition of
isopropyl _-D-1-thiogalactopyranoside (IPTG) to 0.4mM. After 4 hours, two 1ml
aliquots were removed from the culture. Total, soluble and insoluble cell extracts
were made from the samples removed from the culture at both timepoints. To make a
total cell extract, one of the 1ml samples was pelleted, and the pellet was weighed
and resuspended according to its weight. The bacteria were resuspended in 3ml
phosphate buffered saline (PBS) per gram of pellet, and an equal volume of 2x
sodium dodecyl sulphate (SDS) loading buffer (100mM Tris-HCl (pH6.8), 4% (w/v)
SDS (electrophoresis grade), 0.2% (w/v) bromophenol blue, 20% glycerol, 200mM
_-mercaptoethanol) was added. To make soluble and insoluble extracts, the other
sample was pelleted, and resuspended according to weight in lysis buffer (50mM
Tris (pH8), 2mM ethylenediaminetetraacetic acid (EDTA) (pH8)): again, 3ml buffer
was used per gram of pellet. 2_l 1% Nonidet P-40 (NP-40) and 2_l lysonase
(Novagen) were added per 200_l of lysate, and the lysate was incubated at 37°C for
30 minutes. The insoluble fraction was pelleted by centrifugation in a Sorvall
Benchtop microcentrifuge at 13000 rpm for 15 minutes at 4°C, and the supernatant
was removed to a new tube. The insoluble matter was resuspended in the appropriate
volume of lysis buffer or water, and an equal volume of 2x SDS loading buffer was
added to both lysates. All samples were boiled at 95°C for 5 minutes. The solubility
of the expressed protein was assessed by polyacrylamide gel electrophoresis
(PAGE).
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2.1.5. Refolding Insoluble Bacterial Proteins
      The insoluble matter from bacteria expressing tagged proteins was pelleted as
described above, weighed, and resuspended in dH2O accordingly: for every 1g of
pellet, 1ml dH2O was used. All the following steps were carried out at 4°C. The
insoluble lysate was divided into 40_l aliquots, re-pelleted for 15 minutes, and
resuspended in 40_l 0.1M Tris (pH8.5) containing 0.5M, 1M, 2M or 5M urea. The
insoluble proteins were spun down for 15 minutes, the supernatant was removed to a
new tube, and the pellet was resuspended in 40_l dH2O. An equal volume of 2x SDS
protein loading buffer was added to the soluble and insoluble fractions, the samples
were boiled at 95°C for 5 minutes, and analysed by PAGE.
2.2. Mammalian Cell Culture Methods
2.2.1. Mammalian Tissue Culture Conditions
      NIH/3T3 and PCC4 cells were cultured in Dulbecco’s-minimal Eagle’s medium
(D-MEM) (Cat #41965-039 Invitrogen) supplemented with 10% foetal calf serum
(FCS), 100 units/ml penicillin and 100_g/ml streptomycin. Primary mouse
embryonic fibroblasts (pMEF) cells were cultured in D-MEM supplemented with
15% FCS, 100 units/ml penicillin, 100_g/ml streptomycin, 0.3mg/ml l-glutamine,
1% MEM non-essential amino acids (Invitrogen) and 10_M _-mercaptoethanol.
OS25 cells were cultured in Glasgow’s minimal Eagle’s medium (G-MEM) (Cat
#21710-025) supplemented with 10% FCS, 100 units/ml penicillin, 100_g/ml
streptomycin, 0.3mg/ml L-glutamine, 1% MEM non-essential amino acids, 1mM
sodium pyruvate (Invitrogen) and 10_M _-mercaptoethanol on 0.1% gelatin-coated
tissue culture flasks. To maintain OS25 cells in an undifferentiated state, they were
additionally supplemented with 1000 units/ml human recombinant leukaemia
inhibitory factor (LIF).  All cells were grown at 37°C in 5% CO2.
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2.2.2. Differentiation of Tissue Culture Cells
      To induce differentiation of OS25 cultures, cells were plated in media without
LIF for one day. After this time, 5_M RA was added to the tissue culture media, and
was included in the media for the remaining period of differentiation. Cells were
passaged after two and four days of RA treatment. After four days of treatment with
RA, 2.5_M gancyclovir was added to the culture media to select against any
undifferentiated cells that were expressing Oct4.
      PCC4 cells were induced to differentiate by the addition of 5_M RA into the
culture medium. Differentiating cells were passaged as normal for six days.
2.2.3. Culturing pMEFs from Embryos
      11.5dpc and 12.5dpc embryos were removed from their mother’s uterus and
placed in a 9cm tissue culture plate containing PBS supplemented with 100 units/ml
penicillin and 100_g/ml streptomycin. The embryonic heads and internal organs were
removed, and the remaining tissue of each embryo was transferred to one well of a 6-
well plate containing 2ml of pMEF media. The following steps were carried out in a
tissue culture hood. To separate the fibroblast cells, each embryo was placed into the
barrel of a 5ml syringe and passed through a 21G needle 3 times. Cells were left to
culture for 2-3 days, with the media being changed each day. When confluent, cells
were trypsinised (50% trypsin in versene), resuspended in 5ml media and transferred
to a 20ml universal tube. The largest particles of tissue were allowed to fall to the
bottom, and the remaining cells in suspension were removed and cultured further.
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2.2.4. Transfection of Tissue Culture Cells
      Cells were seeded one day prior to transfection. Cells at 60-70% confluence were
transfected using plasmid DNA and Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. Cells were used 24 hours after transfection.
2.2.5. Freezing Mammalian Tissue Culture Cells
      A confluent T75 or T175 tissue culture flask was trypsinised and resuspended in
media. The cells were pelleted by centrifugation for 4 minutes at 1200rpm in a
benchtop centrifuge, and washed once in PBS. The cells were pelleted again, and
resuspended in freezing mix (10% dimethyl sulfoxide (DMSO) (Sigma) in FCS)
according to volume of cells (1ml per 25cm2 of confluent cells). 1ml aliquots were
transferred to Nunc Cryotube vials (Sigma), frozen down at -80°C, and transferred to
liquid nitrogen for long-term storage.
2.3. Yeast Methods
2.3.1. Culture of Yeast Cells
      Yeast cells were cultured in yeast peptone dextrose (YPD) or Sabouraud dextrose
(SD) Broth lacking the appropriate nutrients, and shaken at 30°C. Yeast colonies
were grown on YPD- or SD-agar plates lacking the appropriate nutrients at 30°C.
2.3.2. Rescue of Yeast Plasmids
      To rescue yeast two-hybrid prey plasmids, the appropriate colony was picked and
used to inoculate a 10ml culture of SD Broth supplemented with all nutrients except
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leucine. The culture was grown for 2 days at 30°C, and the cells were pelleted in a
bench top centrifuge at 3000rpm for 15 minutes. Cells were resuspended in 250_l P1
from the Qiagen Spin Miniprep kit, and transferred to a 1.5ml microcentrifuge tube
containing 100_l of 400-600_m glass beads (Sigma). 4_l lyticase (Sigma) was added
to the cells, which were incubated at 37°C for 1 hour. The cells were then smashed
open by vortexing for 2 minutes, and the DNA was extracted by completing the
miniprep kit protocol, including the optional washing step with buffer PB. DNA was
eluted in 20_l dH2O. The same day, 10_l of the extracted DNA was used to transfect
100_l of competent DH5_ cells (Invitrogen), which were grown overnight at 37°C.
The DNA was then extracted from these cells by carrying out a miniprep on 3ml
cultures of these cells.
2.3.3. Transformation of Yeast Cells
    5ml of YPD (plus adenine) or the appropriate selective media was inoculated with
a colony of the required yeast strain, and left to grow at 30°C for two days. 1ml of
this culture was spun at 13000 rpm in a microcentrifuge tube for 30 seconds and the
media was removed by inversion and shaking, leaving the cells in 50_l media. 2_l of
salmon sperm carrier DNA (10mg/ml) was added, and the cells were resuspended.
1_g of the desired plasmid was added, and the cells were vortexed. 0.5ml of PLATE
mixture (40.5% PEG, 0.1M lithium acetate, 10mM Tris-HCl (pH 7.5), 1mM EDTA)
was added, and the cells were vortexed again. 20_l of 1M DTT was added, the cells
were vortexed, and incubated on the bench overnight. The following day, the cells
were heat-shocked for 10 minutes at 42°C, and spun down at 13 000 rpm for 30
seconds. The liquid was removed, the cells were washed in 0.5ml H2O, re-pelleted,
and resuspended in 100_l H2O. 10_l of the cells, and the remaining cells, were plated
onto the appropriate selective plates, and left to grow for 3-4 days at 30°C.
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2.4. Preparation and Analysis of Proteins from Mammalian Cells
2.4.1. Whole Cell Protein Extracts
      Cells in a confluent 9cm tissue culture plate were washed with PBS twice, and
lysed in 500_l 2x SDS loading buffer. Lysates were sonicated with two 10-second
pulses at 10_m on a Soniprep 150 sonicator (MSE), boiled at 95°C for 5 minutes and
stored at -20°C. To preserve post-translational modifications of proteins, 20mM N-
ethylmaleimide (NEM) was included in both the PBS washes and the 2x SDS
loading buffer.
2.4.2. Nuclear and Cytoplasmic Extracts
      Cells in a confluent 9cm tissue culture plate were washed twice with PBS, and
scraped off in 500_l cell lysis buffer (10mM Tris (pH7.5), 100mM NaCl, 2.5mM
MgCl2, 35_g/ml digitonin, Complete protease inhibitors (Roche)). Cell lysates were
incubated on ice for 5 minutes, and then centrifuged in a benchtop microcentrifuge at
4500rpm for 8 minutes at 4°C to separate the nuclear and cytoplamic fractions. The
cytoplasmic supernatant was removed to a new tube, and the nuclear pellet was
resuspended in 400_l nuclear lysis buffer (10mM Tris (pH7.5), 100mM NaCl,
2.5mM MgCl2, 35_g/ml digitonin, 0.5% Triton X-100, Complete protease inhibitors
(Roche)). The nuclear extract was incubated on ice for 5 minutes, sonicated twice for
10 seconds at 10_m, and cleared of insoluble material by centrifugation at 13000rpm
for 5 minutes at 4°C in a benchtop microcentrifuge. If required for immediate
analysis, an equal volume of 2x SDS loading buffer was added to the nuclear and
cytoplasmic extracts, and the samples were boiled at 95°C for 5 minutes. To preserve
post-translational modifications of proteins, 20mM NEM was included in the PBS
washes, the lysis buffers and the 2x SDS loading buffer.
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2.4.3. Polyacrylamide Gel Electrophoresis (PAGE)
      6-12% polyacrylamide gels were cast according to Sambrook and Russell in
Molecular Cloning (CSHL Press) using a Hoefer Inc. gel system. Protein samples
and Benchmark pre-stained protein marker (Invitrogen) were loaded, and gels were
run in Tris-glycine buffer (25mM Tris, 250mM glycine (pH8.3), 0.1% SDS).
Alternatively, samples were run out on NuPAGE pre-cast gels (Invitrogen) according
to the manufacturer’s instructions. Gels were stained with Gel-Code Blue stain
(Pierce) subjected to the western blotting procedure, or silver-stained.
2.4.4. Western Blotting
      Proteins run out on polyacrylamide gels were transferred using a Genie Blotter
(Idea Scientific) in buffer containing 25mM Tris, 190mM glycine and 20% methanol
onto Hybond-P membrane (Amersham Biosciences) for one hour. Membranes were
washed briefly in PBS containing 0.1% Tween-20 (PBST) and blocked in 10%
western blocking reagent (WBR) (Roche) in PBST for one hour at room temperature
or overnight at 4°C. Membranes were incubated in PBST containing 5% WBR and
the appropriate dilution of primary antibody (see Table 2.2) for one hour at room
temperature or overnight at 4°C. Blots were washed three times for 5 minutes in
PBST, and incubated with a dilution of 1:10000-20000 secondary antibody-
horseradish peroxidase (HRP) conjugate in 5% WBR in PBST for one hour at room
temperature. Blots were washed five times in PBST, incubated in SuperSignal West
Pico Chemiluminescent Substrate (Pierce) for 1 minute and exposed to
autoradiography film (Amersham).
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Antibody Species Dilution Source (Product No.)
_-Zfp647 Sheep 1:1000 – 2000 Own
_-Zfp647 Rabbit 1:1000 Own
_-Rbak serum Guinea pig 1:2500 Own
Affinity purified _-Rbak Guinea pig 1:200 Own
_-KAP-1 Rabbit 1:2000 Bethyl Labs (A300-274A)
_-Tif1_ Mouse 1:2000 Gift from Prof Pierre Chambon
(Weber et al, 2002)
_-GST Rabbit 1:2000 Sigma (G7781)
_-His6 Mouse 1:1000 Qiagen (34670)
_-c-myc Mouse 1:250 Santa Cruz (sc-40)
_-HA Rabbit 1:1000 Sigma (H6908)
_-GMP-1 Mouse 1:1000 Invitrogen (33-2400)
_-Sentrin-2 Rabbit 1:1000 Invitrogen (51-9100)
_-Ubiquitin Rabbit 1:2000 – 5000 DakoCytomation (Z0458)
_-Nedd8 Rabbit 1:2000 – 5000 Abcam (ab4751)
_-tubulin Mouse 1:5000 Sigma (T6793)
_-RanGAP1 Goat 1:2000 Abcam (ab2081)
_-Poly(ADP-ribose) Mouse 1:500 – 1000 Abcam (ab14459)
_-rabbit secondary Goat 1:10000 Sigma (A0545)
_-sheep secondary Donkey 1:10000 Sigma (A3415)
_-mouse secondary Goat 1:10000 - 20000 Sigma (A2304)
_-Guinea pig secondary Rabbit 1:10000 Sigma (A5545)
Table 2.2. Antibodies used for western blotting and immunoprecipitations.
2.4.5. Immunoprecipitation of Mammalian Proteins
2.4.5.1. Conjugation of Antibody to Sepharose Beads
      Protein G Sepharose 4 Fast Flow beads (GE Healthcare) were washed three times
with 0.1M sodium phosphate buffer (pH 8.1). 20_l of sepharose was used per
immunoprecipitation, and for each control. Antibody (see Table 2.2) was added at
0.2mg per ml of sepharose in a final volume of 0.7ml 0.1M sodium phosphate buffer,
and the beads were left on a rotating wheel at 4°C for an hour. Beads were then
washed in the buffer used to prepare the extracts to be immunoprecipitated, so as to
remove any unbound antibody.
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2.4.5.2. Immunoprecipitation from Cell Extracts
      For small-scale immunoprecipitations, nuclear extracts were prepared as
described above from 1x 9cm tissue culture plate. For large-scale
immunoprecipitations for mass spectrometry experiments, nuclear extracts were
prepared from 8x 14cm tissue culture plates. Nuclear extracts were pre-cleared using
sepharose beads. 20-100_l protein G Sepharose 4 Fast Flow beads (GE Healthcare)
were washed three times in nuclear lysis buffer (10mM Tris (pH7.5), 100mM NaCl,
2.5mM MgCl2, 35_g/ml digitonin, 0.5% Triton X-100, Complete protease inhibitors
(Roche)) and incubated in the extracts to be used for the immunoprecipitation for 1-4
hours at 4°C. The beads were then removed from the extracts by centrifugation, and
the extracts were incubated with 20-100_l sepharose beads bound by the antibody of
choice on a rotating wheel for between 1 hour and overnight at 4°C. Small-scale
immunoprecipitations were carried out in a final volume of 700_l; large-scale
immunoprecipitations were carried out in a final volume of 5ml. The beads were
pelleted and washed up to six times for 10 minutes with 800_l of nuclear lysis buffer,
each wash being carried out at 4°C. All remaining buffer was removed from the
beads using a syringe attached to a 25G needle. The beads were resuspended in 25-
50_l 2x SDS loading buffer, boiled at 95°C for 5 minutes, cooled on ice, and
analysed by PAGE and western blotting or silver staining. Immunoprecipitations
were stored at -20°C.
2.4.5.3. Silver Staining of PAGE Gels
      Gels were fixed in 30% ethanol and 10% acetic acid for 30 minutes, followed by
another fixation for 30 minutes in 30% ethanol, 0.5M sodium acetate, 0.2% soldium
thiosulphate and 0.125% glutaraldehyde (glutaraldehyde was omitted from silver
stained gels being analysed by mass spectrometry). The gels were then washed three
times in dH2O for 10 minutes, and stained by incubation in 0.1% AgNO3, 0.01%
formaldehyde for 20 minutes. The stain was removed, and the gels were rinsed
briefly in a small amount of developer (2.5% Na2CO3.10H2O, 0.01% formaldehyde),
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which was aspirated off immediately. This process was repeated for as long as a
precipitate was visible in the developer. Once the precipitate was no longer visible,
the gels were incubated in the remainder of the developer solution until the gel was
adequately stained. The staining was stopped by removal of the developer and
incubation in 1% glycine until the gel was needed. To generate samples for mass
spectrometry, gels were transferred to a 14cm tissue culture plate in a tissue culture
hood, and the bands were excised using a clean razor blade. Samples were
transferred to eppendorffs previously washed with methanol and distilled water, and
samples were frozen at -20°C. For mass spectrometry analysis, the samples were
transferred on ice to the SIRCAMS department at the University of Edinburgh.
2.4.6. Purification of His6-Tagged Proteins
      A 9cm tissue culture plate with cells at 60-70% confluence was transfected with
plasmid DNA encoding His6-tagged SUMO-1 (a gift from Professor Anne Dejean
(Institut Pasteur, Paris) Müller et al, 2000), SUMO-2 (a gift from Professor Ron Hay
(University of Dundee)), Ubiquitin (a gift from Dr Lee Finlan), Nedd8 (a gift from
Dr David Girdwood), Zfp647 or the pcDNA3.1(+) vector. 24 hours later, the cells
were scraped from the plate in 5ml media, and pelleted by centrifugation at 1200rpm
for 5 minutes in a benchtop centrifuge. The cells were resuspended in 10ml PBS; 1ml
was removed, the cells pelleted, and resuspended in 100_l 2x SDS loading buffer to
allow the analysis of the input. The cells in the remaining 9ml sample were re-
pelleted, and lysed in 5ml Buffer 1 (6M guanidium-HCl, 0.1M Na2HPO4, 0.1M
NaH2PO4, 10mM Tris (pH8), pH to 8). At this point, cell lysates could be frozen at -
80°C. Imidazole was added to the samples to a final concentration of 5mM, _-
mercaptoethanol was added to a final concentration of 10mM, and the lysates were
sonicated briefly. Any insoluble matter was removed by centrifugation at 4000rpm
for 5 minutes at room temperature in a benchtop centrifuge, and the supernatant was
transferred into a 15ml tube containing 50_l Ni2+-NTA-agarose beads (QIAGEN)
previously prepared by washing twice with 4ml Buffer 1 and pelleting at 2000rpm
for 2 minutes. The cell lysates and agarose beads were left to rotate for 2-3 hours at
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room temperature and then washed as follows: twice in 4ml Buffer 1 containing
10mM _-mercaptoethanol; three times in 4ml Buffer 2 (8M Urea, 0.1M Na2HPO4,
0.1M NaH2PO4, 10mM Tris (pH8), pH to 8) containing 10mM _-mercaptoethanol;
twice in 4ml Buffer 3 (8M Urea, 0.1M Na2HPO4, 0.1M NaH2PO4, 10mM Tris
(pH6.3) pH to 6.3) containing 10mM _-mercaptoethanol. The beads were transferred
to a 1.5ml siliconized microcentrifuge tube in a final volume of 1.5ml Buffer 3 and
pelleted at 2000rpm for 1 minute. Beads were then washed as follows: 1ml Buffer 3
containing 0.2% Triton X-100; 1ml Buffer 3; 1ml Buffer 3 containing 0.1% Triton
X-100; three times in 1ml Buffer 3. The proteins were eluted from the beads by
addition of 40_l elution buffer (for 1ml, mix 250_l 1M imidazole, 330_l 2x SDS
loading buffer and 420_l dH2O), mixed by finger-flick, and incubated either at 37°C
for 1-2 hours, or overnight at 4°C. Beads and eluates were stored at -20°C, and
proteins were analysed by PAGE and western blotting.
2.5. Generation of Guinea Pig _-Rbak Antibody
2.5.1. Large-Scale Expression and Purification of GST-Fused Rbak Protein
      DNA encoding the linker region of Rbak was ligated into pGEX-4T-1 (GE
Healthcare). This vector was transformed into competent BL21 (DE3) pLysS E. coli
cells. Successfully transformed cells were used to inoculate a 20ml overnight culture.
These cells were then diluted into a 400ml culture, which was left to grow at 37°C
until it reached an OD600 of 0.6. The culture was induced by the addition of IPTG to
0.4mM, and was grown for a further 4 hours. Bacterial cells were then pelleted by
centrifugation at 6000g at 4°C for 20 minutes, and were frozen down at -20°C
overnight. The following day, cell pellets were resuspended in 15ml lysis buffer
(20mM Tris (pH7.6), 1mM EDTA, 1mM ethylene glycol tetraacetic acid (EGTA),
100mM NaCl, 10% glycerol, 1mM dithiothreitol (DTT) and Complete protease
inhibitors (Roche)). Lysozyme (Sigma) was added to 1mg/ml, and the cells were
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incubated on ice for 30 minutes. The lysate was sonicated on ice for 5 minutes at
10_m, followed by the addition of Triton X-100 to 0.1% to ensure release of the
fusion protein from the cells. The lysate was centrifuged at 12000g for 20 minutes at
4°C, and 15ml supernatant was removed. 2ml of 50% (v/v) glutathione-agarose
(Sigma) previously suspended in PBS was added, and this was incubated at 4°C for
30-60 minutes on a roller mixer. The resin was loaded into a column (Econo, Bio-
Rad), and the supernatant was allowed to drip through. A 1ml sample was retained as
binding buffer (BB). The column was washed with 10ml PBST (PBS containing 1%
Triton X-100 and protease inhibitors (Roche)): a 1ml sample was retained as wash
buffer (W). Glutathione-S-transferase (GST)-Rbak was eluted by the addition of
elution buffer (10mM reduced glutathione (Sigma) in 50mM Tris-HCl (pH8)
(prepared fresh) plus Complete protease inhibitors (Roche)): five 1ml aliquots were
passed through the column and collected separately as eluates 1-5 (E1-5). 50_l of
each sample was removed, mixed with 50_l 2x SDS loading buffer and boiled at
95°C for analysis by PAGE and western blotting with _-GST antibody. After
analysis, fractions E1 and E2 were pooled and concentrated in a centricon-10 column
(Amicon/Millipore) following the manufacturer’s instructions. All samples were
frozen down at -20°C.
2.5.2. Immunisation of Guinea Pigs
      250_g of purified GST-Rbak linker antigen was sent to Eurogentec, and was used
to immunise two Guinea pigs using Eurogentec’s standard 87-day immunisation
programme. Animals were injected with 30_g antigen on days 0, 14, 28 and 56 of the
programme, and were bled on days 0 (pre-immune), 38, 66 and 87 (final bleed). The
immune responses of the animals were checked by western blotting NIH/3T3
extracts and bacterially expressed GST-Rbak linker protein with diluted pre-immune
and final bleed sera.
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2.5.3. Generation of Rbak Affinity Column
      1g of cyanogen bromide-activated Sepharose 4B (Sigma) was resuspended in
3.5ml wash buffer (1mM HCl) and left to swell. The swollen gel was washed in a
total of 200ml wash buffer using a glass scintered funnel, collected in a 15ml falcon
tube, and made into a 50% slurry with wash buffer. For a 1.5ml column, 7.5mg of
purified GST-Rbak linker protein (see above) was passed over a PD-10 column (GE
Healthcare) previously equilibrated with coupling buffer (0.1M NaHCO3, 0.5M
NaCl, pH to 8), and eluted in 3.5ml coupling buffer. 3ml of the sepharose gel slurry
was transferred to a clean 15ml falcon tube, and washed with 12ml of coupling
buffer. The sepharose was centrifuged at 500g for 1 minute, the buffer removed, and
the sepharose was resuspended in the antigen solution. The sepharose was mixed by
inversion for 90 minutes (1 hour per ml of sepharose) at room temperature.
Following this, the matrix was washed in 13ml of coupling buffer briefly, and then
washed for 2 hours with 13ml of 0.1M Tris-HCl (pH8) at room temperature. The
sepharose was washed with 0.1M sodium acetate (pH4), 0.5M NaCl for ten minutes,
followed by one wash with 0.1M Tris-HCl (pH8), 0.5M NaCl, also for ten minutes.
These two wash steps were repeated a further two times, followed by three ten
minute washes with 13ml PBS. The matrix was resuspended in PBS, and poured into
a column (Econo, Bio-Rad). The sepharose was washed with 15ml PBS, and the
column was sealed with parafilm, leaving 3ml buffer on top of the sepharose, and
stored at 4°C.
2.5.4. Affinity Purification of Polyclonal Rbak Antibodies
      To purify the Guinea pig Rbak antibodies, serum was initially passed over a
GST-LEDGF (lens epithelium-derived growth factor) column to remove antibodies
against GST protein, and then purified on a GST-Rbak column. 5ml of Guinea Pig
final bleed serum was diluted to 50ml in PBS, and passed through a 0.45_m filter. 10
bed volumes of PBS (i.e. 10ml for a 1ml column) were passed over a GST-LEDGF
(p52) column previously made by Dr Heidi Sutherland, and the diluted serum was
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then passed over this column three times. The GST-LEDGF column was
subsequently washed, eluted and re-washed in the same manner as the GST-Rbak
column to remove any antibodies against GST remaining on the column. The Guinea
pig serum was then passed over the GST-Rbak affinity column three times, and the
column was washed with 10 bed volumes of PBS. The column was then washed with
20 bed volumes of high salt wash buffer (10mM Tris-HCl (pH7.5), 500mM NaCl)
followed by 20-50 bed volumes of PBS. Whilst washing the column, 10-15
microcentrifuge tubes were set up containing 35_l 1M Tris-HCl (pH8.8). When
finished washing, 0.5ml aliquots of elution buffer (100mM glycine, 150mM NaCl,
10% glycerol) were allowed to pass over the column, collected in the
microcentrifuge tubes, mixed by inversion immediately and kept on ice. The
antibody concentration in each fraction was evaluated by diluting 5_l in 100_l PBS
and measuring its UV absorbance value at 280nm (A280) on a spectrophotometer. An
A280 value of 1 equates to 0.75mg/ml of pure immunoglobulin G (IgG). The peak
fractions were pooled and concentrated using a centricon-10 column (Amicon,
Millipore), and the antibody was stored at -20°C.
2.6. Nucleic Acid Manipulation Methods
2.6.1. Gel Electrophoresis
      1-2% agarose (Hi-Pure Low EEO Agarose, Biogene UK) gels were prepared
using 1x TAE buffer (40mM Tris-acetate, 1mM EDTA (pH8)) or TBE buffer (45mM
Tris-borate, 1mM EDTA (pH8)). Gels were run in 1x TAE or TBE containing
0.5mg/ml ethidium bromide. DNA samples, digests and polymerase chain reaction




2.6.2.1. Extraction of Plasmid DNA from Bacterial Cultures
      For small-scale plasmid preps, 3ml of LB was inoculated with a single bacterial
colony and grown overnight at 37°C. The next day, plasmid DNA was extracted
using a QIAGEN QIAprep spin miniprep kit according to the manufacturer’s
instructions.
      For large-scale preps, a 3ml LB culture containing a single bacterial colony
grown over the course of a day was used to inoculate a 400ml culture which was
grown overnight at 37°C. The next day, plasmid DNA was extracted using a
QIAGEN Maxi prep kit according to the manufacturer’s instructions, until the DNA
was precipitated from the isopropanol solution. Following this, the DNA was
resuspended in 500_l dH2O, and transferred to a microcentrifuge tube. 50_l of 3M
sodium acetate (pH5.5) was added, followed by 1ml of 100% ethanol, and the
solution was inverted to precipitate the DNA. The DNA was pelleted by
centrifugation at 13000rpm in a benchtop microcentrifuge at 4°C for 15 minutes,
washed with 1ml 70% ethanol and re-centrifuged for 10 minutes. The DNA pellet
was left to air-dry and resuspended in dH2O according to the pellet size (typically
200_l).
2.6.2.2. Digestion of Plasmid DNA
      Digestion of plasmid DNA was carried out using SuRE/Cut restriction enzymes
(Roche) and the supplied buffer according to the manufacturer’s instructions. DNA
was analysed by gel electrophoresis, and where required for ligation, digests were
purified by gel extraction.
74
2.6.2.3. Gel Extraction of Digested Plasmid DNA
      Following gel electrophoresis, DNA samples were excised from the gel using a
clean razor blade on a UV-light box. DNA was then extracted from the gel slice
using the QIAGEN Gel Extraction kit. The DNA was typically eluted in 50_l dH2O.
2.6.2.4. Ligation of Digested Samples
      200ng of DNA, typically consisting of 100ng of each of the digested vector and
insert sequences, 2_l 10 x ligation buffer (NEB), 1_l 1% NP-40, 2_l T4 DNA ligase
(NEB) and 7_l H2O were left at 16°C overnight. The following day, 10_l of the
ligation was transfected into competent DH5_ cells.
2.6.3. Polymerase Chain Reaction
2.6.3.1. Sequencing of Plasmid DNA
      500ng-1_g of plasmid DNA was mixed with 1_l of T7 sequencing primer (5’:
TAATACGACTCACTATAGGG) at 3.2_M and 4_l BigDye (Applied Biosystems)
in a final reaction of 20_l. PCR was carried out on a DNA Engine Tetrad (MJ
Research), for 25 cycles of 96°C for 30 seconds, 50°C for 15 seconds, and the
appropriate annealing temperature for 4 minutes. To precipitate the DNA, 5_l of
125mM EDTA and 60_l 100% ethanol were added, and samples were incubated on
ice for at least 20 minutes. The DNA was pelleted at 13000rpm for 30 minutes at
4°C, the pellet was washed in 70% ethanol and centrifuged at 13 000rpm for 15
minutes at 4°C, and was air-dried and handed in to sequencing.
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2.6.3.2. Cloning of Plasmid DNA by PCR
      20ng of plasmid DNA encoding the desired sequence was used in a 50_l PCR
reaction, containing 1_l of forward and reverse primers at a concentration of 10_M,
1_l of dNTPs (Promega) at 10mM, 1_l of Turbo Pfu Polymerase (Stratagene), 5_l of
10x Pfu polymerase buffer and dH2O up to 50_l. Table 2.3. shows the primer
sequences used for generating each of the vectors described in the thesis. 5_l of the
PCR products were analysed by gel electrophoresis. The remaining 45_l of PCR
products were purified using the QIAquick PCR Purification Kit (QIAGEN) and
eluted in 50_l of elution buffer. The PCR products and vectors to be cloned into were
digested and ligated as described above, and transformed into competent DH5_ E.
coli cells. Correct cloning was checked by sequencing of the newly created vectors.

























































































Table 2.3. Plasmid constructs. Vectors and primers used to create the plasmids constructed as part
of this thesis. NB: pCGT7 inserts were digested with BamHI; pCGT7 was digested with BglII.
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2.7. In Vitro Expression of Proteins
2.7.1. In Vitro Transcription and Translation of Tagged Proteins
      Target proteins were cloned into either of the two yeast two-hybrid vectors,
pGADT7 or pGBKT7. Polymerase chain reaction (PCR) was carried out using
primers designed to anneal from 6 nucleotides upstream of the T7 promoter, and at
the stop codon of the inserted protein. The primer sequences used are shown in Table
2.4. PCR products were checked by agarose gel electrophoresis. 5_l of the 50_l
reaction was used as the template in an in vitro transcription and translation (TNT)
reaction using the TNT Quick for PCR DNA kit (Promega) according to the
manufacturer’s instructions. To radioactively label the protein, the reaction was
supplemented with 4_l of [35S]-methionine (1,000Ci/mmol at 10mCi/ml). The






           Table 2.4. Primers used to PCR-amplify tagged Zfp647 for in vitro expression.
2.7.2. Analysis of [35S]-Labelled Proteins
      To analyse [35S]-labelled proteins, 2_l of a radioactive TNT reaction was added to
18_l of 2x SDS loading buffer and incubated at 95°C for 2 minutes. This was then
loaded onto a pre-cast 10% Novex Bis-Tris gel (Invitrogen), and run according to the
manufacturer’s instructions. The gel was fixed in a solution containing 10%
methanol, 10% acetic acid and 10% glycerol for 15 minutes. The gel was washed in
dH2O for 5 minutes, and then incubated with KODAK™ ENLIGHTNING™ Rapid
Autoradiography Enhancer (Perkin Elmer) containing 10% glycerol for 30 minutes.
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The gel was then dried under a vacuum at 80°C for 90 minutes, and exposed to
autoradiography film (GE Healthcare) for 2-5 days.
2.7.3. Immunoprecipitation of [35S]-Labelled Proteins
      To analyse the efficiency of the immunoprecipitation of one protein, 45_l of an in
vitro TNT reaction was incubated with sepharose beads which had been previously
bound by the appropriate antibody, and 450_l immunoprecipitation (IP) buffer
(20mM Tris (pH7.5), 100mM NaCl, 1% Triton X-100, 20% glycerol, Complete
protease inhibitors (Roche)) for 90 minutes at 4°C on a rotating wheel. The beads
were then washed three times with IP buffer, and resuspended in 20_l 2x SDS
loading buffer. 10-20_l of the final volume was analysed by PAGE.
2.7.4. Co-Immunoprecipitation of In Vitro-Expressed Proteins
      Two differently tagged proteins were in vitro  transcribed and translated, one
using unlabelled methionine contained within the kit, and the other with [35S]-
labelled methionine. After removing a 5_l sample for analysis, the remaining 45_l of
each of the reactions were mixed together and incubated at 37°C for 1 hour. The co-




      Slides were seeded with cells one day prior to use. The following day, slides
were washed twice for five minutes in PBS containing 1.5mM MgCl2 and 1mM
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CaCl2 (all PBS used after this point also contained MgCl2 and CaCl2). Cells were
fixed in 4% paraformaldehyde (pFA) in PBS for 20 minutes at room temperature,
and then washed three times in PBS. Autofluorescence caused by pFA was quenched
by treating the cells with PBS containing 50mM NH4Cl for 10 minutes at room
temperature. Cells were permeabilised with PBS containing 0.2% Triton X-100 for
12 minutes at room temperature, and then washed three times in PBS. Cells were
blocked by incubation in 50_l PBS containing 5% donkey serum (Vector Labs)
under a parafilm coverslip in a humidified chamber for 20 minutes at room
temperature. Slides were then incubated under a fresh coverslip with 50_l blocking
solution containing primary antibody (Table 2.5) for 1 hour at 37°C, or overnight at
4°C. Cells were washed three times in PBS, re-blocked for 10 minutes at room
temperature, and then incubated in 50_l block containing the appropriate secondary
antibody for 1 hour at 37°C. Slides were finally washed three times in PBS, mounted
in Vectashield (Vector Labs) containing 0.4mg/ml DAPI under a glass coverslip and
sealed with rubber solution (Truflex/Pang).
Antibody Species Concentration Source (Product no.)
Zfp647 Rabbit 1:75 Own
KAP-1 Rabbit 1:200 Bethyl Labs (A300-274A)
Tif1_ Mouse 1:200 Gift from Prof Pierre
Chambon (Weber et al,
2002)
PML Mouse 1:200 Millipore (MAB3738)
Zfp37 Rabbit 1:100 Gift from Dr Niels Galjart
(Payen et al, 1998)
Zfp90 Rabbit 1:100 Gift from Dr Niels Galjart
(Payen et al, 1998)
Uhrf1 Rabbit 1:200 Gift from Dr Pier Paolo Di
Fiore (Citterio et al, 2004)
Affinity purified Rbak Guinea pig 1:20-100 Own
FITC-_-rabbit secondary Goat 1:100 Vector Labs (FI-1000)
Texas red-_-rabbit secondary Goat 1:100 Vector Labs (TI-1000)
FITC-_-mouse secondary Horse 1:100 Vector Labs (FI-2000)
Texas red-_-mouse secondary Horse 1:100 Vector Labs (TI-2000)
FITC-_-Guinea pig secondary Goat 1:100 Vector Labs (FI-7000)






      During my Masters project, I carried out a yeast two-hybrid screen to identify
potential Zfp647-interacting proteins. Zfp647 (as well as another KRAB zinc finger
protein, NT2) has been shown to localise to foci containing KAP-1 and HP1 in
differentiated ES cells, which are also situated adjacent to the PML-NBs. To identify
other proteins that might be in KAKA foci, or other proteins involved in the function
of Zfp647, I used the full-length sequence of Zfp647 as the bait. Dr Heidi Sutherland
and Dr Stephanie Briers have studied the expression of Zfp647 in mouse embryos
and adults, and found that the protein is expressed from at least 8.5 days post-coitum
(dpc) until 15.5dpc, thus I used an 11.5dpc mouse embryonic cDNA library as the
prey for my screen. The yeast two-hybrid screen, undertaken as part of my Masters
project in the Bickmore lab, yielded 107 potential Zfp647-interacting proteins;
however, none of these interactions were verified during the course of the project. I
therefore sought to test the results by using the yeast two-hybrid method to identify
false positive results. Following this, I intended to try and co-immunoprecipitate
endogenous Zfp647-interacting proteins from tissue culture cells, and also prove
certain interactions made by Zfp647 using tagged, exogenously expressed proteins.
3.2. Verification of Yeast Two-Hybrid Results
3.2.1. Yeast Two-Hybrid Screen Verification Method
      The potential Zfp647 interactors identified in my yeast two-hybrid screen fell
into six main categories: KRAB zinc finger and tripartite motif proteins (Table 3.1);
non-KRAB domain-containing zinc finger proteins (Table 3.2); chromatin-associated
proteins (Table 3.3); proteins involved in post-translational modification (Table 3.4);
RNA-binding and translation proteins (Table 3.5); and cytoskeletal proteins
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Table 3.1. Auto-activation results for the KRAB zinc finger and tripartite motif proteins rescued from

















Zfp647 (NM_172817) 30 231 ++ 10 No
Zfp1 (NM_001037665) 1 208 ++ 193 No
Zfp26 (NM_011753) 4 129 +/++ 83 No
Zfp30 (NM_013705) 2 232 +/++ 191 No
Zfp51 (NM_009558) 1 494 +++ 90 No
Zfp60 (NM_009560) 1 402 ++ 123 No
Zfp68 (NM_013844) 2 245 ++/+++ 320 No (poor
growing)
Zfp75 (NM_172918) 1 389 ++ 336 No
Zfp90 (NM_011764) 2 365 ++/+++ 464 No
Zfp101 (NM_009542) 1 206 + 46 No
Zfp169 (NM_026450) 2 119 ++ 39 No
Zfp189 (NM_145547) 1 313 ++++ 226 No
Zfp202 (NM_030713) 1 223 + 450 No
Zfp354c (NM_013922) 1 265 ++ 316 No
Zfp386 (NM_019565) 1 350 +++ 199 No
Zfp563 (NM_001024950) 1 84 ++ 669 No
Zfp612 (NM_175480) 13 267 +++ 145 No
Rslcan2 (NM_001001130) 1 73 ++ 452 No
Rslcan11
(NM_001012448)
2 218 ++/+++ 136 No
Rslcan15 (NM_177712) 1 94 +++ 641 No








1 341 + 365 No
Trim23 (NM_030731) 1 8 ++++ 387 No
Trim28 (KAP-1)
(NM_011588)

















Zfp3 (NM_177565) 2 164 +++/++++ 250 No
Zfp62 (NM_009562) 2 625 +++ 164 No
Zfp280c (NM_153532) 2 574 ++ 289 No
Zfp319 (NM_024467) 3 303 ++++ 241 No
Zfp623 (NM_030199) 7 117 +++/++++ 54 No
Zfp668 (NM_146259) 6 168 +++ 71 No
Zfp768 (NM_146202) 1 334 +++ 177 No
Zfp771 (NM_177362) 7 127 ++ 16 No
Gli3 (NM_008130) 1 1 ++ 352 Partial
Zscan21 (NM_001044703) 1 122 + 453 No





3 202 ++++ 95 Yes
Table 3.2. Auto-activation results for zinc finger proteins rescued from Zfp647 yeast two-hybrid

















Prdm5 (NM_027547) 1 335 + 76 No
Prdm15 (XM_907577) 3 402 ++ 141 No
Chromodomain (similar to
HP1_) (NM_007624))





1 1494 +++ 282 No
PREDICTED: Baz1a
(XM_885873)
2 1296 ++/+++ 310 No
Uhrf1 (NM_010931) 3 503 ++++ 326 No
Morf4l1 (Mortality factor 4
like 1) (NM_024431)
1 6 + 746 No
Snw1 (NM_025507) 1 1 + 754 No
Table 3.3. Auto-activation results for chromatin binding proteins rescued from Zfp647 yeast two-

















Mnat1 (Ménage a trois 1)
(NM_008612)









19 18 ++ 312 No
Ube3a (ubiquitin protein
ligase E3A ) (NM_011668)




1 32 ++++ 682 Yes
Table 3.4. Auto-activation results for ubiquitin machinery proteins rescued from Zfp647 yeast two-



















81 1 + 91 No
Rps5 (Ribosomal protein
S5) (NM_009095)









1 197 + 503 No
F1l1 (FIP1 like 1)
(NM_024183)
1 427 ++++ 548 Yes
Rpl5 (Ribosomal protein
L5) (NM_016980)




1 163 + 681 Yes on 3x
Table 3.5. Auto-activation results for translation-associated proteins rescued from Zfp647 yeast
two-hybrid screen. Strength of interaction (+ to ++++) was estimated by X-_-gal staining.
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(Table 3.6). Proteins that did not belong to any of these groups are shown In Table
3.7. Many of these proteins have known DNA-binding domains such as zinc fingers,
thus it is possible that a number of these may be false positive results. Zfp647 was
cloned into the Clontech vector pGBKT7, which fuses the DNA binding domain of
the GAL4 transcription factor to the bait protein. The mouse cDNA library had been
cloned into the pGADT7 vector, which creates a fusion of the prey protein and the
GAL4 activation domain. The yeast strain AH109, into which the bait vector was
transformed, carries the nutritional markers ADE2 and HIS3, which are under the
control of GAL4 promoters. Y187 also carries the lacZ and MEL1 genes, which
encode the _-galactosidase and _-galactosidase enzymes. After mating the AH109
bait strain and the A187 prey yeast strain, an interaction between a prey protein and
the bait leads to the coming together of the two GAL4 domains. This allows the
expression of the ADE2 and HIS3 genes, enabling the mated yeast strain to survive
on media deficient in adenine and histidine. The initial positive results of the screen
were selected for in this way. An interaction between the bait and prey also leads to
the expression of the lacZ and MEL1 genes, which can catalyse the breakdown of the
chemicals X-gal or X-_-gal releasing a dark blue pigment. The strength of the
interaction between the bait and the prey proteins can then be assessed by the
blueness of the yeast colony. However, it is possible that as the prey proteins are
already fused to the GAL4 activation domain, if they bound to the promoters of the
selective markers without interacting with the bait protein, the markers would be
transcribed, giving a false positive result.
      To identify any false positive clones from the screen, one clone encoding each
interactor was rescued from the yeast colonies picked from the screening plates.
These clones are shown in Tables 3.1 – 3.7, and were sequenced to verify the prey
protein present. They were then transformed into yeast strain AH109 carrying either
the empty pGBKT7 vector or pGBKT7-Zfp647. Any clone that allowed growth on
media deficient in adenine and histidine in the absence of Zfp647 demonstrated that
it did not require another protein’s presence to express the nutritional markers, and
was therefore a false positive result (Figure 3.1). 15 clones did not grow when re-



















1 223 + 6 No
Rdx (Radixin)
(NM_009041)
6 1 ++ 18 No
Becn1 (Beclin1)
(NM_019584)
1 110 ++++ 48 No
Tbcb (Tubulin folding
cofactor B) (NM_025548)
1 32 +++ 156 Yes
Myh10 (NM_175260) 5 1636 ++ 188 No
Kif5b (Kinesin family
member 5B) (NM_008448)
1 364 + 254 No
Spag5 (Sperm associated
antigen 5) (NM_017407)





2 1450 +/++ 342 No
Ndel1 (Nuclear distribution
gene E-like homolog 1)
(NM_023668)
1 1 ++++ 430 No
Lasp1 (LIM and SH3
protein 1) (NM_010688)
1 1 + 445 No
Myo6 (Myosin VI)
(NM_001039546)
1 978 ++ 535 No
Vim (Vimentin)
(NM_011701)
1 10 +++ 660 No
Table 3.6. Auto-activation results for cytoskeletal proteins rescued from Zfp647 yeast two-hybrid


















containing 136  (Ccdc136)
(XM_485735)
10 71 ++ 19 No
Ran binding protein 9
(Ranbp9) (NM_019930)








1 1 + 252 No
MTERF domain containing 1
(Mterfd1) (NM_025547)
10 110 ++/+++ 280 No
ATPase, H+ transporting, V0
subunit C  (Atp6v0c)
(NM_009729)
1 32 ++ 335 Yes
RIKEN cDNA 4930432O21
gene (XM_001471514)
1 233 ++ 381 No
Thioredoxin 2 (NM_019913) 2 1 ++++ 496 No
Myelocytomatosis oncogene
(Myc) (NM_010849)
1 151 + 739 No
Replication factor C 1 (Rfc1)
(NM_011258)
1 821 ++ 758 No
Table 3.7. Auto-activation results for unclassified proteins rescued from Zfp647 yeast two-hybrid
screen. Strength of interaction (+ to ++++) was estimated by X-_-gal staining.
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proteins that were tested, ten grew when co-transformed with the empty pGBKT7
vector, and were therefore false positives. These proteins were the GLI-Krüppel
family member GLI3 (Gli3); zinc finger and SCAN domain containing 22 (Zscan22);
DnaJ (Hsp40) homolog, subfamily C, member 21 (Dnajc21); ubiquitin protein ligase
E3A (Ube3A); ubiquitin C (Ubc); RNA binding motif protein 17 (Rbm17); RAN
binding protein 9 (Ranbp9); FIP 1 like 1 (F1l1); ATPase, H+ transporting V0 subunit
C (Atp6v0c); and tubulin folding cofactor B (Tbcb).
3.2.2. Interaction with KAP-1 and ARD1
      Of the 800 clones recovered in the screen, 31 encoded the known KRAB zinc
finger protein co-repressor protein KAP-1. This therefore acted as a positive control,
demonstrating that Zfp647 was capable of interacting correctly in the yeast cells.
Previous studies have shown that the interaction between KAP-1 and the KRAB
domain is mediated by the amino terminus of KAP-1, and it is still unclear from the
literature which domains of KAP-1 are required for this interaction. To identify
KAP-1’s interaction domain, I sequenced each of the KAP-1 yeast clones from the
N-terminus. Many clones in a cDNA library are missing the 5’ end of the mRNA
sequence, due to 5’-3’ degradation of the mRNA during the preparation of the
library, thus the remainder of the sequence must contain the interacting domain. In
the case of the KAP-1 clones, 31 positive colonies were picked and sequenced, and
were found to encode 11 distinct clones. The shortest protein recovered started at
amino acid 119, C-terminal of the RING domain (Figure 3.2). This indicates that the
RING finger is not necessary for interacting with KRAB zinc finger proteins, and
thus it is likely that only the B-boxes and coiled coil domains are required for KAP-
1’s interaction with Zfp647, as shown previously for KAP-1’s interactions with the
KRAB domains of ZNF10 and KRAZ1 (Moosmann et al, 1996; Agata et al, 1999).
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      Zfp647 also interacted with another tripartite motif protein known as Trim23 or
ARD1 (ADP-ribosylation factor domain protein 1). It has been previously reported
that the human homologue of Zfp647, ZNF250, interacts with the human ARD1
protein in a high throughput yeast two-hybrid screen (Rual et al, 2005). This screen
utilized the human ORFeome v1.1 library, which encodes ~ 7200 distinct proteins.
None of the other 13 ZNF250-interacting proteins found in the screen by Rual et al
were identified in my Zfp647 yeast two-hybrid screen. Similarly to my results,
ZNF250 was shown to interact with DNA-binding proteins (ZNF165, LDOC1),
chromatin-binding proteins (ZBTB8) and cytoskeletal proteins (HOOK1, HOOK2
and KRTAP4-12) (Rual et al, 2005). ARD1 and KAP-1 both encode an RBCC
domain at their amino terminus, and thus may also interact with Zfp647 through the
same portion of this structure. Because the only ARD1 clone recovered from the
screen initiated at the eighth amino acid of the protein and therefore also retained the
RING motif (Figure 3.2), I could not determine whether this is in fact the case from
this analysis.
      Unlike the transcription intermediary factors Tif1_, Tif1_ (KAP-1), Tif1_ and
Tif1_, ARD1 does not encode a PHD and bromodomain at its C-terminus; instead it
has an ADP-ribosylation factor domain. Proteins with this domain are associated
with vesicular transport, and can also stimulate ADP-ribosyltransferase activity
mediated by the cholera toxin, although the only function that ARD1 has been shown
to possess is in vitro ubiquitin E3 ligase activity (Vichi et al, 2005). No in vivo
targets of this activity have been demonstrated to date (Professor Martha Vaughan
(National Institutes of Health, Bethesda), personal communication). Antibodies have
been raised against the protein, but the native protein has not been detected in any
tissues or cells tested thus far (Professor Martha Vaughan (National Institutes of
Health, Bethesda), personal communication).
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3.2.3. KRAB Zinc-Finger Protein Homo- and Hetero-Oligomerisation
      One of the most interesting findings from the yeast two-hybrid screen was the
revelation that Zfp647 could interact with itself, and 23 other KRAB zinc-finger
proteins. Zfp647 was encoded in 30 of the 800 clones sequenced, making it the third
highest ‘hit’ in the yeast two-hybrid screen, after ribosomal protein S7 and KAP-1
(see Table 3.1). One other KRAB zinc-finger protein, ZBRK1 is known to homo-
oligomerise through an extended C-terminal domain which is not present in Zfp647
(Tan et al, 2004b), thus another part of Zfp647 must be responsible for self-
interaction. Sequencing of the 30 positive colonies from the screen revealed that 4
distinct clones were present. The cDNA sequences of these clones started at
nucleotide positions 529, 530, 658 and 692 of the Zfp647 sequence; the shortest of
these initiates at the second amino acid of Zfp647’s third zinc finger (Figure 3.2).
Therefore it is most probable that it is through the last 11 zinc fingers that Zfp647
binds to itself.
      Each of the other KRAB zinc-finger proteins from the screen were analysed in
the same manner, and it was found that the KRAB domain, and varying portions of
the linker domain, was missing from each of these sequences. This suggests that the
zinc fingers of Zfp647, as found with the KRAB zinc-finger proteins KZLP
(Watanabe et al, 2007) and Nizp1 (Nielsen et al, 2004), have a protein-binding
function in addition to their putative DNA-binding capabilities. Some of the proteins
identified in the yeast two-hybrid screen (Zfp1, Zfp354c and Zfp612) show a
relatively high level of homology to Zfp647 (between 66 and 70%) across their zinc
finger domains. I therefore investigated whether the zinc finger domains of the
KRAB zinc finger proteins identified in the screen were more similar to Zfp647 than
a group of KRAB zinc finger proteins not identified in the screen. I chose to include
some proteins related to those recovered from the screen (for example, Rslcan12 and
Zfp354a) to see whether they were more dissimilar to Zfp647 than Rslcan11 and
Kid-3. Philippe Gautier (MRC Human Genetics Unit) aligned the peptide sequences
of the zinc finger domains using the MEGA program, an integrated software tool for
Molecular Evolutionary Genetics Analysis (http://www.megasoftware.net). The zinc
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finger domains had variable numbers of zinc finger motifs, and any gaps in the
alignment were removed from the sequence in a pairwise fashion. The minimal
bootstrap value for the phylogenetic tree produced (Figure 3.3) was 50%, meaning
that any of the branches seen in the tree must be present in at least 50% of the trees
generated by the program. No significant clustering of any of the KRAB zinc finger
proteins was observed in the tree, and it appears that those proteins from the yeast
two-hybrid screen (shown in red in Figure 3.3) were no more similar to Zfp647 than
the other proteins (shown in green in Figure 3.3). These results suggest that the
interactions between Zfp647 and KRAB zinc finger proteins identified by the yeast
two-hybrid screen are not due to a high level of similarity between the proteins’ zinc
finger domains.
3.2.4. Zfp647 Interactions with Other Transcription Factors
      Zfp647 interacted with 12 zinc finger proteins (Table 3.2). Three of these
proteins (Gli3, Zscan22 and Dnajc21) auto-activated the expression of the yeast
nutritional markers. Six of the proteins that did not autoactivate the markers (Zfp3,
Zfp280c, Zfp319, Zfp623 and Zfp768) encoded only zinc finger motifs, making it
extremely likely that Zfp647 interacted with these proteins through their zinc fingers.
Disregarding the false positive results, the remaining proteins contained two different
domains: Zfp62 and Zfp771 encode a SFP repressor domain, and Zscan21 contains a
SCAN domain (Figure 3.2). Those proteins containing a SFP domain are believed to
be transcriptionally repressive, whereas Zscan21 is thought to activate transcription.
Thus Zfp647 may potentially interact with both transcriptional activators and
repressors. Additionally, Zfp647 interacted with SNW domain containing 1 (Snw1),
a protein that binds to Daxx, and that can function as a transcription co-factor (Tang
et al, 2005). Snw1 has no recognisable domains when analysed by the SMART
program (http://smart.embl-heidelberg.de/). When over-expressed in tissue culture
cells, Snw1 co-localises with Daxx, often at the PML-NBs, to which Daxx is
recruited by PML (Tang et al, 2005). This protein may therefore provide a link




      None of the chromatin-associated proteins that were pulled out in the screen
caused the autoactivation of the nutritional markers (Table 3.3). These proteins were
PR domain containing 5 (Prdm5) and Prdm15, mortality factor 4 like 1 (Morf4l1),
bromodomain adjacent to zinc finger domain 1A (Baz1a), jumonji domain containing
1c (Jmjd1c), ubiquitin-like, containing PHD and RING finger domains, 1 (Uhrf1)
and an unknown chromodomain protein (Figures 3.2 and 3.4). Morf4l1 can associate
with both HAT and HMTase complexes (Pardo et al, 2002), and loss of the function
of this protein is lethal during embryogenesis (Tominaga et al, 2005). Uhrf1 is
known to bind to and ubiquitylate histone proteins (Citterio et al, 2004). It is also
responsible for loading Dnmt1 onto hemi-methylated DNA, and so is essential for
the maintenance of DNA methylation (Sharif et al, 2007). By contrast, the other
three proteins have not been studied to the same degree, although it is known that
they encode domains capable of binding to, and possibly altering, histone
modifications. Jmjd1c encodes a jumonji domain, which can catalyse the removal of
methyl groups from histones, although Jmjd1c has to date not been found to possess
demethylase activity. Similarly, the PR domain found in Prdm5 and Prdm15 is
highly similar to the SET domain, which functions as a protein methyltransferase,
but Prdm5 and Prdm15 have yet to be shown to be capable of methylating histones or
other proteins. However, Prdm5 is known to interact with the repressive H3K9
HMTase G9a (Duan et al, 2007). Thus Zfp647 may interact with chromatin
modifying complexes other than SETDB1 and Mi-2α.
3.2.6. Ubiquitin Machinery / RING Domain Proteins
      Eight proteins that are involved in the ubiquitylation process, or that have the
ubiquitin E3 ligase RING domain were pulled out of the yeast two-hybrid screen.
Two of these proteins were false positives: Ube3a and Ubc. The five remaining
proteins are ménage a trois 1 (Mnat1), ubiquitin specific peptidase 33 (Usp33),
ubiquitin A-52 residue ribosomal protein fusion product 1 (Uba52), Uhrf1 and ARD1
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(Figure 3.4 and Table 3.4). Mnat1, Uhrf1 and ARD1 have a RING domain; Uhrf1
and ARD1 possess ubiquitin E3 ligase activity. Uhrf1 can ubiquitinate histones in an
in vitro context, in particular histone H3 (Citterio et al, 2004). ARD1 can
ubiquitylate itself, GST protein and UbcH6 (an E2 component) when subjected to in
vitro ubiquitylation assays (Vichi et al, 2005). Narrowing down the interactive
domains of these proteins from the plasmid sequences, Zfp647 may bind to the
RING domains of ARD1, Uhrf1 and Mnat1 (Figure 3.4). The ubiquitin machinery
proteins that were not false positives encode a variety of domains: the MAT1
(Mnat1), DUSP (Usp33), UBQ and ribosomal_L40e domains (both Uba52) (Figure
3.4). These proteins have varying functions in ubiquitylation. Uba52 is a source of
ubiquitin within the cell, whereas Usp33 removes ubiquitin molecules from poly-
ubiquitylated substrates (Li et al, 2002). Mnat1 encodes a RING domain, making it a
potential E3 ligase, but thus far is known to act as a stabilising factor to the Cdk7-
cyclin H complex, which is responsible for phosphorylating serine 5 (Ser5) of the
heptapeptide repeats found in the C-terminus of RNA polymerase II, allowing it to
initiate transcription (Devault et al, 1995; Fisher et al, 1995; Tassan et al, 1995). It is
unknown why Zfp647 might be interacting with these particular ubiquitin-related and
RING domain proteins, but these results suggest that there is a link between Zfp647
and ubiquitylation.
3.2.7. RNA Binding and Translation Machinery Proteins
       One RNA-binding protein (Rbm17) of the seven tested via the auto-activation
method yielded a false positive result (Table 3.5). The protein recovered the most
times from the yeast two-hybrid screen, ribosomal protein S7 (Rps7), did not
autoactivate the marker genes. Although the ribosomes are mainly located in the
cytoplasm, and Zfp647 is found in the nucleus, Rps7 could interact with Zfp647 in
an endogenous setting, as it has been shown to be imported into the nucleus by four
different import receptors (Jäkel and Görlich, 1998). Rps7 can interact with other
non-ribosomal proteins, as it has been demonstrated to bind to MDM2, preventing
the MDM2-mediated ubiquitylation and subsequent degradation of the tumour
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suppressor protein p53 (Chen et al, 2007). Whether the interaction between Zfp647
and Rps7 does occur endogenously, however, requires further investigation.
3.2.8. Cytoskeletal Proteins
      The twelve cytoskeletal proteins were also tested for their potential for auto-
activation: one protein (Tbcb) auto-activated the nutritional markers (Table 3.6).
Despite the number of different cytoskeletal proteins pulled out in the screen, I
believe it is unlikely that these factors bind to Zfp647 endogenously, firstly because
of their differing functions to that of Zfp647, and secondly because of the very poor
growth of the colonies when they were re-tested. The majority of the proteins tested
for auto-activation grew well on the selective media, whereas two-thirds of the
cytoskeletal proteins did not grow on at least one of the two selective plates they
were tested on. Therefore I believe these positive results were due to an interaction
that only occurred in the yeast cells. Similarly, many of the proteins pulled out of the
screen but not classified into a particular functional group, shown in Table 3.7, gave
poor growth, and also localize to structures such as the mitochondria (e.g.
Thioredoxin), thus it is unlikely that many of these proteins interact with Zfp647.
3.3. Cellular Localisation of KRAB Zinc-Finger Proteins and
Potential Zfp647-Interacting Proteins
     Studies on the sub-cellular localisation of various KRAB zinc-finger proteins
have generally been carried out using the overexpression of a fluorescently tagged
fusion protein, allowing visualisation of the protein without having to raise an
antibody against it. Due to the high homology between KRAB zinc finger proteins,
particularly those encoded in multi-gene clusters, raising specific antibodies against
these proteins may be problematic. However, we have found that the localisation of a
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GFP-tagged Zfp647 construct does not completely mirror that of the endogenous
protein, revealed by immunofluorescence studies using a rabbit _-Zfp647 antibody
(Briers et al, 2009), suggesting that an exogenous protein does not necessarily
behave in the same manner as the endogenous protein. A number of the papers using
this method of over-expression to study KRAB zinc finger proteins may have lost the
detailed pattern of staining within the cell, and instead only achieve a general picture
of localisation (Qi et al, 2005; Ou et al, 2005; Cao et al, 2005). A few studies have
outlined more specific localisations of KRAB zinc finger proteins, in some cases co-
staining with interacting proteins. For example, Lee et al have described an
interaction between the zinc fingers of the human protein ZNF133 and the protein
inhibitor of activated STAT1 (PIAS1), and demonstrated that the proteins co-
localised at nuclear speckle structures by co-expression of the tagged proteins (Lee et
al, 2007c). PAROT localises to punctate foci within the nucleus, and directly co-
localises with KAP-1, HP1_, HP1_, HP1_ and PML (Fleischer et al, 2006).
      Nevertheless, only a small number of KRAB zinc finger proteins have had
antibodies raised against them. Tanaka et al raised a rabbit polyclonal antibody
against the mouse KRAB zinc finger protein NT2, although they did not use this
antibody to study the sub-cellular localisation of the protein (Tanaka et al, 2002).
Huang et al used a rabbit polyclonal antibody against ZNF23 to detail its nuclear
localization (Huang et al, 2007). Most pertinently for this study, Payen et al, as well
as raising an antibody against Zfp37, which again shows nuclear localisation, raised
an antibody against Zfp90, one of the KRAB zinc finger proteins found to interact
with Zfp647 in my yeast two-hybrid screen (Payen et al, 1998). The localisation of
Zfp90 was not outlined in this paper, however. Zfp90 is the only murine KRAB zinc-
finger protein from the yeast two-hybrid screen to have an antibody raised against it
to date. Another potential interactor that has had antibodies raised against it is Uhrf1,
which binds to and ubiquitinates histones (Citterio et al, 2004).
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3.3.1. Localisation of Zfp647 in Mouse Cells
      Drs Heidi Sutherland and Stephanie Briers showed that Zfp647 can localize to
non-heterochromatic foci in differentiated ES cells (Briers et al, 2009). However, in
NIH/3T3 cells, the localization of Zfp647 was only analysed with the use of the
GFP-tagged Zfp647 construct, which we believe mislocalises. I therefore decided to
study the localisation of endogenous Zfp647 in two cell lines, NIH/3T3 cells and
primary mouse embryonic fibroblasts pMEF cells. This would allow me to see
whether Zfp647 exhibits the same behaviour in these cells as in mouse ES cells, and
therefore whether KAKA foci are a common occurrence in different cell lines, or
whether they are restricted to specific cell types.
      NIH/3T3 cells were grown on glass slides, fixed in pFA and incubated with
rabbit _-Zfp647, mouse _-KAP-1 and mouse _-PML antibodies (Section 2.8.1;
Figure 3.5A-C). In NIH/3T3 cells, Zfp647 appears to be diffuse within the nucleus.
The large punctate foci observed in ES cells did not appear to be present, although
Zfp647 gave a slightly granular appearance, with some small foci present (arrowed in
Figure 3.5B and C). However, Zfp647 was not seen to co-localise with KAP-1 in a
significant number of nuclei, as seen in differentiated ES cells. Similarly, I did not
see the twinning of these smaller Zfp647 foci with PML, which was seen in
differentiated ES cells. KAP-1 is seen to localize to the pericentric heterochromatin
in differentiated ES cells (Figure 1.11). I did not see this localisation in NIH/3T3
cells; instead, KAP-1 was more diffuse, with a granular staining pattern (Figure 3.5A
and B).
      I also studied the localisation of Zfp647 in pMEFs. I generated these cells from
12.5dpc mouse embryos (Section 2.2.3), and carried out immunofluorescence on
early passage cells (either passage 5 or 6) with rabbit _-Zfp647, mouse _-KAP-1 and
mouse _-PML antibodies (Figure 3.5D-E). In approximately 15% of the cells
analysed, Zfp647 could be seen at distinct nuclear foci. These Zfp647 foci co-
localised with KAP-1 (arrowed in Figure 3.5D), which could also be seen at the
pericentric heterochromatin (double arrowheads in Figure 3.5D). Similar to the
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localisation results from differentiated ES cells, the Zfp647 foci were also adjacent to
the PML nuclear bodies in approximately 10% of cells (double arrowheads in Figure
3.5E). Therefore while it appears that the KAKA foci are not obvious in NIH/3T3
tissue culture cells, they are present in a proportion of pMEFs.
3.3.2. Immunofluorescence of Potential Zfp647 Interacting Proteins
      Two antibodies against other KRAB zinc finger proteins (Zfp37 and Zfp90) were
received from Dr. Niels Galjart (Erasmus MC, Rotterdam). Both of these antibodies
were raised against the linker regions of the proteins, and both were raised in rabbits,
therefore it was not possible to co-stain nuclei for any of the KRAB zinc finger
proteins together. I co-stained NIH/3T3 cells with the antibodies specific for either
Zfp37 or Zfp90 with mouse _-KAP-1. Dr Heidi Sutherland performed
immunofluorescence on differentiated ES cells using the same antibodies. The
immunofluorescence results for the NIH/3T3 cells are shown in Figure 3.6A-D.
Zfp37 appeared to be relatively diffuse throughout the nucleus, but was also seen at
what may be nuclear foci (Figure 3.6A). However, these foci do not show any
significant co-localisation with KAP-1 in NIH/3T3 cells. In differentiated OS25
cells, Zfp37 was also nuclear diffuse and was not seen to localise to specific foci in
experiments carried out by Dr Heidi Sutherland (data not shown). Like Zfp37, Zfp90
also localised to the nucleus in NIH/3T3 cells and gave a fine speckled appearance
(Figure 3.6B). There was no significant co-localisation of Zfp90 with KAP-1 in
NIH/3T3 cells, and Zfp90 was not seen to localise to KAKA foci in differentiated
OS25 cells (data not shown).
      An antibody was also received from Dr. Pier Paolo Di Fiore (IFOM, Milan),
which was raised against the histone ubiquitin ligase Uhrf1 (Citterio et al, 2004).
This antibody was raised in rabbit, which was immunised using the full-length
protein (Citterio et al, 2004). Uhrf1 localised to the nuclei of mouse cells, and in
approximately half the cells analysed gave a strong signal from the heterochromatic
DAPI bright spots (arrowed in Figure 3.6C). Where the protein was not localised to
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the heterochromatic bright spots, it was diffuse throughout the nucleoplasm, but did
not co-localise with KAP-1 (Figure 3.6D).
      These experiments therefore suggested that like in undifferentiated ES cells,
Zfp647 is not particularly found in KAKA foci in NIH/3T3 cells, but that these
structures are present in pMEFs. The two other KRAB zinc finger proteins tested,
Zfp37 and Zfp90, did not localize to KAKA foci in either NIH/3T3 or differentiated
ES cells, suggesting that recruitment to the KAKA foci may be specific to specific
proteins in certain cell types.
3.4. Rbak Antibody
      Given the dearth of good antibodies against mouse KRAB zinc-finger proteins, I
decided to generate an antibody against one of those from the yeast two-hybrid
screen. As the majority of the _-KRAB zinc finger protein antibodies that have been
generated were raised in rabbit, my antibody would be raised in Guinea pig, to allow
co-localisation studies in mouse nuclei with rabbit, mouse and sheep antibodies. I
chose to raise the antibody against the RB-associated KRAB repressor protein
(Rbak), which I found interacting with Zfp647 in the yeast two-hybrid screen (Table
3.1). This 711 amino acid protein shows the typical KRAB zinc-finger protein
structure, with an N-terminal KRAB domain and 15 zinc finger motifs (Figure 3.2).
The Rbak gene is found on mouse chromosome 5, band G2, and is not part of a large
multi-gene cluster. One KRAB zinc-finger protein gene, Zfp12, is found in the near
vicinity of Rbak, approximately 60kb away. Zfp12 and Rbak show only 32% peptide
sequence identity over their linker regions, although their KRAB and zinc finger
domains are more similar.
      RBAK was originally identified as an interacting partner of the retinoblastoma
gene product, RB, in a yeast two-hybrid screen using human proteins (Skapek et al,
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2000). This interaction occurs through the linker region of RBAK. It has also been
documented that RBAK interacts with the androgen receptor (AR) through its
carboxy terminus, again in a yeast two-hybrid screen, backed up by co-
immunoprecipitation and mammalian two-hybrid data (Hofman et al, 2003). In this
case, RBAK appears to function as a coactivator of AR rather than a transcriptional
repressor. Skapek et al raised an antibody against the human RBAK protein, but did
not use this resource to analyse the localisation of the endogenous protein (Skapek et
al, 2000). Instead, they expressed myc-tagged Rbak and detected the protein using _-
myc antibodies. It was reported that myc-Rbak localised to the nucleus, and was
possibly excluded from the nucleolus. The linker sequences of the human and mouse
Rbak proteins show only 54% identity at the amino acid level, therefore the mouse _-
human RBAK antibody is unlikely to detect the murine Rbak protein.
3.4.1. Generation of Rbak Antibody
      Primers were designed to amplify the DNA sequence encoding amino acids 69-
257 of Rbak, which comprise the linker region between the KRAB and zinc finger
domains (Figure 3.7A). The Rbak-linker PCR product was cloned into the pGEX-4T-
1 vector (hereafter known as pGEX), N-terminally tagging the protein with GST.
Competent BL21 E. coli cells were transfected with this vector, and were induced to
express GST-Rbak by treatment with IPTG for 3 hours (Section 2.5.1). The protein’s
solubility was tested by making whole cell, soluble and insoluble extracts from these
cells, and running them out by PAGE (Figure 3.7B). pGEX expresses GST protein
when induced, seen at 28kDa. The linker region of Rbak has a predicted molecular
weight of 21kDa. Coupled with the 28kDa GST protein, the Rbak linker antigen
should have a molecular weight of approximately 49kDa. A band corresponding to
GST-Rbak linker can be seen at ~50kDa after 3 hours of induction, and the majority
of the protein is in the soluble fraction (Figure 3.7B). To produce a sufficient amount
of antigen for immunization, a large-scale bacterial culture was induced to express
the GST-Rbak linker. This protein was purified from the bacterial lysate by
incubation with glutathione beads, to which GST binds, and was then concentrated
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and sent to Eurogentec. The antigen was initially used to immunise two Guinea pigs.
Each animal was injected four times with the antigen, on days 0, 14, 28 and 56. Four
bleeds were taken from the animals: one pre-immune serum, two bleeds from days
38 and 66, and a final bleed from day 87. Unfortunately one Guinea pig died prior to
the final bleed being taken, therefore the expression of the antigen and immunisation
of one Guinea pig was repeated. The first animal to be immunised was labelled
SKC026, the second was SKC047.
      To assess whether the final bleed serum contained antibodies specific for Rbak,
the pre-immune and final bleed sera were diluted and used in a western blot against
the Rbak linker antigen. Whole cell lysates from bacteria carrying the pGEX vector
made after 4 hours of induction, and from bacteria transformed with the pGEX-Rbak
linker vector (prior to and following induction) were western blotted with the sera
diluted at 1:2500. The autoradiographs from the experiments using pre-immune and
final bleed sera from animal SKC026 are shown in Figure 3.8A, and those from
animal SKC047 are shown in Figure 3.9A. Neither pre-immune serum detected any
proteins in the bacterial lysates. Both final bleed sera strongly detect a band of
approximately 50kDa (Figures 3.8A and 3.9A), which corresponds to GST-Rbak
linker. As the animals were immunized with a GST-fusion protein, it was likely that
antibodies would be raised against GST as well as the Rbak portion of the antigen:
these antibodies are clearly present in animal SKC026’s final bleed serum, seen in
the pGEX 4 hour lane (Figure 3.8A). Antibodies present in this serum also detect a
non-specific band at 80kDa (Figure 3.8A).
      The final bleed sera were then tested against mouse cell extracts, to see whether
they could bind to endogenous Rbak. The predicted size of the full-length protein is
82kDa, and Skapek et al found that their antibody against human Rbak detected a
band at 80kDa (Skapek et al, 2000). NIH/3T3 whole cell, nuclear and cytoplasmic
extracts were probed with the pre-immune and final bleed sera from both Guinea
pigs, again at a range of dilutions (1:1000 – 1:5000) (Figures 3.8B and 3.9B). The
pre-immune sera from both animals show a minimal amount of signal on the western




these animals (Figures 3.8B and 3.9B) The final bleed serum from Guinea pig
SKC026 strongly detects a band at approximately 90kDa in the whole cell and
nuclear extracts (Figure 3.8B), which would indicate that this serum contains
antibodies that can detect the endogenous mouse Rbak protein. The final bleed serum
from Guinea pig SKC047 also seems to detect this band, but at a much lower level
compared to the SKC026 serum (Figure 3.9B). The SKC047 serum detects another
band at 50kDa more strongly; this unknown protein is found in both the nuclear and
cytoplasmic fractions of the cell (Figure 3.9B). The SKC026 serum also detects a
predominantly cytoplasmic band, at approximately 85kDa (Figure 3.10, indicated
with asterisk). Because of the presence of a strong nuclear band at the correct size on
the western blots carried out with the SKC026 serum, I decided to carry out all
further work using this antibody.
3.4.2. Purification of Guinea Pig _-Rbak Serum
      The final bleed serum of Guinea pig SKC026 was affinity-purified on an affinity
column containing the Rbak linker isolated on sepharose beads (Section 2.5.4).
Ideally, the Rbak protein would have been a His6-tagged construct. This would mean
that the antibodies against GST that are present in the serum would not bind to the
column, purifying only the antibodies specific to Rbak. A His6-tagged Rbak linker
construct was cloned in the pET32a vector, and transfected into E. coli cells.
However, when expressed, the His6-Rbak linker protein was insoluble, and thus
could not be bound to sepharose beads to make a column (data not shown). To
remove antibodies against GST, the serum was first passed over an affinity column
for another GST fusion protein, GST-p52, which is a splice variant of the lens
epithelium-derived growth factor (LEDGF), a protein unrelated to Rbak. The _-Rbak
serum could then be purified over a GST-Rbak affinity column.
      Purified _-RBAK antibody was first tested by western blot against mouse
NIH/3T3 whole cell, nuclear and cytoplasmic extracts in dilutions from 1:200 to
1:1000 (Figure 3.10A show the results using a 1:200 dilution). The western blot of
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the same extracts probed by the unpurifed SKC026 serum is shown alongside these
results. By direct comparison, it is clear that the affinity-purified antibody does not
give as strong a signal as the unpurified serum. There appears to be a band present at
approximately 80kDa in the whole cell and nuclear extracts when blotted with the
purified antibody, which may correspond to Rbak. This band is slightly higher in the
nuclear extract than in the whole cell extract, which is also the case with extracts
probed with the unpurified serum. Non-specific bands are also seen at ~50kDa and
100kDa (Figure 3.10A).
      The purified antibody was also checked for its ability to detect Rbak within
mouse cells by immunofluorescence. NIH/3T3 cells were incubated with 1:20 –
1:100 dilutions of the purified Rbak antibody and 1:1000 rabbit _-KAP-1 antibody,
which were detected with FITC-conjugated _-Guinea pig and Texas red-_-rabbit
secondary antibodies. Images of these cells are shown in Figure 3.10B and C. The
speckled nuclear pattern of KAP-1 can be seen in both cells shown (Figure 3.10B
and C). However, like the immunofluorescence with the unpurified Guinea pig
SKC026 (data not shown), the staining seen with the affinity-purified antibody is
almost completely cytoplasmic, and there is hardly any signal from the nucleus. The
detected protein cannot be the 90kDa band seen in NIH/3T3 extracts, as that protein
was almost completely nuclear (Figure 3.10, right-hand panel). There is no problem
with the permeability of the cells, as the _-KAP-1 antibody has stained the nucleus,
therefore it is unlikely that the SKC026 antibody has been prevented from entering
the nucleus. Thus either the serum is staining an unknown cytoplasmic protein in this
immunofluorescence experiment, or Rbak is not the nuclear protein observed by
western blot, but is instead the lower, more cytoplasmic band. Although we predict
that Rbak is nuclear, and tagged RBAK been observed in the nucleus (Skapek et al,
2000), it may be that mouse Rbak localises to the cytoplasm. Because I was unsure
which of these hypotheses was correct, I did not carry out any further
immunofluorescence experiments with this antibody.
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3.5. Co-Immunoprecipitation of Endogenous Zfp647 Interactors
      My yeast two-hybrid screen has revealed many putative Zfp647 interactors.
However, these proteins were identified using a non-endogenous system, thus they
may not interact with Zfp647 in vivo. I therefore attempted to identify Zfp647-
interacting proteins in an endogenous manner. Because antibodies specific to Zfp647
had been successfully generated in the lab, I chose to immunoprecipitate Zfp647, and
try to identify putative interacting proteins by mass spectrometry. If this method
generated any results that overlapped with those from the yeast two-hybrid screen, it
would serve as an independent verification of these results. The co-
immunoprecipitations were carried out in NIH/3T3 cells. Previous work has shown
that Zfp647 is not recruited to KAKA foci in this cell line, as it is in pMEF or
differentiated ES cells (Figure 3.5). However, carrying out a large-scale
immunoprecipitation was not viable with differentiated ES cells, given the small
amount of protein gained from a flask of these cells, and the large amount of material
required for the mass spectrometry. Similarly, I experienced difficulties growing
pMEF cells for high numbers of passages, which was also needed to generate enough
material for both the immunoprecipitation and the control. Therefore I decided to
carry out the co-immunoprecipitation experiment with NIH/3T3 cells. While this
might not tell me proteins that co-localised with Zfp647 at the KAKA foci, it may
enable me to gain an insight into possible functions of Zfp647 by revealing putative
endogenous interacting proteins, and also other factors that may function in KRAB-
mediated transcriptional repression.
3.5.1. Testing of Rabbit and Sheep _-Zfp647 Antibodies
      I initially tested both the rabbit and sheep antibodies raised against Zfp647 by
western blot to show that both could bind to Zfp647, and were not specific to any
other proteins in the mouse proteome. Both antibodies were raised against the linker
region of Zfp647, and were affinity purified from the final bleed sera using the same
region of the protein. Mouse lines have been established by Drs Heidi Sutherland and
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Stephanie Briers from the gene-trapped Zfp647 ES cells, allowing the generation of
wild type mice and mice both heterozygous and homozygous for gene-trapped
Zfp647. I tested the antibodies against protein extracts made from wild-type and
homozygous gene-trapped mouse embryos (Figure 3.11). The sheep antibody detects
a band at 60kDa, corresponding to the predicted size of Zfp647, in the wild-type
protein extract, which is not seen in the gene-trapped mouse extract. Similarly, this
band is only detected by the rabbit antibody in the wild-type extract and not the gene-
trapped extract. Both the sheep and rabbit antibodies detect this band in a NIH/3T3
cell nuclear extract. The rabbit antibody additionally gives a signal at approximately
40kDa in the mouse gene-trapped extract. This band does not disappear when
endogenous Zfp647 is lost, therefore it seems unlikely that it is a degradation or
cleavage product of Zfp647. Analysis of whole cell, cytoplasmic and nuclear
NIH/3T3 extracts show that the band is cytoplasmic (Figure 3.11), and therefore
should not interfere with immunofluorescence studies of the endogenous protein, nor
with studies carried out using NIH/3T3 nuclear extracts.
3.5.2. Immunoprecipitation of Zfp647
      To successfully co-immunoprecipitate Zfp647-interacting proteins, I first needed
to verify that I could immunoprecipitate Zfp647 itself. As the two _-Zfp647
antibodies were raised in different species, this allowed me to immunoprecipitate
Zfp647 with one antibody, and test for its presence with the other. Because rabbit
antibodies have a much higher affinity to protein G than sheep antibodies have to
either protein A or G (Harlow and Lane, 1988), I bound this antibody to protein G
sepharose beads, incubated these with NIH/3T3 nuclear extract, and washed the
beads (Section 2.4.5). The immunoprecipitated material was then run out by PAGE
and western blotted with sheep _-Zfp647 (Figure 3.12). If the immunoprecipitations
are prepared for PAGE with reducing agent in the Laemmli buffer, the IgG bands run
at approximately the same size as Zfp647, therefore these immunoprecipitations were




above and below the predicted size of Zfp647. The sheep antibody recognizes the
60kDa Zfp647 band in the input, as shown previously (Figure 3.11). The same sized
band can clearly be seen between the IgG bands only in the immunoprecipitation
lane, therefore I have shown that this antibody can successfully immunoprecipitate
Zfp647 from nuclear extracts. I also western blotted the immunoprecipitated material
with mouse _-KAP-1 antibody, to see whether a known protein interactor could be
co-immunoprecipited by this antibody. However, despite numerous attempts at this
experiment, I was unable to confirm the presence of KAP-1 in the
immunoprecipitated material (data not shown). This may be because Zfp647 does not
bind to KAP-1 in NIH/3T3 cells, or the antibody may interfere with the interaction
between the two proteins, therefore preventing the co-immunoprecipitation of
Zfp647-KAP-1 complexes. Alternatively, the Zfp647 epitope may be masked by the
KRAB-KAP-1 interaction, given the proximity of the linker region to the KRAB
domain.
3.5.3. Mass Spectrometry of Co-Immunoprecipitated Proteins
      To identify potential interacting proteins, the immunoprecipitations were run out
by PAGE and silver stained. Any bands present in the immunoprecipitated material
that were not in the control lanes could be potential interactors, and would be cut
from the gel and subjected to mass spectrometry. Although leaving out reducing
agent from the SDS loading buffer when the immunoprecipitations were run out by
PAGE allowed the clear identification of Zfp647 by western blot, I included reducing
agent in the immunoprecipitations that were run out and silver stained to remove the
smear from the lanes. I also scaled up the immunoprecipitations by increasing the
amount of input, beads and antibody used, in order to maximize the signal of any co-
immunoprecipitated material. In total, cells confluent in 8x 14cm tissue culture plates
were harvested for each immunoprecipitation. Two immunoprecipitations were
carried out simultaneously, in the presence and absence of the chemical N-
ethylmaleimide (NEM). NEM is a cysteine protease inhibitor, and preserves
ubiquitin-like modifications on proteins, a topic that will be further discussed in
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Chapter 4. Both immunoprecipitations and their controls were run out by PAGE on a
pre-cast gel and silver stained (Figure 3.13). The control lanes lacking antibody show
a high degree of background: most of the bands present in the immunoprecipitation
lanes are also present in the control lanes (compare lanes 4 and 5 with lanes 2 and 3).
However, a number of bands were present only in the immunoprecipitated lanes, and
three of these (marked in Figure 3.13) were excised from the gel and sent to the
SIRCAMS mass spectrometry service at the University of Edinburgh Chemistry
Department. Here, the samples were digested with trypsin and subjected to matrix-
assisted laser desorption/ionization time of flight (MALDI-TOF) mass spectromeric
analysis, whereby the tryptic fragments are ionised by a laser, and their molecular
weight is calculated by their time of flight through a chamber of known length. From
piecing together different peptide fragments, the computer program ProFound
(http://prowl.rockefeller.edu/) can generate ‘hits’: proteins that contain peptides of
those sizes. The results received for each band are shown in Table 3.8. The
expectation score represents how likely it is that this protein is a true match: an
expectation value of 1 means that you would expect one match if you used the mass
spectrometry data for a particular protein to search a database that you knew did not
contain that protein. The smaller the expectation number, the greater the likelihood
that the match is true: an expectation value of 0.01 means that you would expect one
match to your data in 100 databases that did not contain your protein. Therefore the
expectation value functions similarly to a p-value. The % value shows the percentage
of the protein covered by the recovered peptides; pI shows the estimated protein pI
value; and kDa represents the protein’s estimated molecular weight in kDa.
      Using the typical value of statistical significance of 0.05, none of the protein
results obtained are statistically significant. One result almost reaches statistical
significance, and this is the top-ranked result for Band 3, Jarid1b. Jarid1b is a
jumonji domain-containing protein, also known as PLU-1. The coverage of the
protein by the recovered peptides was not high, at 13% (a good hit is considered to
be one that gives 20% coverage), but the peptides cover a wide range over the length
of the protein, shown in Figure 3.14. At 179kDa, the protein is also approximately
the correct size for the band on the gel, unlike other results in Table 3.8 (for example,
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Table 3.8 Mass spectrometry results for Zfp647 co-immunoprecipitation. Table shows proteins
identified as hits in mass spectrometry of bands shown in Figure 3.14. % indicates the proportion
of the protein covered by the identified peptides.
Band Rank Protein (Accession No.) Expectation % pI kDa
1 1 Protein tyrosin kinase 2 beta (Ptk2b)
(NM_172498)
0.39 13 5.7 117
1 2 Coiled-coil domain containing 18
(Ccdc18) (NM_028481)
0.72 13 5.2 48
1 3 Protein tyrosine phosphatase,
receptor type, f polypeptide
interacting protein alpha 1 (Ppfia1)
(NM_001033319)
0.72 13 5.7 117
1 4  Deleted in liver cancer 1 (Dlc1)
(NM_001127446)
0.83 11 7.5 124
2 1 Phosphodiesterase 10A (Pde10a)
(NM_011866)
0.20 22 6.3 90
2 2 Deleted in liver cancer 1 (Dlc1)
(NM_001127446)
0.35 15 7.5 124
2 3 Protein tyrosine phosphatase,
receptor type, T (Ptprt)
(NM_021464)
0.84 7 6.4 164
2 4 Junction plakoglobin (Jup)
(NM_010593)
0.88 16 6.0 69
3 1 Jumonji, AT rich interactive domain
1B (Jarid1b) (NM_152895)
0.070 13 6.0 179
3 2 Protein tyrosine phosphatase, non-
receptor type 13 (Ptpn13)
(NM_011204)
0.23 13 8.5 116
3 3 MutS homolog 6 (Msh6)
(NM_010830)
0.48 12 6.3 153
3 4 Myosin, heavy polypeptide 9, non-
muscle (Myh9) (NM_022410)
0.53 11 5.4 156
3 5 Deleted in liver cancer 1 (Dlc1)
(NM_01127446)
0.62 13 7.5 125
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Ptpn13). Proteins belonging to the Jarid1 family are H3K4 demethylases
(Christensen et al, 2007; Iwase et al, 2007; Yamane et al, 2007), and can therefore
function as transcriptional repressors. Human JARID1B possesses H3K4
demethylase activity (Yamane et al, 2007), and is upregulated in breast and prostate
cancer (Lu et al, 1999; Xiang et al, 2007). While this result is not statistically
significant, it would be of worth to try to verify whether Zfp647, KAP-1 or another
protein involved in KRAB zinc finger protein-mediated transcriptional repression
interacts with Jarid1b, or other jumonji domain protein, as I have identified two
jumonji domain proteins as possible Zfp647-interactors (Section 3.2.5).
3.6. Co-Immunoprecipitation of Tagged Zfp647
      Despite my yeast two-hybrid screen yielding results that were probably ‘true’
interactions, none of these results were verified by co-immunoprecipitating
endogenous Zfp647 interactors from NIH/3T3 cells. I therefore decided to try and
validate the yeast two-hybrid results using a separate method. The first interaction I
focussed on was that of the self-interaction of Zfp647. Although it had already been
found that the endogenous protein behaves differently to an overexpressed Zfp647
fusion construct with respect to its localisation, I chose to look at the interaction
between two fusion proteins as I did not believe that N-terminal protein tags would
interfere with the interaction domain in Zfp647’s C-terminus. Analysing the
interaction between two fusion proteins would also be the simplest way to detect the
homo-oligomerisation of Zfp647.
3.6.1. Expression of Tagged Zfp647 Constructs
      I initially planned to clone and express two soluble, tagged forms of Zfp647
either by bacterial expression, or in mouse tissue culture cells. This would allow me
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to immunoprecipitate one of the proteins with an antibody against one of the tags,
and detect for an interaction with the alternatively tagged Zfp647 protein by
immunoblotting the immunoprecipitated material with an antibody against the other
tag. I attempted to express three different forms of Zfp647, with GST, T7 and His6
tags.
3.6.1.1. Cloning and Expression of Bacterial GST-Zfp647
      To show that ZBRK1 homo-tetramerises, Tan et al  expressed ZBRK1 fused to
maltose binding protein (MBP) in E. coli (Tan et al, 2004b). This protein was bound
to amylase resin, incubated with in vitro-expressed, radio-labelled ZBRK1, and their
interaction was demonstrated by the detection of a radioactive signal from the resin.
Similarly, Nielsen et al immobilised GST-NSD1, a histone methyltransferase, on
glutathione-sepharose, and confirmed its ability to bind to the KRAB zinc-finger
protein Nizp1 by incubating it with bacterially-expressed His6-Nizp1 and blotting the
resin-bound proteins with an _-His6 antibody (Nielsen et al, 2004). I chose to express
Zfp647 with a GST tag, immobilise this protein on glutathione beads, and carry out
the immunoprecipitation in a similar manner using, as a prey protein, in vitro-
expressed Zfp647.
      The full length sequence of Zfp647 was cloned into the pGEX vector to give the
protein an N-terminal GST tag. This plasmid was transfected into BL21 E. coli cells,
which were induced to express the protein at 37°C for 4 hours. To carry out a co-
immunoprecipitation experiment, the protein must be soluble, as any insoluble matter
is removed from the lysate prior to incubation with beads. Whole cell and soluble
extracts were therefore prepared from these bacterial cultures before and after
induction, and analysed by PAGE (Figure 3.15A). A culture of bacteria carrying the
empty pGEX vector was also induced as a control, and soluble GST protein is clearly
expressed by these cells 4 hours after induction with IPTG. GST-Zfp647 of the
expected size (80kDa) is also expressed following induction of the culture, and can
be seen in the total cell extract. However, unlike the GST protein, GST-Zfp647 is not
125
126
present in the soluble fraction when expressed at 37°C, therefore this protein is
insoluble under these conditions. This may be due to the incorrect folding of the
protein resulting from high levels of expression, which can lead to the formation of
insoluble protein aggregates. The insoluble protein lysates were therefore treated
with up to 5M urea, which denatures the non-covalent bonds of the protein’s
structure, and should help to remove protein aggregates. The proteins were then
allowed to re-fold, ideally solubilising Zfp647. However, when analysed, the urea-
treated lysates did not yield any soluble GST-Zfp647 protein (data not shown).
      GST-Zfp647 was then expressed at a range of temperatures, which may slow
down the level of protein production, promoting the correct folding of Zfp647 and
increasing its solubility. Expression of GST-Zfp647 was attempted at 30°C, 23°C
and 16°C. Protein was only successfully harvested from bacteria growing at 30°C
and 23°C; at 16°C, the culture did not grow well, barely completing one doubling
within 3 hours. Figure 3.15B shows the total, soluble and insoluble extracts from
cultures grown at 30°C; the results from the culture grown at 23°C were identical.
GST-Zfp647 is clearly expressed, but is insoluble. As bacterially-expressed Zfp647
is not soluble at 37°C, 30°C or 23°C, full-length GST-Zfp647 could not be used in a
co-immunoprecipitation experiment.
3.6.1.2. Cloning and Expression of Mammalian His6-Zfp647 and T7-Zfp647
      An alternative to producing Zfp647 bacterially was to clone the protein into
vectors that would allow expression in mammalian cells. I created two such Zfp647
constructs: one in the vector pCGT7, giving the protein an N-terminal T7 tag
(Cáceres et al, 1997); and one in the vector pcDNA3.1(+) (hereafter referred to as
pcDNA). To create the insert for the latter plasmid, the full-length Zfp647 sequence
was amplified by PCR using a 5’ primer containing the nucleotide sequence CAT
CAT CAC CAT CAC CAT, tagging the protein with six histidine residues. I planned
to co-transfect the two vectors into NIH/3T3 cells, make protein extract from these
cells and immunoprecipitate Zfp647 with an _-T7 antibody. The immunoprecipitated
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material would then be western blotted with an _-His6 antibody to detect the ability
of the protein to oligomerise. First, the two plasmids were independently transfected
into NIH/3T3 cells, and soluble and insoluble nuclear extracts were made, in order to
ascertain the solubility of the tagged proteins.
       Extracts were made at a range of NaCl concentrations from untransfected cells
and those transfected pCGT7-Zfp647 or the empty pCGT7 vector. The cells were
fractionated into nuclear and cytoplasmic fractions, and the nuclear extracts were
separated into their soluble and insoluble components (Section 2.4.2). The extracts
were then western blotted using an _-T7 antibody. No band was detected by the _-T7
antibody in the untransfected cells (Figure 3.16A), and no band corresponding to T7-
Zfp647 was detected in the cells transfected with pCGT7 (Figure 3.16A). When
prepared using 100mM NaCl, the vast majority of T7-Zfp647 is found in the
insoluble nuclear extract, which is also the case at 200mM NaCl. This contrasts with
the endogenous protein, which is soluble at 100mM NaCl (see Figure 3.11). I
therefore tested the extracts made using 300-500mM NaCl, and found that only at
500mM NaCl is a significant fraction of the tagged protein soluble, and the majority
is still found in the insoluble nuclear extract.
      The zinc fingers of Zfp647 were also cloned into the pCGT7 vector (creating the
pCGT7-Zfp647-ZF construct), to see whether their expression without the KRAB
domain would yield a soluble protein, as it has been previously demonstrated that
KRAB domains are highly insoluble (Tan et al, 2004a). Soluble and insoluble
nuclear extracts, as well as whole cell extracts, were made from cells transfected with
either the pCGT7 or pCGT7-Zfp647-ZF vector at a NaCl concentration of 200mM
and western blotted with _-T7 antibody (Figure 3.16B). No signal is seen from the
extracts of cells transfected with pCGT7, but a band of ~35kDa is seen in the whole
cell extract from cells expressing T7-Zfp647-ZF. The zinc finger domain of Zfp647
is predicted to have a molecular weight of 41kDa. The T7-Zfp647-ZF protein is only
seen in the insoluble fraction of the nuclear extract (lane 6 compared with lane 5),




      Cells were also transfected with either pcDNA or the pcDNA-His 6-Zfp647
construct. Nuclear extracts were made from these cells and again separated into their
soluble and insoluble fractions. When western blotted with the rabbit _-Zfp647
antibody, the signal from the exogenously expressed protein is visible after a short
exposure of the western blot (Figure 3.16C), whereas the endogenous protein
appeared after a longer exposure (data not shown). Thus although the majority of
His6-Zfp647 is found in the insoluble fraction of the nuclear extract, the quantity of
exogenous protein in the soluble fraction is greater than that of the endogenous
protein.
      It may have been possible to carry out a co-immunopreciptation experiment using
the mammalian-expressed tagged Zfp647 proteins, following dialysis of T7-Zfp647
extracts from a high to low salt concentration, mixing these extracts together and
immunoprecipitating with an antibody against one of the tags. However, I decided to
attempt to express Zfp647 in a different manner, using an in vitro expression kit.
3.6.2. Immunoprecipitations of In Vitro Transcribed and Translated Zfp647
      In vitro expression of mammalian proteins is a widely-used method, whereby
proteins encoded in a plasmid can be transcribed and translated using normal amino
acids to generate tagged proteins, as would occur in mammalian cell lines or
bacterial cultures. There is also the possibility of including [35S]-methionine into the
reaction, labeling the proteins with a radioactive mark. Two differently tagged or
labelled proteins can be incubated together after their production, and co-
immunoprecipitated as with proteins expressed in tissue culture cells. This method
has the additional benefit of ruling out any third party in the interaction, as using
mammalian protein extracts may include factors that bridge between the two proteins
being tested. On the negative side, proteins produced in this way will not be post-
translationally modified, which would be critical if this is a requirement for the
interaction to occur between the endogenous proteins. However, this method of
expressing proteins has been successfully used in the study of KRAB zinc-finger
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protein interactions previously (Tan et al, 2004a and b), therefore I decided to use it
to try to detect the self-interaction of Zfp647.
3.6.2.1. Cloning, Expression and Verification of pGBKT7-Zfp647 and pGADT7-
Zfp647
      The full-length sequence of Zfp647, minus the start codon, was cloned into the
yeast two-hybrid vectors pGBKT7 and pGADT7. As well as encoding the GAL4
activation and DNA-binding domains, pGBKT7 and pGADT7 encode c-myc and HA
tags respectively, thus proteins cloned into them will be N-terminally tagged
accordingly. The transcription of the tagged protein is under the control of a T7
promoter, therefore I expressed them using the Promega TNT T7 Quick for PCR
DNA kit. Primers were designed against the pGBKT7-Zfp647 and pGADT7-Zfp647
plasmids that bound upstream of the c-myc or HA tags at the 5’ end of Zfp647, and
to the 3’ end of the Zfp647 sequence itself, including the stop codon (Table 2.4).
These primers were used to amplify the tagged Zfp647 sequence. As a control, the
primers were also used in a PCR with the empty pGBKT7 and pGADT7 vectors.
This should yield no PCR product, as the 3’ primer binds to the Zfp647 sequence,
thus amplification cannot occur when the vector is empty. The control PCR is
identical to that used to generate Zfp647 in every other way, and can be used as a
negative control in an immunoprecipitation where the only element missing is the
tagged Zfp647 protein.
      The pGBKT7, pGBKT7-Zfp647 and pGADT7-Zfp647 PCR products were used
in TNT reactions, with [35S]-methionine present to radio-label the proteins, and with
unlabelled methionine to check the background signal from the plasmids (Section
2.7.1; Figure 3.17A). Both the unlabelled TNT reactions gave no signal, whereas the
[35S]-labelled pGBKT7 reaction produced a faint band at approximately 70kDa
(Figure 3.17A, unfilled arrow), which is also present in the TNT products from the
Zfp647 vectors. Both the pGBKT7-Zfp647 and pGADT7-Zfp647 TNT reactions
produce a strong band at 80 kDa. This band is 20kDa larger than expected, which is
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due to the fact that the TNT products were run on a pre-cast gel using a MOPS buffer
system, which makes proteins appear to be 10-20kDa greater in mass than they are.
The 80kDa band therefore probably represents the TNT-expressed Zfp647 protein.
Two other relatively strong signals are seen in the [35S]-labelled Zfp647 lanes at
110kDa and 60kDa (Figure 3.17A, highlighted with asterisks).
      To verify the expression of the KRAB zinc-finger protein, the TNT reactions with
both empty vectors and those carrying Zfp647 were repeated with unlabelled
methionine, and the products were immunoblotted with sheep _-Zfp647 (Figure
3.17B). Both empty vectors gave no signal, whereas the antibody detected the same
80kDa band seen in Figure 3.17A in the TNT products of the vectors carrying Zfp647
(Figure 3.17B, filled arrow). The antibody also detected the 60kDa band seen
previously (Figure 3.17B, unfilled arrow), suggesting that this band may be a Zfp647
degradation product.
3.6.2.2. Co-Immunoprecipitation of TNT-expressed Zfp647
      To carry out the co-immunoprecipitation experiment, it was only necessary for
one of the TNT-expressed proteins to have a recognisable tag, as the co-
immunoprecipitated protein could be labelled with [35S]-methionine to allow its
detection. Both the tagged Zfp647 proteins were checked for how well their tags
were recognised. Unlabelled proteins from TNT reactions using the pGBKT7,
pGBKT7-Zfp647 (c-myc-tagged) and pGADT7-Zfp647 (HA-tagged) PCR products
were western-blotted with antibodies against c-myc and HA, shown in Figure 3.17C.
Neither of the antibodies gave a signal from the empty pGBKT7 vector. pGBKT7-
Zfp647 is detected at the expected size only by the c-myc antibody, demonstrating
that this protein was correctly tagged. However, pGADT7-Zfp647 did not give a
band with either antibody, suggesting that either the HA-tag on this protein has not
folded properly, or the _-HA antibody does not work.
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      [35S]-labelled T NT products from both the empty vectors and those carrying
Zfp647 were then subjected to immunoprecipitation by the antibody specific to their
protein tag (Figure 3.18A). The translated proteins were incubated with sepharose
beads bound by either _-c-myc or _-HA antibody, and either 5% of the input, or the
entire immunoprecipitation was run out by PAGE and visualised by autoradiography.
pGBKT7-Zfp647 is efficiently immunoprecipitated by the c-myc antibody, as the
immunoprecipitation signal is stronger than that of the input, whereas pGADT7-
Zfp647 is not pulled down to the same degree by the antibody against HA (Figure
3.18A). The proteins were also immunoprecipitated with the other antibody, i.e.
pGBKT7-Zfp647 was immunoprecipitated with the HA antibody and vice versa: I
found that neither protein immunoprecipitates with the antibody against the other tag
(data not shown).
      As c-myc-tagged Zfp647 was the better choice of protein to be
immunoprecipitated, the pGBKT7-Zfp647 and pGBKT7 PCRs were expressed using
unlabelled methionine. pGADT7-Zfp647 was expressed incorporating [35S]-
methionine. The co-immunoprecipitations were carried out using the protocol
described by Gallo et al, which demonstrated the dimerisation of TNT-expressed
Drosophila ADAR (Gallo et al, 2003). The pGADT7-Zfp647 TNT product was
mixed with either the pGBKT7 or pGBKT7-Zfp647 reaction, and incubated for an
hour at 37°C to allow complexes to form. The TN T reactions were
immunoprecipitated with _-c-myc antibody bound to sepharose beads, and the
immunoprecipitates run out on a polyacrylamide gel and analysed by
autoradiography (Figure 3.18B). 5% of the reactions were run out for the input lanes;
compared to these, and the signal from the immunoprecipitation of pGBKT7-Zfp647
by _-c-myc antibody (Figure 3.18A, lane 8), the signal from the co-
immunoprecipitation lanes are quite weak. The amount of radiolabelled pGADT7-
Zfp647 going into both experiments was equal, but the signal from the
immunoprecipitation with pGBKT7-Zfp647 is much stronger than that from the
immunoprecipitation with pGBKT7. It therefore appears that HA-tagged Zfp647 is





3.7.1. Zfp647 is Capable of Homo-Oligomerisation
      Many KRAB zinc finger proteins have been shown to be capable of interacting
with factors other than KAP-1, possibly giving them extra functions in the cell as
well as regulating the transcription of their gene targets. In this chapter, I have
demonstrated that on top of binding to KAP-1, Zfp647 interacted with itself in a
yeast two-hybrid assay. To verify this self-interaction, I expressed tagged Zfp647 in
both bacterial and mammalian cells, with the intention of using these proteins in a
co-immunoprecipitation experiment. However, it appears that overexpressed Zfp647
is highly insoluble (Figures 3.15 and 3.16). It has previously been shown that the
zinc fingers of a KRAB zinc finger protein are more soluble than the full-length
protein (Tan et al, 2004a), however I found that the zinc fingers of Zfp647 were not
soluble under normal conditions (Figure 3.16B). Therefore I carried out co-
immunoprecipitation experiments with in vitro-expressed Zfp647 proteins. The
signal from the co-immunoprecipitation of Zfp647 was fairly weak, however it did
show that Zfp647 was specifically co-immunoprecipitated in the presence of another
Zfp647 moiety (Figure 3.18B). I intended to carry out a positive control using KAP-1
to compare the signal from the Zfp647-Zfp647 co-immunoprecipitation to that of
Zfp647 with a known interacting protein; however, I had difficulty cloning the full-
length KAP-1 sequence into the yeast two-hybrid vectors, and thus did not manage to
carry this experiment out.
      I have shown that the self-interaction of Zfp647 occurs through the protein’s zinc
fingers, rather than the KAP-1-interacting KRAB domain. The ability to homo-
oligomerise has only been demonstrated for one other KRAB zinc finger protein,
ZBRK1, which also self-interacts through its C-terminal domain (Tan et al, 2004b).
Homo-tetramerisation of ZBRK1 was shown to increase transcriptional repression; it
is therefore possible that formation of Zfp647 complexes may also be important for
its repressive activity, and that many of the other KRAB zinc finger proteins behave
in a similar fashion. We have previously shown that the localisation of Zfp647 is
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altered upon the removal of its zinc finger domain, as gene-trapped Zfp647
mislocalises to the heterochromatin (Briers et al, 2009). Thus it could be that the
homo-oligomerisation ability of Zfp647, rather than its binding to DNA, is
responsible for its localization to the KAKA foci. If we were able to express a
Zfp647 construct in tissue culture cells that showed the same localization as the
endogenous protein, we could mutate the protein-protein interaction domain to assess
whether this affects the protein’s recruitment to the KAKA foci.
3.7.2. Recruitment of Zfp647 to KAKA Foci is Cell-Type Dependent
      Dr Heidi Sutherland has previously detailed its localisation of Zfp647 in mouse
ES cells (Briers et al, 2009); in this thesis I have looked at Zfp647’s localisation in
NIH/3T3 and pMEF cells. I have found that unlike differentiated ES cells, NIH/3T3
cells do not have KAKA foci. Although the pattern of Zfp647 staining in these cells
is slightly granular, they do not show the same distinct Zfp647- and KAP-1-
containing foci seen in differentiated ES cells. In comparison, pMEFs do appear to
have KAKA foci. These foci were seen in approximately 15% of cells. Each of the
cell lines tested has been embryonically derived, and both the NIH/3T3 cells and
pMEFs are fibroblasts; however, only the NIH/3T3 cells are immortalized, which
may in some way be responsible for the differing behaviour of Zfp647 in this cell
line. Alternatively, KAKA foci may be cell type-specific: certain factors promoting
the formation of KAKA foci could be lacking in NIH/3T3 cells, or Zfp647 may be
carrying out a different function in these cells. Therefore finding Zfp647 target genes
and endogenous protein binding partners may shed light on why the protein gives
different staining patterns in these cell lines. In the future, it may be of interest to
look at the nuclear localisation of Zfp647 in tissue samples from regions of the
mouse that it is expressed in, such as neural or heart tissue (Briers, 2005). We could
then see whether the staining pattern seen in tissue samples matches that seen in ES
and pMEF cells, or NIH/3T3 cells, and also whether KAKA foci are present in vivo.
Unlike the localisation pattern of KRAZ1 and KRAZ2 (Matsuda et al. 2001), we
have not seen Zfp647 localise to the pericentric heterochromatin in ES, pMEF or
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NIH/3T3 cells. It could therefore be the case that different KRAB zinc finger
proteins show different localisation patterns, according to their roles in the cell, or
that over-expressed KRAB zinc finger fusion proteins mis-localise in the nucleus, as
we have demonstrated with GFP-tagged versus wild-type Zfp647 (Figures 1.9 and
1.10; Briers et al, 2009).
3.7.3. Recruitment to KAKA Foci is KRAB Zinc Finger Protein-Specific
      I identified 20 KRAB zinc finger proteins that interact with Zfp647 in my yeast
two-hybrid screen, and thus could possibly co-localise with this protein at the KAKA
foci in ES or pMEF cells. The localisation pattern of the majority of these proteins
could not be analysed, as they have not had antibodies raised against them. This is
not surprising, given the high levels of homology between proteins belonging to the
same gene cluster (e.g. the Rslcan proteins), and the fact that so few KRAB zinc
finger proteins have had a definite function assigned to them, thus most of these
proteins have not been studied in great detail. I therefore raised an antibody against
one of the KRAB zinc finger proteins identified in my yeast two-hybrid screen,
Rbak. The antibody was raised in Guinea pig, to allow immunofluorescence studies
with other antibodies raised in rabbit, mouse or sheep. Despite the pre-immune
serum recognizing a nuclear band in cell extracts corresponding to Rbak (Figure 3.9),
both the serum and the purified antibody failed to stain the nuclei of NIH/3T3 cells
(Figure 3.10). However, the unpurified serum also detected a mainly cytoplasmic
band by western blot (Figure 3.9), therefore it may be possible that this band is in
fact Rbak, and the protein is cytoplasmic. To ascertain where Rbak localises to
within the cell, it may be possible to inhibit its expression by a method such as
RNAi, and see whether the nuclear or cytoplasmic western blot band disappears.
      We have received antibodies against the KRAB zinc finger proteins NT2 (Tanaka
et al, 2002), Zfp37 and Zfp90 (Payen et al, 1998), allowing us to analyse whether
these proteins also co-localise with KAP-1 at KAKA foci. Dr Heidi Sutherland found
that, like Zfp647, NT2 co-localised with KAP-1 in differentiated ES cells (Briers et
138
al, 2009). I have stained NIH/3T3 cells with the other two KRAB zinc finger protein
antibodies, and found that these proteins do not form distinct nuclear foci; likewise,
Dr Heidi Sutherland has obtained the same results from differentiated ES cells. This
suggests either that not all KRAB zinc finger proteins localize to KAKA foci, or that
their recruitment to these structures, if present in the cell, is cell type-specific. Given
the number of KRAB zinc finger proteins in the mouse genome, it is not surprising to
find that they do not all show the same pattern of staining, as one would predict them
to be involved in a wide range of pathways.
3.7.4. Zfp647 Interacts with ARD1, Another Tripartite Motif Protein
      One of Zfp647’s interactions that was intriguing was that with ARD1. Although
only one yeast colony out of the 800 in my screen encoded this protein, it is of
interest as it is a member of the tripartite motif family, and has previously been
shown to interact with the human Zfp647 homologue ZNF250, also in a yeast two-
hybrid screen (Rual et al, 2005). ARD1 was the only tripartite motif protein reported
to interact with ZNF250 in this screen; likewise, ZNF250 was the only KRAB zinc
finger protein found to interact with ARD1 in the same screen. Although it has been
pubished that ARD1 and KAP-1 do not interact (Reymond et al, 2001), Rual et al
reported that these two proteins can co-purify (Rual et al, 2005). Thus it may be of
interest to research the relationship of these two tripartite motif proteins, to see if
they do interact in vivo, to analyse their localisation (does ARD1 localise to the
KAKA foci or PML-NBs, both of which contain other tripartite motif proteins?) and
to determine whether Zfp647 can interact with tripartite motif proteins other than
KAP-1.
3.7.5. Zfp647 Interacts with Jumonji Domain-Containing Proteins
      I have found that Zfp647 interacts with two jumonji domain-containing proteins,
Jmjd1c and Jarid1b. Jmjd1c was identified in my yeast two-hybrid screen, whereas I
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discovered the interaction with Jarid1b by co-immunoprecipitating Zfp647
interactors from a NIH/3T3 nuclear extract (Figures 3.13 and 3.14). The jumonji
domain has the ability to demethylate histones (Cloos et al, 2008). Jmjd1c has not
been shown to possess histone demethylase activity to date, but Jarid1b can remove
methyl groups from H3K4 (Christensen et al, 2007; Seward et al, 2007; Yamane et
al, 2007), and has been associated with breast, prostate and skin cancer (Lu et al,
1999; Xiang et al, 2007; Roesch et al, 2008). Both interactions require further
confirmation to prove that they can interact with Zfp647, for example by in vitro co-
immunoprecipitation experiments using epitope-tagged Jmjd1c or Jarid1b. Another
KRAB zinc finger protein, Zkscan17, has been shown to interact with a different
jumonji domain-containing protein, JARID2 (Mysliwiec et al, 2007), therefore there
may be a link between these two classes of proteins.
      In my in vitro  co-immunoprecipitation experiments, there was a very high
amount of background from proteins non-specifically interacting with the sepharose
beads, which can be problematic if it increases the number of proteins identified in
the mass spectrometry stage, possibly masking true interactors (Trinkle-Mulcahy et
al, 2008). The mass spectrometry experiments could therefore be repeated using a
protocol such as SILAC (stable isotope labelling with amino acids in cell culture)
(Ong et al, 2002; Schulze and Mann, 2004). Cells are grown in the presence or
absence of amino acids labelled with heavy carbon or arginine isotopes. Extracts
from these cells are then subjected to an immunoprecipitation experiment, whereby
the unlabelled cells are immunoprecipitated with a control antibody (e.g. _-GFP) and
the heavy-labelled cells are immunoprecipitated with an antibody against the protein
of interest, in this case _-Zfp647. The two immunoprecipitations are then pooled, run
out by PAGE, and subjected to mass spectrometry. When the mass spectrographs are
compared, a protein present in both the normal and heavy-labelled samples gives two
peaks, owing to the shift in molecular weight caused by the heavy isotopes. Any non-
specific background signal should give the same sized intensity peak in both the
heavy- and normally-labelled samples, whereas a protein that is specifically co-
immunoprecipitated by the _-Zfp647 antibody should give a higher peak in the
heavy-labelled sample than in the normal sample. As there are many combinations of
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heavy isotopes that can be used in SILAC experiments, it would be possible to
compare proteins that are co-immunoprecipitated in NIH/3T3 cells with those from
pMEF or differentiated ES cells. This could give an insight into other proteins
interacting with Zfp647 at the KAKA foci, as these proteins may only be co-
immunoprecipitated in the pMEF or ES cell extracts. Alternatively, the protein
interactors of Zfp647 could be compared using the SILAC technique in
undifferentiated and differentiated ES cells, to analyse whether these alter as the
localisation of the protein changes.
      One of the most interesting aspects of the yeast two-hybrid screen was the
identification of a number of proteins involved in the ubiquitylation process. These
included four proteins with RING domains, which are predicted to be able to catalyse
the ubiquitylation (or possibly sumoylation) of a substrate protein. I therefore began






      A number of reasons led me to investigate whether Zfp647 is post-translationally
modified. Firstly, five proteins that are involved with the ubiquitin machinery, or that
have been shown to function as ubiquitin E3 ligases, were pulled out of my yeast
two-hybrid screen (Section 3.2.6). Protein ubiquitylation is most commonly
associated with degradation, as many proteins are poly-ubiquitylated before being
destroyed by the proteasome. In this case, chains of the 76 amino acid ubiquitin
moiety are covalently attached to lysine residues of a protein. These are recognised
by the 26S proteasome, which cleaves the target protein into fragments that can be
recycled by the cell (Hershko and Ciechanover, 1998). Poly-ubiquitylation can occur
routinely as part of the cell cycle (e.g. cyclins (Cohen-Fix et al, 1996)) or to remove
mis-folded or aggregated proteins from the cell (e.g. the endoplasmic reticulum-
associated degradation pathway (reviewed in Vembar and Brodsky, 2008)). Mono-
ubiquitylation can also alter a protein’s function, rather than signal its impending
destruction (Welchman et al, 2005).
      Secondly, two KRAB zinc-finger proteins were identified in a proteomics screen
looking for proteins that are modified by the 101 amino acid, 11kDa small ubiquitin-
like modifier (SUMO) in HeLa cells (Vertegaal et al, 2006). These proteins were
ZNF317 (comprised of a KRAB domain and 13 zinc-finger motifs) and RBAK
(Section 3.4). Like ubiquitin, SUMO is attached to lysine residues of target proteins.
Although sumoylation has been linked to the protein degradation process (PML
protein is poly-sumoylated prior to degradation when cells are treated with As2O3,
discussed in Section 1.2.5.), this modification functions more commonly to alter the
behaviour of a protein or its localization in the cell, typically by changing its
interactions with other proteins. The finding that KRAB zinc finger proteins can be
modified by SUMO may mean that within the cell there are different subsets of each
protein, capable of carrying out different tasks. Sumoylation of the KRAB zinc
finger proteins may also be required for their repressive function.
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      Finally, since starting this project it has been found that KAP-1 is also modified
by SUMO at six sites within the C-terminal end of the protein (Mascle et al, 2007;
Lee et al, 2007b). Sumoylation of KAP-1 by Ubc9 is directed by its PHD and
bromodomains, and is necessary for the interactions between KAP-1, SETDB1 and
Mi-2α (Figure 4.1; Ivanov et al, 2007). The binding of KAP-1 to a KRAB domain
actually increases the sumoylation levels of KAP-1 (Mascle et al, 2007). Therefore
sumoylation is already known to play a role in the KRAB-mediated transcriptional
repression pathway, and KAP-1 itself has been shown to possess E3 ligase activity.
4.1.1. The Ubiquitin-Like Proteins
      There are three major ubiquitin-like modifying proteins found in mammalian
cells: ubiquitin, SUMO and Nedd8. These proteins do not show a high degree of
similarity at the amino acid level (ubiquitin and SUMO-1 are 18% identical;
ubiquitin and Nedd8 are 58% identical; SUMO-1 and Nedd8 share 19% identity),
however they each possess a conserved structure, the ubiquitin fold (Welchman et al,
2005). The method of conjugation for each of the ubiquitin-like proteins is also
highly similar (Figure 4.2). The proteins are first activated to allow them to be
covalently attached to the substrate protein; in the case of SUMO and Nedd8, C-
terminal amino acid residues are removed from the protein, revealing the reactive
diglycine motif. All three of the modifiers are activated by E1 activating enzymes,
which results in their attachment to the E1 enzyme (Hershko and Ciechanover,
1998). The ubiquitin-like protein is then passed to an E2 ubiquitin-conjugating
enzyme (Ubc). Mammals possess at least 30 different Ubcs specific for ubiquitin,
whereas SUMO and Nedd8 are only transferred to one or two enzymes specific for
their modification: Ubc9 for SUMO (Johnson and Blobel, 1997); UbcH12 and Ube2f
for Nedd8 (Huang et al, 2009). All three of the modifying proteins can then be
transferred to their intended substrate directly from the E2 enzyme. For ubiquitin and
Nedd8, this process is catalysed by an E3 ligase. The E3 ligase can interact with both
the substrate and the E2 enzyme, and thus acts as a substrate recognition factor for




this manner, whereas HECT (homologous to the E6-AP carboxyl terminus) domain-
containing E3 ligases actually act as recipients of the activated ubiquitin molecule,
which can then be transferred to the substrate (Scheffner et al, 1993). In the case of
SUMO, Ubc9 can bind to a conserved motif found in the substrate protein, with the
consensus of ψKxD/E, where ψ stands for a large, hydrophobic amino acid
(isoleucine (I), leucine (L), methionine (M), phenylalanine (F) or valine (V)), and x
represents any amino acid (Rodriguez et al, 2001). Therefore the sumoylation of
many proteins does not require the presence of an E3 ligase. However, not all
proteins that encode the consensus sequence are sumoylated, and not all proteins that
are sumoylated encode the consensus sequence (Vertegaal et al, 2006). Thus proteins
belonging to this latter class are sumoylated with the aid of an E3 ligase to direct
Ubc9 to the substrate; KAP-1’s PHD and bromodomains function as its E3 ligase
(Ivanov et al, 2007).
      Modification by each of the ubiquitin-like proteins is reversible. Deubiquitinating
enzymes (DUBs), sentrin-specific proteases (SENPs) and Nedd8 isopeptidases
catalyse the removal of ubiquitin, SUMO and Nedd8. These enzymes function
continuously, therefore the pool of modified forms of an endogenous protein that is
susceptible to dynamic modification turnover can be undetectable in cell extracts (Li
et al, 2007; Martin et al, 2007; Rajan et al, 2005)
4.1.2. Substrates of the Ubiquitin-Like Modifiers
      The major substrates of Nedd8 are the cullin family, which themselves function
as scaffolding proteins for ubiquitin E3 ligases, as they can interact with RING
domain-containing proteins to aid in the recruitment of the ubiquitin activating E2
enzymes (Welchman et al, 2005). The modification of the cullins by Nedd8 can
prevent their binding to inhibitory proteins, thus neddylation can influence the
activity of ubiquitin E3 ligases. By contrast, many different classes of protein are
modified by ubiquitin and SUMO. In some cases, these two modifications compete
for the same lysine in the substrate’s sequence. For example, ubiquitylation of IκB at
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lysine 21 results in the protein’s degradation, whereas sumoylation of the same
residue stabilizes the protein (Welchman et al, 2005). Ubiquitylation is often
associated with the endocytosis pathway, and a number of transcriptional regulators
are also modified by ubiquitin. The bulk of SUMO substrates are also involved in the
transcription process (Girdwood et al, 2004). Factors such as Sp3, c-Jun, the histone
deacetylases HDAC1 and HDAC4, histone H4 and p300 can all be sumoylated, and
their modification in this manner is associated with an increase in transcriptional
repression (Girdwood et al, 2004). As discussed in Section 1.3.5, KAP-1 is also
subjected to modification by SUMO at six lysine residues (Lee et al, 2007b; Mascle
et al, 2007). Sumoylation of KAP-1 is essential for its interaction with Mi-2_ and
SETDB1 (Ivanov et al, 2007), and thus this modification enhances KAP-1’s
transcriptional repressor function.
4.1.3. Effect of Sumoylation on Nuclear Localisation
      While the exact details of how SUMO alters the behaviour of some of its
substrates is unknown, it is clear that there is an association between sumoylation
and nuclear localization. In particular, there is a close link between sumoylated
proteins and the PML-NBs. Homozygous Ubc9-knockout mice have disrupted PML-
NBs (Nacerddine et al, 2005), and knockout of SUMO-1 also leads to a decrease in
both PML levels and the number of PML-NBs seen in mouse cells (Evdokimov et al,
2008). Sumoylated PML is only observed at the PML-NBs, and not in the
nucleoplasm (Ishov et al, 1999), and it has been argued that PML sumoylation is
essential for the formation of PML-NBs, as PML-/- cells transfected with a mutant
form of PML that cannot be sumoylated do not display these nuclear bodies (Zhong
et al, 2000). The SIM domains of PML and other proteins that localize to the PML-
NBs are also essential for maintaining PML-NB structure, as these allow sumoylated
forms of PML and proteins such as Daxx to interact (Ishov et al, 1999; Lin et al,
2006; Shen et al, 2006). Additionally, the overexpression of SENP2 leads to the
redistribution of several PML-NB proteins (Dellaire and Bazett-Jones, 2004).
Therefore it has been proposed that PML-NBs can act as repositories for sumoylated
148
transcription factors and other proteins (Girdwood et al, 2004), and their composition
could be continuously altered by the sumoylation and desumoylation of PML-NB-
associated proteins.
      Sumoylation is also important for the regulation of the nuclear pore complexes,
which are responsible for the trafficking of certain proteins in and out of the nucleus.
One of the major recipient of the SUMO modification in mammalian cells is
RanGAP1 (Ran GTPase-activating protein 1). RanGAP1 activates Ran, itself a
GTPase involved in the transport of RNA and proteins between the nucleus and
cytoplasm (Bischoff et al, 1994). Sumoylation of RanGAP1 is required for its
localization to the nuclear periphery, through its interaction with RanBP2, another
protein situated at the periphery (Matunis et al, 1996; Mahajan et al, 1997).
RanGAP1, RanBP2 and Ubc9 have been shown to be capable of forming a ternary
complex (Reverter and Lima, 2005). In accordance with this finding, a small
proportion of cellular Ubc9, which is generally found in the nucleoplasm, can be
visualized at the nuclear pore complexes (Lee et al, 1998; Saitoh et al, 2002). The
SUMO proteases SENP1 and SENP2 can be found at the nuclear envelope, as well as
in PML-NBs (Best et al, 2002; Hang and Dasso, 2002; Zhang et al, 2002). Yeast that
have lost either the SUMO activating enzyme Uba2 or the SUMO protease Ulp1 are
unable to import proteins bearing a classic nuclear localization signal into the
nucleus (Stade et al, 2002). Therefore sumoylation and desumoylation of nuclear
pore proteins appear to play an important role in controlling the transport of certain
factors in and out of the nucleus.
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4.2. Modification of Zfp647
 4.2.1. Detection of High Molecular Weight Forms of Zfp647
      The ubiquitin-like modifications can be rapidly turned over in vivo, a process that
can also continue following cell lysis. Therefore the modified forms of a protein
often go undetected when analysed by western blot. To prevent the removal of
modifications, cell extracts can be made in the presence of N-ethylmaleimide
(NEM). NEM reacts with the thiol groups found in cysteine residues, causing their
covalent modification. As the enzymes that remove ubiquitin, SUMO and Nedd8
tags from proteins have a reactive cysteine residue at their core, NEM prevents these
enzymes from catalyzing the modification’s removal.
      To see if modified forms of Zfp647 could be detected, I analysed protein extracts
prepared in the presence of NEM. NIH/3T3 cells were treated with 20mM NEM for
one hour at 37°C, and whole cell extracts were prepared with buffers containing
20mM NEM. Cells were also treated with the proteasome inhibitor MG132 at a
concentration of 10µM, and the same volume (15µl) of the MG132 solvent, DMSO.
If Zfp647 is poly-ubiquitylated ahead of its degradation, the inhibition of the
proteasome would lead to the accumulation of this modified form of the protein, thus
distinguishing it from any other form of the protein seen. Extracts were run out by
PAGE and western blotted with sheep _-Zfp647 antibody (Figure 4.3). The extracts
made from DMSO- and MG132-treated NIH/3T3 cells show the major 65kDa band
normally seen with this antibody, and non-specific bands can also be seen at ~45 and
50kDa. Treatment of the cells with NEM leads to the appearance of at least two other
strong bands, at ~70 and 85kDa. The 85kDa band appears to be present at very low
levels in extracts made in the absence of NEM, but incubation of the cells with this
chemical increases the signal from this protein band so that it is present at
approximately the same level as the main Zfp647 band. There are also bands visible
between 70kDa and 85kDa. It therefore appears that Zfp647 is post-translationally
modified in tissue culture cells. The absence of any extra bands in extracts made
from cells treated with MG132 suggests that these modifications have not arisen due
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to blocking of the degradation-mediated poly-ubiquitylation of Zfp647.
4.2.2. Verification of High Molecular Weight Zfp647 Species
      To confirm that the high molecular weight bands are Zfp647, and not another
protein species that is only present after NEM treatment, I decided to cross-test the
two _-Zfp647 antibodies. First, to verify that the rabbit _-Zfp647 antibody could
identify modified Zfp647, I probed the NIH/3T3 cell extracts made following
treatment with DMSO, MG132 and NEM with this antibody (Figure 4.3). Rabbit _-
Zfp647 detects the 65kDa Zfp647 band in all three extracts, and the 40kDa
cytoplasmic band detected by this antibody (Figure 3.12) is also seen in each of the
extracts. Whilst the DMSO- and MG132-treated cell extracts are identical in their
pattern of staining, the pattern seen following NEM treatment is different. Three
higher molecular weight bands are seen between 65kDa and 80kDa, one of which
appears to be the same weight as that observed with the sheep antibody, and two high
molecular weight species highlighted by the sheep _-Zfp647 antibody are replaced
by one at 115kDa. Thus, except for the band at 70kDa, the proteins detected by the
sheep _-Zfp647 antibody are different to those observed with the rabbit antibody;
however, the staining by both antibodies is changed when NEM is present.
      Despite the apparent differences in their specificity, I decided to test whether
both antibodies can recognise the 70kDa Zfp647 band. To do this, I made nuclear
extracts from NIH/3T3 cells prepared in the presence or absence of NEM, and
immunoprecipitated Zfp647 using the rabbit antibody. I then ran the
immunoprecipitates out by PAGE, and western blotted them using the sheep _-
Zfp647 antibody (Figure 4.4). As seen previously, there is cross-reaction between the
rabbit and sheep antibodies, as the IgG bands are visible at 60kDa. In the absence of
NEM, sheep _-Zfp647 only detects the 65kDa Zfp647 band in the input lane,
whereas when prepared with NEM, two further bands at ~75kDa and ~85kDa are
seen in the input, similar to those in Figure 4.3. In the immunoprecipitation lane, in
the absence of NEM, Zfp647 can be seen just above the IgG band, at ~65kDa. When
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NEM is present, however, the strongest Zfp647 band seen is that at ~75kDa,
corresponding to the modified protein. Thus both antibodies can recognize this
protein, making it very likely that it is in fact a modified form of Zfp647.
4.2.3. Effect of KAP-1 on Zfp647 Modification
       KAP-1 is known to direct its own modification by acting as an E3 ligase,
binding to the E2-conjugating enzyme Ubc9 and directing it to the sites at which it
can be sumoylated (Ivanov et al, 2007). It may be possible that KAP-1 could also
direct Ubc9 to sumoylate a KRAB zinc finger protein that it is bound to.
Alternatively, the RING domain of KAP-1 could function as a ubiquitin E3 ligase to
modify a KRAB zinc finger protein.
      To assess whether KAP-1 has any effect on Zfp647 modification, I chose to look
at whether the higher molecular weight forms of Zfp647 were present in cells
deficient in KAP-1. I received two PCC4 EC cell lines from Dr Daniel Wolf
(Howard Hughes Medical Institute, New York), one of which is wild-type. The other
cell line, named 111, encodes a small interfering RNA (RNAi) expression construct
targeted against KAP-1, which has previously been shown to dramatically reduce
KAP-1 protein levels when compared to PCC4 cells carrying a scrambled RNAi
construct (Wolf et al, 2008). The PCC4 cells can be easily differentiated by the
addition of RA, and I chose to look at undifferentiated cells and those treated with
RA for 6 days in case the differentiation process affects either the level or activity of
KAP-1. Whole cell extracts were made from both lines, and were western blotted
with rabbit _-KAP-1 to verify the low level of KAP-1 in the 111 cells (Figure 4.5).
KAP-1 is present at high levels in both the undifferentiated and differentiated
extracts from wild-type cells. In comparison, KAP-1 is barely seen in the PCC4 111
cells. Down-regulation of the expression of KAP-1 over the course of differentiation
has been previously described (Cammas et al, 2004; Wolf and Goff, 2007; Briers et
al, 2009), but is only apparent in the –NEM lanes in Figure 4.5, possibly due to the
long exposure of the western blot. The extracts were also blotted with an _-tubulin
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antibody as a loading control (Figure 4.5). Despite the reports of KAP-1 modification
by SUMO, extra bands corresponding to sumoylated KAP-1 were not seen in the
extracts treated with NEM in the PCC4 cells, and I also did not observe modified
KAP-1 in NIH/3T3 cells (data not shown). Thus, either the _-KAP-1 antibody used
does not recognize modified KAP-1, KAP-1 is not modified in either of these cell
lines, or the level of modified endogenous KAP-1 is too low to be visualised.
      Western blots of the PCC4 cell extracts incubated with sheep _-Zfp647 antibody
are shown in Figure 4.6. In the PCC4 111 cells, the signal corresponding to Zfp647
seems to be lower than that in the wild-type cells. This is seen in the extracts made
both with and without NEM. Modified Zfp647 can be seen in each of the extracts
made with NEM, at ~5kDa above the height of the main Zfp647 band, but the
intensity of this band appears reduced, presumably due to the decreased overall level
of Zfp647. The higher molecular weight form of Zfp647 can also be seen faintly in
the undifferentiated PCC4 cell extracts from both the wild-type and 111 lines after a
longer exposure (middle panel). These results suggest that the loss of KAP-1 does
not have an effect on Zfp647 modification, but may in fact impact upon the overall
levels of Zfp647 protein in the cell.
4.3. Is Zfp647 Modified by a Ubiquitin-Like Protein?
4.3.1. Analysis of Zfp647 Sequence
      There does not appear to be any consensus sequence for the sites of attachment of
ubiquitin and Nedd8. However, SUMO tends to be attached to lysines that are part of
the consensus sequence ψKxD/E (Rodriguez et al, 2001), therefore I analysed the
amino acid sequence of Zfp647 for the presence of this sequence. Zfp647 has 46
lysine residues, but none of these are part of a ψKxD/E consensus (Figure 4.7). Two




and followed by a glutamic acid residue at positions 101 and 137 (AKEE for the
lysine at position 99; YKTE for the lysine at position 135; see Figure 4.7). Thus
although Zfp647 does not have a consensus sumoylation motif, it does have two
lysine residues that almost conform to the consensus. Although the four amino acid
consensus sequence was initially thought to be essential (Sampson et al, 2001),
proteins lacking this motif have been shown to be sumoylated in vitro (Vertegaal et
al, 2006). Indeed, of the six sumoylation sites in KAP-1, only two, at positions 554
and 676, conform to the consensus motif (Lee et al, 2007b; Mascle et al, 2007).
4.3.2. Detection of Modification by Immunoprecipitation
      Because the amino acid sequence of Zfp647 did not suggest whether this protein
is subjected to sumoylation, I tried to ascertain what species was modifying this
protein using biochemical means. Both ubiquitin and SUMO seemed likely
candidates, due to the yeast two-hybrid results and the links between transcriptional
repressors and SUMO. Furthermore, NEM is known to preserve the modification of
substrates by the ubiquitin-like proteins. The molecular weights of the modified
bands (5-10kDa and 20-25kDa greater than the main Zfp647 band) could possibly be
due to the addition of one and two ubiquitin-like modifications, as these proteins
weigh approximately 9kDa (ubiquitin and Nedd8) and 11kDa (SUMO). It has also
been found that proteins modified by SUMO on different lysine residues can actually
run at different mobilities when analysed by western blot. Mascle et al showed that
KAP-1 mono-sumoylated at either lysine 779 or 804 ran with a distinctly higher
mobility than KAP-1 sumoylated at lysine 554 (Mascle et al, 2007). Therefore these
two different modified forms of Zfp647 could be due to single modifications at
different sites within the protein’s structure.
      There are three forms of SUMO, SUMO-1, -2 and -3. SUMO-2 and SUMO-3
show a very high level of homology to each other, differing by only three amino
acids, and are considered to function in exactly the same manner (Hay, 2005).
Therefore these proteins will be jointly referred to as SUMO-2/-3. SUMO-1 shares
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50% identity with SUMO-2/-3, and is known to behave independently of the two
other SUMO family members. Screens for proteins modified by sumoylation have
shown that some proteins are specific for which SUMO protein they are modified by,
whereas some proteins can be modified by any of the SUMO proteins (Vertegaal et
al, 2006).
      I obtained antibodies against SUMO-1, SUMO-2, ubiquitin and Nedd8, with the
intention of immunoprecipitating modified Zfp647 with an _-Zfp647 antibody, and
western blotting the immunoprecipitated material with the antibodies against the
ubiquitin-like modifiers. As three of these antibodies were raised in rabbit, I
immunoprecipitated Zfp647 with sheep _-Zfp647 to avoid high levels of background
in the western blot. The immunoprecipitations were carried out using NIH/3T3
whole cell extracts either with or without NEM. To test for the presence of modified
Zfp647 in the immunoprecipitate, I first western blotted the pull-down material with
rabbit _-Zfp647 (Figure 4.8). The input lanes show the effect of NEM on Zfp647: the
main band detected increases in size by approximately 10kDa. The 65kDa Zfp647
band is visible in the immunoprecipitation above the IgG band. Modified Zfp647 is
present in the +NEM immunoprecipitation, demonstrating that like rabbit _-Zfp647,
the sheep _-Zfp647 antibody is capable of immunoprecipitating both unmodified and
modified Zfp647. The immunoprecipitation carried out in the presence of NEM was
then western blotted with each of the antibodies specific for the ubiquitin-like
modifiers (Figure 4.9). The 75kDa modified Zfp647 band was not detected in the
immunoprecipitated lanes. Therefore there was no indication from this experiment
that Zfp647 was modified by SUMO, ubiquitin or Nedd8.
4.3.3. Transfection of Cells with Ubiquitin-Like Modifiers
      To try to ascertain whether any of the ubiquitin-like proteins could be covalently
attached to Zfp647, I decided to transfect cells with tagged forms of ubiquitin,




ubiquitin-like modifiers, and the extra weight of the epitope tag would increase the
size of the modified band, as shown with KAP-1 (Mascle et al, 2007). Thus this
method could demonstrate if any of the modifiers was responsible for the higher
molecular weight forms of Zfp647. I received plasmids encoding His6-tagged
ubiquitin (Dr Lee Finlan, MRC Human Genetics Unit), SUMO-1 and SUMO-2
(Professor Ron Hay, University of Dundee) and Nedd8 (Dr David Girdwood, MRC
Human Genetics Unit). NIH/3T3 cells were transfected with these plasmids, and
whole cell extracts of untransfected and transfected cells were western blotted with a
mouse _-His antibody to check the expression of each of the proteins. The SUMO-1
plasmid from Ron Hay did not seem to express SUMO-1 (Figure 4.10A), and
therefore another plasmid encoding this protein was obtained from Professor Anne
Dejean (Institut Pasteur, Paris). When extracts were made from cells transfected with
this plasmid, SUMO-1 was clearly expressed, seen at the bottom of the gel (Figure
4.10B). A band corresponding to SUMO-2 is seen at the bottom of the gel in the
third lane of Figure 4.10A, and a dark smear at high molecular weight suggests that
this protein is being incorporated into high molecular weight proteins. SUMO-2/-3
contains the four amino acid sumoylation consensus sequence ψKxD/E, and so can
be incorporated into polySUMO chains, whereas SUMO-1 does not contain the
consensus motif, thus the inclusion of SUMO-1 into chains stops their growth
(Tatham et al, 2001). Free ubiquitin and Nedd8 were not seen within the cell extract
(Figure 4.10A), but cells transfected with these proteins give a strong smear at high
molecular weight, again suggesting that the protein is being expressed and attached
to substrate proteins. Therefore cells transfected with these plasmids can successfully
express the encoded modifier proteins.
      Nuclear extracts of cells transfected with each of the His 6-tagged modifying
proteins were analysed for any possible increase in the amount of the modified forms
of Zfp647, or an increase in the molecular weight corresponding to the extra weight
of the His6 tag, which has a molecular weight of ~1kDa. The extracts were western
blotted with sheep _-Zfp647, and with mouse _-tubulin (Figure 4.11). The level of
unmodified Zfp647 is equal in all lanes, as is the level of the 85kDa modified Zfp647




made with NEM, and in the cells transfected with the ubiquitin plasmid, the upper of
these two bands appears to have increased in size. The other bands in this lane
remain the same size, therefore this experiment suggests that this modification band
may result from the mono-ubiquitylation of Zfp647. Interestingly, the 85kDa band
can be seen at a low level in the –NEM extract prepared from cells transfected with
the pCGT7 vector, but not in those transfected with each of the ubiquitin-like
modifiers. It may be that the extra modifiers have an effect on the cell’s protein
turnover machinery, whereby a cell overloaded with the ubiquitin-like proteins
causes the degradation of some, or maybe a large proportion, of the cell’s
ubiquitinated, sumoylated, neddylated, or otherwise modified proteins. It may
therefore by interesting to analyse whether this turnover is also seen in cells inhibited
with MG132, the proteasome inhibitor, which could possibly play a part in such a
pathway.
4.3.4. Nickel Pull-Down of His6-Tagged Modified Proteins
      To try to verify whether Zfp647 is ubiquitylated, or possibly sumoylated or
neddylated, I carried out a nickel pull-down, which can be used to demonstrate the
modification of a substrate by one of the ubiquitin-like proteins (Rodriguez et al,
2001; Seeler et al, 2001). In this method, His6-tagged modifiers are expressed in
tissue culture cells, and become covalently attached to their acceptor proteins. The
modified proteins can be purified due to the fact that the histidine residues
comprising the tag bind with very high affinity to Ni2+-NTA agarose. Proteins pulled
down by the nickel agarose can then be probed for the presence of the suspected
substrate.
      I transfected NIH/3T3 cells with His 6-tagged SUMO-1, SUMO-2, ubiquitin or
Nedd8, or the empty pcDNA3.1 vector. These cells were lysed in a buffer containing
6M guanidium hydrochloride, which completely denatures proteins, disrupting any
non-covalent interactions both within the protein structure and between interacting
proteins. Since ubiquitin-like proteins are covalently attached to their substrates,
166
these modifications remain as part of the substrate protein. The modifications cannot
be removed from their substrates in this buffer, as the SENPs, DUBs and Nedd8
isopeptidases are also denatured by the guanidium hydrochloride treatment. The cell
lysates were then incubated with Ni2+-NTA agarose beads. These beads bind to the
His6-tag, even in its denatured state, and can therefore be used to pull down any
factors covalently modified by a His6-ubiquitin-like protein. The beads were washed,
and the proteins associated with them were analysed by western blot. As a positive
control, the pulled-down proteins were probed for the presence of RanGAP1, one of
the major SUMO substrate protein in mammalian cells.
      The inputs into the pull-downs and the proteins eluted from the nickel beads were
run out by PAGE and western blotted with an _-RanGAP1 antibody (Figure 4.12A).
RanGAP1 is present in all input lanes, and appears at a weight of approximately
85kDa. In the pull-down material, RanGAP1 is only detected in the lanes of the cells
transfected with His6-SUMO-1 and His6-SUMO-2 (Figure 4.12A). This result is in
agreement with published data that has shown that RanGAP1 can be modified by
both SUMO-1 and SUMO-2 (Vertegaal et al, 2006). The RanGAP1 signal seen in
the input lane is at approximately 85kDa, whereas the bands in the pull-down lanes
are at approximately 95kDa, indicating that this is the modified form of RanGAP1.
      The input fractions were also tested for the presence of Zfp647. Zfp647 was
present in each of the transfected cell extracts (Figure 4.12B). However, when the
pull-down material was probed for Zfp647, a band corresponding to this protein was
found in each of the lanes (Figure 4.12B), suggesting that either Zfp647 is non-
specifically pulled down by the nickel beads, or the antibody used to detect the
protein cross-reacts with something present in the pulled down material. Therefore I
repeated the western blots of the inputs and pull-down material with rabbit _-Zfp647
(Figure 4.13A). In the input lanes, the rabbit antibody primarily detects the non-
specific cytoplasmic band at 40kDa, but also detects the Zfp647 band at 65kDa. Like
the sheep _-Zfp647 antibody, however, the rabbit antibody gives a strong signal from




      Because of the presence of zinc fingers in Zfp647, it is possible that these motifs
bind to the nickel agarose non-specifically. Zinc finger structures have been shown to
bind to metals other than zinc (Makowski and Sunderman, 1992; Asmuß et al, 2000),
and nickel, cadmium, cobalt and arsenic have been found to inhibit DNA repair
pathways, possibly by alteration of zinc finger protein structure (Hartwig, 1998;
Asmuß and Sunderman, 2000). I therefore tested whether Rbak behaved similarly to
Zfp647 in this assay. I have been unable to detect sumoylated Rbak in NIH/3T3 cell
extracts with Guinea pig _-Rbak unpurified serum. This may be because the antibody
is unable to detect the modified forms of the protein, or may result from low levels of
sumoylated Rbak in this cell-type. The input and pull-down fractions from the nickel
pull-down were western blotted with Guinea pig _-Rbak unpurified serum (Figure
4.13B). Rbak is present in each of the input lanes (left panel), but no signal is
detectable from the pull-down lanes (right panel). Thus Rbak does not non-
specifically interact with nickel-agarose, unlike Zfp647, showing that this is not a
trait common to all KRAB zinc finger proteins. The metal binding ability of zinc
fingers has been shown to differ between proteins (Asmuß and Sunderman, 2000),
therefore the zinc fingers of Zfp647 may be capable of binding to nickel, whereas
Rbak’s zinc fingers cannot. Rbak was not detected in the cells transfected with His6-
tagged SUMO, and so I was unable to demonstrate that Rbak is sumoylated in
NIH/3T3 cells.
4.4. Modification of Zfp647 by Poly(ADP-Ribose)
4.4.1. Poly(ADP-Ribosyl)ation
      My studies trying to determine what species Zfp647 is modified by appeared to
suggest that this protein could be mono-ubiquitylated. However, mono-ubiquitylation
only appeared to be responsible for one of the extra bands seen with NEM treatment,
and I had found that two further modified bands could be seen (Figure 4.11).
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Therefore I decided to test whether Zfp647 was subjected to another modification,
poly(ADP-ribosyl)ation. Like the ubiquitin-like proteins, ADP-ribose can be
conjugated to a substrate protein as a monomer by ADP-ribosyltransferases, or in
chains by the poly(ADP-ribose) polymerases (PARPs) (Figure 4.14). ADP-
ribosylation is associated with bacterial toxins, for example cholera toxin, which
ADP-ribosylates G proteins within the intestines, leading to the characteristic fluid
loss associated with this disease (Kaper et al, 1995). In Section 3.2.2, I showed that
Zfp647 interacts with ARD1 in a yeast two-hybrid assay. ARD1 contains an ARF
domain, which can stimulate ADP-ribosylation activity by proteins such as the
cholera toxin, although ARD1 has not been directly shown to possess this activity.
Poly(ADP-ribosyl)ation is commonly associated with DNA repair pathways. The
founding, and probably most studied, member of the PARP family, PARP-1,
interacts with and possibly poly(ADP-ribosyl)ates factors from both the base-
excision repair and single-strand-break pathways upon formation of DNA nicks
(Menissier de Murcia et al, 1997; Schreiber et al, 2006). Upon binding to nicked
DNA, PARP-1 also poly(ADP-ribosyl)ates itself. Because of the high negative
charge of the poly(ADP-ribose) mark, modified PARP-1 is released from the
negatively charged DNA, and it has been suggested that this transient association of
PARP-1 to damaged DNA regulates the DNA repair pathway (Smith, 2001). PARP-1
can also bind to PARP-2; PARP-2 has been shown to be required for efficient single-
strand-break repair (Schreiber et al, 2002).
      PARPs have also been implicated in the regulation of chromatin structure and
transcription. PARP-1 can ADP(ribosyl)ate histone H1 (Section 1.1.3.5), which may
lead to the removal of nucleosomes and the relaxation of chromatin structure (Ausió
et al, 2001), although it has also been reported that PARP-1 can alter chromatin
structure independent of its modification ability (Kim et al, 2004). PARP-1 is also
known to have a stimulatory effect on transcription factors, for example NF-κB
(Hassa et al, 2003) and the Mediator complex (Pavri et al, 2005). The insulator
protein CTCF, which helps to prevent the preading of hetero- or euchromatic
domains, is also subjected to poly(ADP-ribosyl)ation in vivo (Yu et al, 2004).
Modification of CTCF does not disrupt its DNA-binding capability, as found with
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PARP-1. Instead, poly(ADP-ribosyl)ation appears to be important for CTCF’s
insulator function, as cells treated with a PARP inhibitor, 3-aminobenzamide (3-AB),
leads to a loss of insulator function at CTCF binding sites (Yu et al, 2004).
Additionally, the nucleosome remodeller ISWI has been shown to be poly(ADP-
ribosyl)ated in Drosophila, which inhibits the enzyme’s function (Sala et al, 2008).
      PARP-1 and PARP-2 have recently been linked to the regulation of cell
differentiation by their effect on KAP-1 and HP1 (Quénet et al, 2008). It was shown
that PARP-2 binds to KAP-1, HP1_ and HP1β; PARP-1 binds weakly to KAP-1 and
HP1β; and that both PARPs were able to poly(ADP-ribosyl)ate HP1_ on its hinge
domain. PARP-2 also co-localises with KAP-1 in primitive-endoderm-like (PrE)
cells, generated by the differentiation of F9 EC cells, and the loss of PARP-2 leads to
the impaired localisation of KAP-1 at the pericentric heterochromatin in these cells.
Quénet et al also demonstrated that PARP-1 and PARP-2 may play a role in
regulating the expression of mesoderm- and endoderm-specific genes through their
interaction with and possible modification of KAP-1 and HP1 (Quénet et al, 2008).
As it can regulate the behaviour of KAP-1 and HP1, I speculated that poly(ADP-
ribosyl)ation may be involved in the regulation of other transcription factors.
4.4.2. Immunoprecipitation of Poly(ADP-Ribosyl)ated Proteins
      To see whether Zfp647 is poly(ADP-ribosyl)ated, I carried out an
immunoprecipitation using a mouse _-poly(ADP-ribose) antibody on NIH/3T3
nuclear extract, and then western blotted the immunoprecipitated material with the
sheep _-Zfp647 antibody (Figure 4.15). As controls, I repeated the experiment
substituting the same amount of IgG for the mouse _-poly(ADP-ribose) antibody.
The experiment was carried out in the presence of NEM to preserve the modified
forms of Zfp647, but a nuclear extract from cells not treated with NEM was run to
show unmodified Zfp647. The higher molecular weight forms of Zfp647 can be seen
in the input lane, and the lower of the two main modified forms also appears to be
present in the immunoprecipitation lane, therefore this experiment suggested that
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Zfp647 may indeed be modified by poly(ADP-ribose). I also carried out the
immunoprecipitation using rabbit _-Zfp647 antibody, and western blotted the
immunoprecipitated material with the mouse _-poly(ADP-ribose) antibody; however,
the western blots did not show any bands specific for Zfp647 (data not shown).
4.4.3. Effect of PARP Inhibition on Zfp647 Modification
      To verify whether Zfp647 is poly(ADP-ribosyl)ated, I analysed the modification
status of Zfp647 in cells in which PARP function was inhibited by treatment with 3-
AB (Purnell and Whish, 1980). 3-AB, like other PARP inhibitors, functions by
competing with free nicotinamide adenine dinucleotide (NAD+), which is required as
a precursor and substrate in the poly(ADP-ribosyl)ation reaction (Figure 4.14; Hassa
and Hottiger, 2008). 3-AB is commonly used at concentrations of 2 or 3mM,
typically for up to 24 hours (Kuo et al, 1996; Rajesh et al, 2006; Ding et al, 2008). I
treated NIH/3T3 cells with 2mM 3-AB for 18 hours, and made whole cell extracts
from these cells, as well as cells treated with the 3-AB solvent DMSO for the same
time period. Extracts were made from cells both in the absence and presence of
NEM, and were run out by PAGE. The gels were then western blotted with sheep _-
Zfp647 and mouse _-tubulin antibodies (Figure 4.16). The western blot probed with
the mouse _-tubulin antibody shows that the loading of each of these extracts was
equivalent. In the western blot probed with sheep _-Zfp647, the 65kDa Zfp647 band
is visible in each of the lanes. In the extracts treated with NEM, the modified forms
of Zfp647 seen at approximately 70 and 80kDa are present in the cell extracts treated
with both DMSO and 3-AB. In this experiment, it appeared that treatment of cells
with 3-AB did not prevent the modification of Zfp647, raising doubts as to whether
Zfp647 is poly(ADP-ribosyl)ated. However, as I have not included a positive control
for the action of 3-AB, I cannot prove that the PARPs have been inhibited, therefore
this result is inconclusive.
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4.5. Modification of Zfp647 in ES Cells
4.5.1. Relocalisation of Zfp647 in Differentiated ES Cells
      The relocalization of Zfp647 in ES cells over the course of differentiation has
been previously studied by Dr Heidi Sutherland, using OS25 cells (Section 1.4.2). In
undifferentiated cells, Zfp647 shows a nuclear diffuse pattern of staining, but upon
RA-induced differentiation, the protein relocalises to non-heterochromatic foci
(Figure 1.9; Briers et al, 2009). The percentage of cells showing these KAKA foci is
graphed in Figure 4.17. Zfp647 is first seen at non-heterochromatic foci after four
days of differentiation: 2% of cells show this pattern of staining. After six days of
RA differentiation, Zfp647 localises to non-heterochromatic foci in 44% of cells. In
38% of these cells, KAP-1 co-localises with Zfp647. The prevalence of the foci
decreases after this point, and after ten days of differentiation, the Zfp647 foci are
only seen in 7.5% of cells.
4.5.2. Modification of KAP-1 in ES Cells
      It has been reported that each of the SUMO isoforms can be visualised at the
PML bodies, resulting from the high concentration of sumoylated PML and other
factors located at these structures (Boddy et al, 1996; Briers et al, 2009). As KAP-1
is also sumoylated, and can be visualised at structures adjacent to these SUMO-
containing PML-NBs in differentiated ES cells, Dr Heidi Sutherland tested whether
the modified forms of KAP-1 could be detected in ES cells, and also whether the
modification of KAP-1 is different in differentiated cells compared with
undifferentiated cells, as the localisation of this protein does. In whole cell extracts
prepared with NEM, unmodified KAP-1 could not be seen in undifferentiated ES
cells. However, in cells differentiated with 10 days of RA treatment, a band ~50kDa
greater than endogenous KAP-1 could also be seen by western blot, indicating that
KAP-1 is modified, probably by sumoylation, in differentiated, but not
undifferentiated, ES cells (Briers et al, 2009).
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4.5.3. Detection of Modified Forms of Zfp647 in ES Cells
      Because the modification of transcription factors has been linked with their
ability to co-localise with other proteins and to nuclear structures (Zhong et al, 2000;
Quénet et al, 2008), and the results obtained by Dr Heidi Sutherland suggested that
KAP-1 modification is dynamic over the course of ES cell differentiation, I decided
to see whether the modification status of Zfp647 also changes as ES cells
differentiate. I chose to use OS25 cells, as these cells had been used to analyse the
localisation of Zfp647. OS25 cells were first generated to allow the differentiation of
pluripotent cells to neuroepithelial or oligodendrocyte precursor cells (Billon et al,
2002). Although RA induces the cells to differentiate down a neural pathway, I did
not positively select for either neuroepithelial or oligodendrocyte precursor cells.
OS25 cells have a hygromycin-thymidine kinase construct cloned into the Oct4 locus.
To differentiate the cells, I grew them in the absence of leukaemia inhibitory factor
(LIF) and in the presence of RA, and also selected against undifferentiated, Oct4-
expressing, cells by treating them with gancyclovir.
      Whole cell extracts were made from OS25 cells before the differentiation process
was initiated, and then 1, 3, 5, and 7 days after the LIF was first removed from the
growth media. Extracts were made in the absence and presence of NEM, run out by
PAGE and western blotted with sheep _-Zfp647 (Figure 4.18). The relative protein
levels of these extracts was assayed by western blotting the extracts for histone H3.
Zfp647 is present in each of the lanes, showing that the expression of this protein
does not change during OS25 differentiation. This corroborates Dr Heidi
Sutherland’s immunofluorescence data, as Zfp647 could be seen throughout
differentiation, and it was the localization of the Zfp647 signal that changed. In the
undifferentiated cell extract, an extra band is present above the 65kDa Zfp647 band.
After 1 and 3 days of differentiation, the extra band has almost disappeared, but
reappears in the day 5 and 7 extracts. It therefore appears that the modification of
Zfp647 alters over the period of differentiation: it is lost at the beginning of the
differentiation process, but reappears as the cells become differentiated.
Interestingly, the re-emergence of the 70kDa modified band coincides with the re-
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localisation of Zfp647 to the KAKA foci. It may be possible that the modification of
Zfp647 is in some way linked to the protein’s localisation within the nucleus.
4.6. Discussion
4.6.1. Zfp647 is Post-Translationally Modified
      KAP-1 has been shown to be sumoylated (Lee et al, 2007b; Mascle et al, 2007)
and this modification is required for its interaction with two of the effector proteins
in the KRAB-mediated transcriptional repression machinery, Mi-2_ and SETDB1
(Ivanov et al, 2007). Because KAP-1 functions as a SUMO E3 ligase, it may be
possible that this protein can direct the modification of other proteins it interacts
with, including the KRAB zinc finger proteins. Alternatively, the RING domain of
KAP-1, or any of the RING domain proteins pulled out of my yeast two-hybrid
screen, could facilitate the ubiquitylation (or sumoylation) of Zfp647. Therefore I
tested whether Zfp647 is post-translationally modified in vivo. One of the most
common reasons for protein modification is poly-ubiquitylation, which typically
leads to a protein’s degradation by the proteasome. As Zfp647 interacts with RING
domain proteins that could function as ubiquitin E3 ligases, the amount of cellular
Zfp647 may be regulated by its poly-ubiquitylation catalysed by these proteins. I
therefore tested to see whether inhibition of the proteasome using the chemical
MG132 had an effect on Zfp647. If Zfp647 is targeted for destruction, I would have
expected to see an accumulation of modified forms of Zfp647 as they could no
longer be removed from the cell. However, MG132 had no effect on the pattern of
Zfp647 staining seen by western blot (Figure 4.3), therefore it is unlikely that
Zfp647’s association with RING domain proteins leads to its poly-ubiquitylation and
subsequent degradation.
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      I have found that modified forms of Zfp647 are detected in the presence of NEM,
a cysteine protease inhibitor, in NIH/3T3, PCC4 EC and ES cells. Treatment of cells
with NEM leads to the appearance of typically two extra Zfp647 bands, at either 70
or 75kDa, and 85kDa. The size of the lower band is not as constant as that of the
85kDa species (compare Figure 4.4 with Figure 4.11), thus it may be that there are at
least three different modified forms of Zfp647, or these forms may not behave
consistently on PAGE gels. Another band, seen in Figures 4.6 and 4.18, only appears
to be 1-2kDa larger than the unmodified form of Zfp647. Since NEM is a general
inhibitor of proteins that depend on cysteine residues in their active sites, it could
prevent the action of many enzymes in the cell. However, given the indications from
the yeast two-hybrid screen that Zfp647 may interact with the ubiquitin (or ubiquitin-
like protein) machinery, I decided to try and see whether Zfp647 is modified by one
of the three major ubiquitin-like proteins: ubiquitin, SUMO or Nedd8. The size of
two of the extra Zfp647 bands, at approximately 10 and 20kDa above the main
Zfp647 band, correlate with the size of one and two covalently attached ~10kDa
ubiquitin-like modifiers. Despite being able to successfully immunoprecipitate the
modified forms of Zfp647, probing the immunoprecipitated material with antibodies
specific for the ubiquitin-like modifiers did not confirm that any of these proteins
was covalently attached to Zfp647 (Figure 4.9). However, given that there was barely
any signal from each of the input lanes in these immunoprecipitations, the antibodies
used may not be particularly good at detecting the endogenous modifier proteins.
This problem, coupled with the seemingly small pool of modified Zfp647
immunoprecipitated by the sheep _-Zfp647 antibody (Figure 4.8) may have lead to
the modification of Zfp647 by one of the ubiquitin-like proteins going undetected. In
the future, this experiment could be repeated using cells transfected with soluble,
tagged Zfp647, which may increase the amount of modified Zfp647 that is present, a
step that is often required to visualise proteins covalently linked to the ubiquitin-like
modifiers (Mascle et al, 2007).
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4.6.2. Zfp647 is Possibly Mono-Ubiquitylated
      Transfection of tissue culture cells with His 6-tagged ubiquitin-like modifiers has
suggested that Zfp647 could be mono-ubiquitylated. One of the modified Zfp647
bands increased in size in the presence of His6-tagged ubiquitin (Figure 4.11). This
increase in size could be due to the extra molecular weight of the modifier’s tag,
which, consisting of six histidine residues, should add 1-2kDa to the protein’s
molecular weight. The exogenous ubiquitin protein did not affect any of the other
NEM-dependent bands. Interestingly, the band that shifted in size was already 1-
2kDa greater than the size of endogenous Zfp647, which may suggest that only
Zfp647 that is already modified can be ubiquitylated. The modification of Zfp647 by
tagged ubiquitin could be further tested by transfecting the cells with ubiqutin
carrying a larger epitope, for example GFP, which would demonstrate more clearly
the change in size caused by its ubiquitylation. I attempted to verify the mono-
ubiquitylation of Zfp647 by using the nickel pull-down method, but Zfp647 non-
specifically precipitates with the nickel beads used, thus this experiment was not
successful. Unlike Zfp647, Rbak did not non-specifically interact with the beads,
suggesting that this property is not shared by all KRAB zinc finger proteins. In
western blots of cell extracts treated with NEM, I was unable to detect any modified
forms of Rbak, and the antibody did not give any signal from the nickel pull-down
material. Thus either this antibody is unable to detect modified forms of Rbak, as the
modification could interfere with the antibody’s binding to its epitope; the amount of
modified Rbak present in NIH/3T3 cells is too small to be detected; or Rbak is not
sumoylated in NIH/3T3 cells. Transfection of cells with soluble, tagged Rbak and the
ubiquitin-like modifiers and analysis by western blot with antibodies specific for the
epitope tags could therefore be used to confirm whether or not Rbak is modified in
these cells.
      There are two main approaches that I would take in the future to see whether
Zfp647 is post-translationally modified by one of the ubiquitin-like proteins. First,
TNT-expressed Zfp647 could be subjected to in vitro ubiquitylation, sumoylation or
neddylation assays. Zfp647 can be successfully expressed using the TNT system, and
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these assays do not require endogenous protein. Since the putative E2 (in the case of
ubiquitin) or E3 ligases are unknown, the assay could be supplemented with
NIH/3T3 cell extract to allow efficient modification of Zfp647 (Mouchantaf et al,
2006). If any of these experiments showed that Zfp647 was modified by ubiquitin,
SUMO or Nedd8, the region of the protein that harbours the modified lysine
residue(s) could be narrowed down, and the target lysine(s) identified by mutation of
the plasmid that Zfp647 was expressed from, an advantage that this system has over
analysis of the endogenous protein. The other approach that could be taken would be
to immunoprecipitate modified Zfp647 and subject the immunoprecipitated material
to mass spectrometry, which can be used to identify modification by the ubiquitin-
like proteins, as well as modifications such as acetylation and phosphorylation
(Witze et al, 2007). To increase the amount of material to be analysed, I could over-
express Zfp647 in the cell, as I have found that His6-tagged Zfp647 is modified in the
presence of NEM (data not shown).
      I have also attempted to see whether Zfp647 is modified by another type of
modification, poly(ADP-ribose). The PARPs are known to interact with KAP-1 and
HP1, and may poly(ADP-ribosyl)ate these proteins in vivo (Quénet et al, 2008).
Poly(ADP-ribosyl)ation can result in varying increases in the size of the substrate
protein: HP1 poly(ADP-ribosyl)ation leads to an increase in size of <5kDa (Quénet
et al, 2008), whereas poly(ADP-ribosyl)ation of CTCF was visualised as an increase
in size of ~40kDa (Yu et al, 2004), therefore any of the modified forms of Zfp647
could be candidates for this modification. While NEM has been reported to be
inhibitory to the ADP-ribosylation process, as it can covalently modify potential
cysteine acceptor sites (Hoshino et al, 1990; van Heyningen and Baxty, 1997), it may
be possible that NEM inhibits the removal of the poly(ADP-ribose) from Zfp647 by
altering the activity of poly(ADP-ribose) glycohydrolase (PARG), or one of the other
enzymes that reverse poly(ADP-ribosyl)ation (Davidovic et al, 2001). I carried out
an immunoprecipitation of modified Zfp647 from tissue culture cells, and probed the
immunoprecipitated material with an antibody specific for poly(ADP-ribose) (Figure
4.15). This suggested that the lower of the two modified bands may indeed by
poly(ADP-ribosyl)ated Zfp647, and so I further tested this by inhibiting PARP
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activity with 3-AB. Analysis of Zfp647 in cells treated with this chemical showed
that there was no effect on Zfp647 modification. However, this experiment did not
include a positive control to prove that the inhibitor was in fact preventing
poly(ADP-ribosyl)ation by the PARPs. The experiment therefore needs to be
repeated with an assay for poly(ADP-ribosyl)ation, possibly by detecting the forms
of proteins known to be poly(ADP-ribosyl)ated in vivo, such as PARP-1 (Smith,
2001) or NF-κB (Hassa et al, 2003). Alternatively, an in vitro poly(ADP-
ribosyl)ation assay could be employed (Yu et al, 2004), which would show if Zfp647
can be modified in this manner. Co-immunoprecipitations between either
endogenous or over-expressed Zfp647 and the PARP enzymes could also be carried
out, which would strengthen the argument that Zfp647 is poly(ADP-ribosylated).
4.6.3. KAP-1 Does Not Influence Zfp647 Modification
      I have also tested whether KAP-1 itself influences Zfp647 modification. KAP-1’s
PHD and bromodomains function as a SUMO E3 ligase, catalysing KAP-1
sumoylation by Ubc9, and this protein also possesses a RING domain, which may act
as a ubiquitin, SUMO or Nedd8 E3 ligase. Zfp647 modification was tested in EC
cells in which KAP-1 was downregulated through an integrated RNAi construct
(Figures 4.5 and 4.6; Wolf et al, 2008). These results showed that Zfp647
modification was not affected by the loss of KAP-1, but the amount of Zfp647
visible was slightly reduced in the PCC4 111 cells. Therefore it appears unlikely that
KAP-1 modifies, or aids in the modification of, Zfp647. The expression of another
KRAB zinc finger protein, Zfp809, has also been found to be reduced in the PCC4
111 cell line when compared with wild-type cells (Dr Daniel Wolf, personal
communication). KAP-1 may instead be involved in regulating the expression or
stability of KRAB zinc finger proteins. KAP-1 has been shown to bind to chromatin
at the sites of the KRAB zinc finger protein genes, and H3K9 methylation is also
found at these loci (O’Geen et al, 2007). It is therefore difficult to picture how the
loss of KAP-1 causes a decrease in transcription of these genes, unless KAP-1
binding does not repress KRAB zinc finger protein gene expression, as suggested by
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Vogel et al (Vogel et al, 2007). The effect of KAP-1 on transcription of Zfp647
expression could be tested relatively easily by qRT-PCR of the Zfp647 gene in the
wild-type and 111 PCC4 cells. Alternatively, KAP-1 may in some way stabilise
KRAB zinc finger proteins. Binding to KAP-1, and possibly other KRAB-mediated
transcriptional repressor proteins, may prevent KRAB zinc finger protein turnover,
similar to the stabilisation of Ezh2 by the PRC proteins Suz12 (Pasini et al, 2004)
and Eed (Montgomery et al, 2005). The loss of Zfp647 protein stability could also be
suggested by qRT-PCR data, as if the Zfp647 mRNA level does not change, but the
protein level decreases, KAP-1 may be important for Zfp647 stability.
4.6.4. Zfp647 Modification is Dynamic During ES Cell Differentiation
      We have previously found that Zfp647 localisation is dynamic over the course of
ES cell differentiation (Briers et al, 2009). The modification of certain proteins,
including transcription factors, has been shown to impact upon their localisation,
particularly to the PML bodies. For example, sumoylated orphan nuclear receptor
LRH-1 is only found at the PML-NBs, and release from the PML-NBs occurs at the
same time as the protein’s desumoylation (Chalkiadiki and Talianidis, 2005).
Therefore, I investigated whether the modification of Zfp647 is also dynamic in ES
cells. I found that the larger, 85kDa, modified form of Zfp647 was only present at
low levels in ES cells. The smallest modified form of Zfp647 was not always seen
(Figure 4.18). This form was present at low levels in undifferentiated ES cells, but
disappeared upon treatment with RA, only to reappear 3-5 days later. The
modification of Zfp647 correlates with the protein’s localisation, as the KAKA foci
are first seen in OS25 cells after 4 days of differentiation (Figure 4.17). It is therefore
tempting to speculate that the protein’s modification is linked to its localisation, and
that modification may be required for recruitment to the KAKA foci. I do not believe
that this modified form of the protein is sumoylated, as difference in molecular
weight to the endogenous protein is too small. It may therefore be possible that
another type of modification is involved in the recruitment of proteins to the KAKA
foci. If the species of modification was successfully identified using one of the
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methods outlined above, it may then be possible to chemically inhibit the
modification of Zfp647, and visualize whether this impairs the recruitment of Zfp647
to the KAKA foci in differentiated ES cells.
      An extra band is visible in Figure 4.18, at approximately 40kDa. This may be a
Zfp647 degradation product, as the 65kDa band appears to be slightly weaker in
strength in those lanes where this extra band is present (undifferentiated and day 5
lanes). This may therefore be a product of Zfp647 turnover; that controlled Zfp647
degradation is occurring at these timepoints. Interestingly, this band appears when
the modified Zfp647 species is present. One possible reason for this turnover is that
in order to change the localisation and/or modification status of Zfp647, the pre-
existing quotient of the protein is degraded, breaking down any Zfp647 structures,
allowing the newly produced, potentially modified, Zfp647 to become concentrated





      The KRAB zinc finger proteins are a very large family of transcriptional
repressors found in mammalian genomes. Although the precise functions of most of
these proteins are yet to be identified, it is thought that they can play important roles
in such divergent processes as the regulation of DNA methylation (Li et al, 2008),
sexual dimorphism (Krebs et al, 2003), correct positioning of the body axis (García-
García et al, 2008) and the prevention of retroviral replication (Wolf and Goff,
2009). As the vast majority of the KRAB domain-containing proteins are associated
with a zinc finger domain, it is thought that the main way in which KRAB zinc finger
proteins exert an effect is through binding to a particular gene target and recruiting
other factors to supress its transcription. These gene targets may be unique to one
KRAB zinc finger protein, or could possibly be shared by closely related proteins
encoded in a gene cluster. While the search for gene targets of the KRAB zinc finger
proteins has not yielded many results, investgations into the protein-protein
interactions of these factors has uncovered possible functions for a number of
proteins, for example ZBRK1 (Zheng et al, 2000), Zkscan17 (Nielsen et al, 2004)
and NRIF (Casademunt et al, 1999).
      Like the number of known endogenous gene targets, the number of good
antibodies that have been raised against the KRAB zinc finger proteins is also low.
This may be due to high levels of homology found between certain proteins, leading
to difficulties in raising antibodies with a high level of specificity, or alternatively
may result from the KRAB zinc finger proteins’ low profile within the biological
field. Therefore most studies that have analysed the localisation of these proteins
within the cell have depended on overexpression of tagged KRAB zinc finger protein
constructs. We have shown that the localisation of GFP-Zfp647 in fact differs to that
of the endogenous protein, as we have been able to raise a specific antibody against
Zfp647 (Briers et al, 2009). This may also be true for other over-expressed KRAB
zinc finger protein fusion proteins. We have found that endogenous Zfp647, and
NT2, another murine KRAB zinc finger protein (Tanaka et al, 2002), localise to
distinct non-heterochromatic foci in undifferentiated ES cells, alongside KAP-1, HP1
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and SETDB1 (Briers et al, 2009). A very similar pattern of localisation has been
reported for another KRAB zinc finger protein, PAROT (Fleischer et al, 2006). Two
KRAB zinc finger proteins, KRAZ1 and KRAZ2, have been shown to be targeted to
the centromeric heterochromatin through their interaction with KAP-1, and it is
therefore postulated that KRAZ1 and KRAZ2 repress transcription of their targets by
association with these domains of silent chromatin. Zfp647 and NT2 may silence
their gene targets in a similar manner, by the recruitment of these genes to another
transcriptionally silent environment, the KAKA foci. Because of their proximity to
the PML bodies, it may instead be that these foci are associated with PML-NB
function. Most relevant to the behaviour of transcription factors, the KAKA foci
may, like the PML-NBs, be a site of storage of the KRAB zinc finger proteins, if
they are not required at a particular timepoint or cell cycle stage. The formation of
the foci may play a role in, or depend upon, the modification status of KAP-1 (Lee et
al, 2007b; Mascle et al, 2007) or the KRAB zinc finger proteins (Vertegaal et al,
2006). I have found that the KAKA foci are not present in NIH/3T3 cells, whereas
they are clearly visible in pMEFs. I showed that the foci in pMEFs also twinned with
PML bodies, as has been shown in the ES cells (Briers et al, 2009). Therefore it is
possible that the KAKA foci are cell-type specific: certain cell-specific factors may
be required to induce the formation of these foci. Alternatively, they may be protein-
specific: I did not see KAKA foci in NIH/3T3 cells with antibodies against Zfp647,
Zfp37 and Zfp90; however, other proteins may co-localise with KAP-1 in these cells.
The two cell types that we have seen the KAKA foci in (ES cells and pMEFs)
suggests that they may only be present in primary or untransformed cell lines.
      Chapter 3 details the work I have carried out to identify protein-protein
interactions that Zfp647 can make. The yeast two-hybrid results that I have shown
are not false positives demonstrate that Zfp647 is capable of self-interaction, and
interacting with a number of other KRAB zinc finger proteins. My in vitro co-
immunoprecipitation results suggested that the two tagged Zfp647 moieties
specifically interact, although the signal from the interaction was fairly weak. Homo-
oligomerisation has been demonstrated for one other KRAB zinc finger protein,
ZBRK1, which, like Zfp647, interacted with itself through its C-terminus. Tan et al
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showed that ZBRK1 homo-tetramerises, and that this interaction enhances ZBRK1’s
transcriptional repression activity (Tan et al, 2004b). Furthermore, the repressive
effect exerted by the C-terminus was shown to be independent of ZBRK1’s DNA-
binding ability, thus the authors argued that higher-order structures of ZBRK1 may
form on its DNA targets, which could aid in the repression of these sequences by
recruitment of more silencing proteins. The finding that Zfp647 can self-interact
suggests that other KRAB zinc finger proteins may function in this manner, and the
KAKA foci we have observed may result from these higher-order structures. The
repressive effect caused by the oligomerisation of ZBRK1 is independent of the
protein’s DNA binding ability. Therefore, it may be the case that various KRAB zinc
finger proteins, interacting through their zinc finger domains, can aid in the
repression of one protein’s gene targets, without compromising the specificity of the
sequences that are being silenced.
      I have found that Zfp647 may interact with two jumonji domain-containing
proteins, Jarid1b and Jmjd1c using two separate methods, although I have not been
able to verify either of these interactions through independent means. These potential
interactors are of interest because it has been shown that another KRAB zinc finger
protein, Zkscan17, can interact with JARID2 (Mysliwiec et al, 2007). Jarid1b is a
histone H3K4 demethylase (Seward et al, 2007; Yamane et al, 2007), and would thus
aid in transcriptional silencing. Whether Jmjd1c possesses any demethylase activity
has yet to be established. It has been found that the tethering of KAP-1 to a
chromatinised DNA sequence causes a decrease in H3K4 methylation and H3K9
acetylation, and an increase in H3K9, H3K36 and H4K20 methylation (Sripathy et
al, 2006). Thus far, HP1, SETDB1 and Mi-2_ have been shown to function in the
KRAB-mediated repression pathway, accounting for the decreases in histone
acetylation and increase in H3K9 methylation at KRAB zinc finger protein binding
sites. It may therefore be possible that the jumonji domain-containing proteins play a
role in this pathway by removing pre-existing methyl marks on H3K4, as histone
demethylase function has only been assigned to the jumonji proteins and LSD1 to
date (Cloos et al, 2008).
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      Work that I have presented in Chapter 4 demonstrates that Zfp647 is post-
translationally modified when treated with the cysteine protease inhibitor NEM. The
most prominent extra Zfp647 bands appear at <5, 10 and 20kDa above the
unmodified form of the protein when analysed by western blot. I have found
evidence to suggest that Zfp647 may be mono-ubiquitylated, as transfection of tissue
culture cells with a His6-tagged ubiquitin construct causes the increase in size of one
of these modified bands, although I have been unable to verify this result by other
means. Out of the modifications that I was testing, I previously thought that the
protein most likely to give a positive result was SUMO, as two KRAB zinc finger
proteins have been shown to be sumoylated in vitro (Vertegaal et al, 2006), and
KAP-1 acts as both a sumoylation substrate and its own E3 ligase (Lee et al, 2007b;
Mascle et al, 2007; Ivanov et al, 2007). However, transcription factors such as c-
myc, Tat and CIITA have been shown to be mono-ubiquitylated, which corresponds
with an increase in their transcriptional activation ability (Bres et al, 2003; Greer et
al, 2003; Kim et al, 2003; von der Lehr et al, 2003). Ubiquitylation of Zfp647 may
also affect this protein’s influence on transcription, possibly by inhibiting its
interactions with other proteins. The co-immunoprecipitations shown in Figure 3.14
were carried out either in the presence or absence of NEM. Most of the bands that are
seen in the co-immunoprecipitation lanes do not differ between these two lanes,
however some, including the Jarid1b band, are specific to one lane. In the case of
Jarid1b, this band is only seen in cells not treated with NEM. Therefore it may be
that modification of Zfp647 prevents its interaction with this protein.
      Finally, I have found evidence that the modification of Zfp647 is dynamic
throughout ES cell differentiation. As we have previously shown that Zfp647
localisation also changes during differentiation, it may be possible that the two
processes are linked, whereby modification is required for Zfp647 localisation to the
KAKA foci, or modification actually occurs at these sites. The former of these two
scenarios seems more likely, as Zfp647 modification occurs in NIH/3T3 cells, but
Zfp647 localization to KAKA foci is not evident.
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5.2. Future Perspectives
      There are a number of experiments that immediately follow on from the work
that I have presented in this thesis, some of which I have not been able to carry out in
the time available. Firstly, to prove that Zfp647 is capable of interacting with the
proteins identified in the yeast two-hybrid screen, these interactions should be tested
in a second, independent system. While I have had difficulty expressing Zfp647 in a
soluble form, many of these other proteins may more soluble, allowing co-
immunoprecipitation experiments using endogenous Zfp647 and over-expressed,
tagged interactor protein. The interactions that I would be most interested in initially
are those of Zfp647 with itself, other KRAB zinc finger proteins, and the jumonji
domain-containing proteins. Homo- and hetero-oligomerisation could play a part in
regulating the localization of Zfp647 and other KRAB zinc finger proteins, therefore
identifying the domain and amino acid residues responsible for interaction could
prove to be important for other future projects. Likewise, it would be interesting to
find out whether Jmjd1c and Jarid1b can bind to KRAB zinc finger proteins directly,
as witnessed with Zkscan17 and JARID2 (Mysliwiec et al, 2007), and also whether
these proteins can bind to other KRAB zinc finger protein repressors such as KAP-1
and HP1. If the jumonji proteins can bind to KAP-1, this may point to these proteins
being general KRAB-mediated transcriptional repressors, rather than effector
proteins recruited by particular KRAB zinc finger proteins to a few specific genes.
As I have seen that NEM treatment may affect Jarid1b’s interaction with Zfp647, it
would also be of worth to couple the investigations into Zfp647’s modification and
protein-protein interactions, to see whether the prevention of Zfp647 modification by
amino acid mutation also enhances or prevents its interaction with any potential
interactors.
      The nature of the modification of Zfp647 has not been clearly identified in this
thesis. Evidence suggests that the protein can be ubiquitylated, however this remains
to be verified. The next step to be taken in proving that this is the case, as outlined
earlier, is to test Zfp647 in an in vitro ubiquitylation assay. If Zfp647 does not appear
to be ubiquitylated by this assay, it could also be tested for sumoylation or
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neddylation in a similar manner, or by mass spectrometry. Once the species and
location of modification are identified, the effect of modification on Zfp647’s
function can be tested. KAP-1 sumoylation is known to be enhanced by interaction
with KRAB zinc finger proteins (Mascle et al, 2007), and is required for its
interaction with Mi-2_ and SETDB1 (Ivanov et al, 2007), therefore it is possible that
modification of KRAB zinc finger proteins regulates their interaction with KAP-1 or
other interacting proteins. If Zfp647 modification enhances or is required for
interaction with KAP-1, this may explain why the signal achieved from my in vitro
co-immunoprecipitation experiment was weak. Given that we have previously
demonstrated that over-expressed Zfp647 mis-localises in tissue culture cells, it may
be difficult to study the role Zfp647 modification plays in its localisation. However,
if a Zfp647 construct could be generated, possibly one that is expressed at a low
level, that shows the same localisation as the endogenous protein in pMEF cells,
mutation of amino acid residues that are critical for modification could be used to
analyse the effect of loss of modification on the formation of the KAKA foci, to see
whether modification is important for the recruitment of KRAB zinc finger proteins
to these structures.
      Following these experiments to verify the results I have presented in this thesis,
one of the most important steps would be to identify the gene targets of Zfp647.
Currently, the materials that we have available are a gene-trapped mouse line, and
two antibodies that can both bind to endogenous Zfp647. Gene targets could be
identified in a number of ways: expression analysis of gene-trapped homozygous
mice versus their wild-type littermates by microarray (Lockhart et al, 1996); ChIP-
on-chip experiments using either or both of the antibodies on whole genome arrays
(Weinmann et al, 2002); or ChIP-seq experiments using one of the new generation of
whole-genome sequencing machines (Johnson et al, 2007). The discovery of
Zfp647’s gene targets would make it one of very few KRAB zinc finger proteins
whose binding sites in the genome were known, and would allow the further
investigation of the KAKA foci. For example, it would allow the study of the
localization of the gene targets in relation to the KAKA foci in undifferentiated and
differentiated ES cells. If these sequences were found to be recruited alongside
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Zfp647 to the KAKA foci, it would suggest that KAKA foci could be functioning as
a silent transcriptional environment. This could be backed up by qRT-PCR analysis
of the expression of the targets in cells at both differentiation states. Most studies
looking at the repression (or activation) of transcription stimulated by KRAB zinc
finger proteins have generally fused either the KRAB domain or full-length protein
to a DNA-binding domain of another transcription factor, thus tethering it to a
reporter gene. Simple ChIP-PCR experiments alongside expression analysis in cells
where gene targets are either bound by or free from Zfp647 would therefore be one
of the first demonstrations of the effect of binding of a KRAB zinc-finger protein to
its endogenous gene targets.
      As discussed in Section 1.3.6, the KRAB zinc finger protein genes have been
shown to be bound in vivo by both KAP-1 and HP1β (O’Geen et al, 2007; Vogel et
al, 2006). KAP-1 binding sites were typically ~800bp long, whereas the domains
bound by HP1 were much larger, at up to 4Mb in length. Vogel et al did not find
significant downregulation in the expression of KRAB zinc finger protein genes that
were bound by HP1β, and therefore speculated that the heterochromatinisation of
these genes was perhaps a method to prevent their HR-driven excision from the
genome (Vogel et al, 2006). However, O’Geen et al reported that those proteins
subjected to KAP-1 binding and histone H3K9 methylation were expressed at lower
levels compared to all other expressed genes, and stated that they had found that
particular KRAB zinc finger proteins were expressed at high levels in the Ntera2
cells used in their experiments. Therefore they predicted that the KRAB zinc finger
protein genes are auto-regulated by certain KRAB zinc finger proteins and KAP-1. It
is therefore possible that the KAKA foci that we see in OS25 cells are domains of
KRAB zinc finger protein genes bound by certain KRAB zinc finger proteins, KAP-
1 and HP1. Fluorescence in situ hybridization could be carried out on the cells using
the three KRAB zinc finger protein genes (ZNF333, ZNF426 and ZNF554) described
by O’Geen et al that are silent in Ntera2 cells to show their localization, and this
technique could be carried out alongside immunofluorescence for KAP-1 and HP1 to
see whether the genes co-localise with these proteins at the non-heterochromatic
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KAKA foci. If the master-regulator KRAB zinc finger proteins implied by O’Geen et
al were also known, then their proximity to these genes could also be assayed.
      Finally, we have found that KAKA foci are situated adjacent to PML-NBs in ES
cells (Briers et al, 2009) and in pMEF cells. The role of PML in this localization
could be investigated by the study of Zfp647 in pMEFs lacking PML (Wang et al,
1998). If the KAKA foci failed to form in these cells, or their localization was
different in another way to that in wild-type cells, this would suggest that the PML
network is required for the anchoring of the KAKA foci. Additionally, if it is
discovered that Zfp647 is sumoylated, the localization of the KAKA foci could also
be looked at in cells where PML’s SIM is mutated, as this also has a profound effect
on the structure of PML-NBs, and could in turn influence KAKA foci formation (Lin
et al, 2006; Shen et al, 2006). The effect of loss of PML on Zfp647 gene target
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Introduction
Zinc-finger proteins (ZFPs) that contain the Krüppel-associated box
(KRAB) domain comprise the largest single family of transcriptional
regulators in the mammalian genome (Huntley et al., 2006; Ravasi
et al., 2003; Urrutia, 2003). The basis for their rapid evolution and
expansion in mammalian lineages (there are ~400 members in the
human or mouse genomes), as well as the target genes that they may
regulate, remain poorly understood (Krebs et al., 2005; O’Geen et
al., 2007). KRAB-ZFPs are thought to repress transcription via
interaction with KRAB-associated protein 1 (KAP1)/TIF1β/TRIM28.
In turn, KAP1 is thought to function as a co-repressor by assembling
a complex with HP1 (Ryan et al., 1999) and the chromatin modifying
enzymes: SETDB1 H3-K9 histone methyltransferase (HMTase)
(Schultz et al., 2002), NuRD (Schultz et al., 2001) and histone
deacetylases (HDACs) (Nielsen et al., 1999).
Because of a paucity of known physiological targets of KRAB-
ZFPs, most progress towards understanding their mechanism of
action has come from studies using reporter genes. KRAB domains,
which are tethered to a transgene, can repress transcription via
KAP1. KAP1 recruits SETDB1 and HP1α to a region around the
promoter, resulting in stable transgene silencing (Ayyanathan et al.,
2003). This suggests that KRAB-ZFPs might repress gene
expression by a localised alteration of chromatin structure and H3K9
methylation. However, the silenced reporter transgene was also seen
to re-localise to domains of pericentromeric heterochromatin in the
nucleus, suggesting that KRAB-KAP1 repression mechanism may
also operate at the level of nuclear organisation.
This latter idea is substantiated by reported changes in the
subnuclear distribution of KAP1. During the retinoic acid (RA)-
induced differentiation of F9 embryonal carcinoma (EC) and
embryonic stem (ES) cells, KAP1 relocalises from the nucleoplasm
to the pericentromeric heterochromatin (Cammas et al., 2002). It
has been suggested that this might also recruit target genes, and,
by implication, the KRAB-ZFPs, to these sites (Cammas et al.,
2004). Epitope-tagged KRAB-ZFPs have indeed been reported to
be concentrated at pericentromeric heterochromatin in some cells
(Matsuda et al., 2001); (Payen et al., 1998; Sutherland et al., 2001).
However, the subcellular localisation of endogenous KRAB-ZFP
proteins has not been extensively studied.
Here, we have investigated the nuclear distribution of gene-
trapped KRAB-ZFPs during the RA-induced differentiation of
embryonic stem (ES) cells. We show that, upon differentiation, these
fusion proteins, which all retain a KRAB domain, but have lost
their zinc fingers, are recruited to pericentromeric heterochromatin
in a KAP1-dependent manner. However, we show that these gene-
trapped KRAB-ZFPs are mislocalised. Endogenous KRAB-ZFPs,
Zfp647 and NT2 do not localise to the domains of pericentric
heterochromatin, but, rather, they locate at discrete foci in the nuclei
of differentiated ES cells, and these overlap with non-
pericentromeric foci of KAP1 and with HP1 proteins. We have
termed these KRAB and KAP1-associated (KAKA) foci.
We demonstrate that, whereas the pericentromeric localisation
of KAP1 is dependent on trimethylation of H3-K9 that is catalysed
by Suv39h1/h2, the formation of KAKA foci is not. We also
The KRAB-zinc finger proteins (KRAB-ZFPs) represent a very
large, but poorly understood, family of transcriptional
regulators in mammals. They are thought to repress
transcription via their interaction with KRAB-associated
protein 1 (KAP1), which then assembles a complex of chromatin
modifiers to lay down histone marks that are associated with
inactive chromatin. Studies of KRAB-ZFP/KAP1-mediated
gene silencing, using reporter constructs and ectopically
expressed proteins, have shown colocalisation of both KAP1 and
repressed reporter target genes to domains of constitutive
heterochromatin in the nucleus. However, we show here that
although KAP1 does indeed become recruited to pericentric
heterochromatin during differentiation of mouse embryonic
stem (ES) cells, endogenous KRAB-ZFPs do not. Rather,
KRAB-ZFPs and KAP1 relocalise to novel nucleoplasmic foci
that we have termed KRAB- and KAP1-associated (KAKA) foci.
HP1s can also concentrate in these foci and there is a close
spatial relationship between KAKA nuclear foci and PML
nuclear bodies. Finally, we reveal differential requirements for
the recruitment of KAP1 to pericentric heterochromatin and
KAKA foci, and suggest that KAKA foci may contain
sumoylated KAP1 – the form of the protein that is active in
transcriptional repression.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/122/7/937/DC1
Key words: Chromatin, Heterochromatin, Histone methylation, HP1,
Nuclear organisation, Transcriptional repression
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establish that there is close spatial proximity between KAKA foci
and PML-nuclear bodies (PML-NBs). We suggest that KAKA foci
represent a novel nuclear domain involved in the post-translational
modification of KRAB-ZFPs and KAP1 by sumoylation, and that
they may also be the sites of KRAB-ZFP-mediated gene silencing
in the nucleus.
Results
Gene-trapped KRAB-ZFPs relocate to pericentric
heterochromatin upon differentiation
We have previously described how a gene-trap screen (which uses
an ATG- and promoter-less gene-trap vector, and relies on in-frame
splicing into an endogenous gene transcript) can be used to identify
proteins that reside in different sub-nuclear compartments
(Sutherland et al., 2001). One of the genes trapped in a continuation
of this screen was Zfp647 in the cell line ES492. Sequence analysis
indicated that the protein encoded by Zfp647 is a KRAB A+B family
member (Shannon et al., 2003), which is separated by a linker region
of 96 amino acids from 13 C2H2 zinc fingers. Although the
majority of gene-traps do integrate into introns, in the ES492 cell
line the vector has inserted into the 5 end of the final ZF-encoding
exon (after amino acid 147) of Zfp647, and uses a cryptic splice
donor. A schematic representation of Zfp647 and the trapping of
this locus, is shown in Fig. 1A. Our previously described gene-
trapped KRAB-domain containing proteins showed a nuclear
diffuse localisation in ES cells. However, these gene-trapped
proteins were also found concentrated at domains of constitutive
heterochromatin (which is pericentromeric in mouse) in a subset
of ES cells, the morphology of which suggested they may be
differentiated (Sutherland et al., 2001).
To determine whether gene-trapped KRAB proteins do relocalise
in the nucleus upon differentiation, we used immunofluorescence with
an antibody (α-β-gal) that recognises the β-galactosidase (β-gal)
region of the gene-trapped KRAB proteins to analyse their nuclear
distribution before and after differentiation with retinoic acid (RA).
Undifferentiated cells were identified by co-immunofluorescence with
an antibody that detects stage-specific embryonic antigen-1 (SSEA-
1) on the cell surface (Matsui et al., 1992) [data not shown]. In
undifferentiated ES492 gene-trapped cells, the Zfp647-β-gal fusion
protein was found in fine speckles distributed across the nucleus, but
excluded from pericentric heterochromatin, and mostly excluded from
nucleoli (Fig. 1B). However, with differentiation, Zfp647-βgal was
found to concentrate at pericentric heterochromatin (brightly staining
DAPI foci) in a significant proportion of cells (Fig. 1B,D). We
observed (data not shown) a similar relocalisation of β-gal fusion
proteins to heterochromatin upon RA-induced differentiation for five
other ES cell lines with gene-traps of different KRAB-ZFPs
(Sutherland et al., 2001).
This is reminiscent of the differentiation-dependent relocalisation
of KAP1 to heterochromatin reported in EC and ES cells (Cammas
et al., 2002). To determine whether KAP1 and KRAB-β-gal fusion
proteins moved to heterochromatin together, we analysed their
subnuclear distribution by co-immunofluorescence, both before and
after RA-induced differentiation. In undifferentiated ES cells, KAP1
also showed staining in fine speckles distributed across the nucleus,
but excluded from pericentric heterochromatin and nucleoli, although
Journal of Cell Science 122 (7)
Fig. 1. Gene-trap of Zfp647 and subcellular localisation of Zfp647 fusion proteins with β-gal and GFP. (A) Schematic diagram of gene-trap of Zfp647 locus in the
ES492 cell line. Arrows indicate position of gene-trap integration into the Zfp647 locus to generate a fusion protein with β-geo (β-gal and neomycin).
(B) Deconvolved images from single optical sections of immunofluorescence on ES492 cells before (–RA) and after (+RA) 6 days of differentiation with retinoic
acid. Gene-trapped Zfp647 was detected with antibody that detects β-gal (red in merge). Co-staining was with an antibody that recognises KAP1 (green in merge).
DNA was counterstained with DAPI (blue in merge). Double arrowheads indicate colocalisation of Zfp647-β-gal fusion protein with KAP1 at pericentric
heterochromatin. Scale bars: 5μm. (C) NIH3T3 cells transiently transfected with: GFP-tagged Zfp647 construct lacking the zinc fingers (GFP-ZfpΔZF); a construct
lacking the KRAB domain (GFP-Zfp647ΔKRAB); or full-length Zfp647 (GFP-Zfp647). GFP signal is on the left, DAPI staining is on the right. Double arrowheads
show concentrations of GFP-Zfp647 at constitutive heterochromatin (DAPI-bright foci). Arrow indicates a concentration of GFP-Zfp647 at a site that does not
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no colocalisation with Zfp647-β-gal speckles was detected (Fig. 1B,
top panel). With differentiation, both KAP1 and KRAB-β-gal fusion
proteins localised together at heterochromatin in many cells (Fig. 1B,
bottom panel). We never saw KRAB-fusion proteins concentrated at
heterochromatin unless KAP1 was present there, suggesting that the
relocalisation of KRAB-fusion proteins to pericentric heterochromatin
upon differentiation may be dependent on the prior nuclear re-
localisation of KAP1 there (Cammas et al., 2002).
Re-localisation of KRAB-ZFPs and KAP1 to heterochromatin
after addition of RA could result from differentiation per se, or from
changes in the cell cycle as rapidly dividing ES cells differentiate.
Therefore, we analysed the localisation of gene-trapped KRAB-
ZFPs in BrdU pulse-labelled cells. Before and after differentiaton,
we could see KRAB-β-gal fusion proteins concentrated at
heterochromatin in both BrdU-positive and negative cells (data not
shown). Therefore, KRAB-ZFP movement to heterochromatin is
not just a consequence of withdrawal from the cell cycle.
Localisation of GFP-tagged Zfp647
All of our gene-trapped KRAB-ZFPs retain the KAP1-interacting
KRAB domain, but lack the zinc fingers (ZFs) of the endogenous
protein. As the ZFs probably target the proteins to specific genes,
or are responsible for interaction with other proteins, the gene-
trapped proteins may mislocalise relative to their wild-type
counterparts. We therefore generated constructs of GFP fused with
full-length Zfp647, as well as deletion constructs to investigate
domains responsible for subcellular localisation.
A construct consisting of GFP fused to Zfp647 lacking the ZFs
(GFP-Zfp647ΔZF), thus similar to the gene-trapped protein, could
localise to pericentric heterochromatin cells (Fig. 1C, double
arrowheads) when transiently expressed in NIH3T3 cells, but also
showed some cytoplasmic localisation. The ZFs of Zfp647 alone
(GFP-Zfp647ΔKRAB) were distributed diffusely throughout the
cell, with no concentration at heterochromatin (Fig. 1C,D). This
indicates that amino acids 1 to 147, which comprise the KRAB
domain and some of the linker region, are necessary for retention
of Zfp647 in the nucleus and its recruitment to domains of
heterochromatin. Full-length Zfp647 tagged with GFP at either the
N or C terminus (GFP-Zfp647 or Zfp647-GFP) produced a nuclear
diffuse staining pattern, but in up to 20% of cells the fusion protein
also colocalised with foci of pericentric heterochromatin (Fig. 1C,
double arrowhead). This is consistent with data for other transfected
epitope-tagged KRAB ZFPs (Matsuda et al., 2001).
Interestingly, in some transfected cells, the GFP-Zfp647 or
Zfp647-GFP fusion proteins were also concentrated in smaller foci,
which were not at pericentric heterochromatin (arrowed in Fig. 1C
and quantified in Fig. 1D).
Generation of antibodies against endogenous Zfp647
The subnuclear localisation of GFP-tagged Zfp647 is generally
consistent with that of the gene-trapped KRAB-ZFPs, and with
previous studies of KAP1 (Cammas et al., 2002), except that the
smaller foci seen with GFP-tagged protein were not apparent in the
gene-trapped cells. Therefore, we wished to examine the subcellular
localisation of endogenous Zfp647. We raised antibodies specific
to amino acids 90-174 in the linker region (broken line above linker
of Zfp647 protein diagrammed in Fig. 1A), as this is the region that
is most divergent between different KRAB-ZFPs. By western blot,
the affinity-purified antibody (α-Zfp647) raised in sheep detected
a band close to the expected size of 60 kDa in extracts from wild-
type 12.5 days postcoitum (dpc) mouse embryos, and this band was
much reduced in intensity in homozygous mutant animals (–/–)
generated from the ES492 gene-trap ES cells (Fig. 2A). We believe
that the residual band may represent some splicing around the gene-
trap integration, rather than crossreaction with any another KRAB
ZFPs, as Zfp647 is not in a cluster of closely related KRAB ZFPs
and there is little homology between Zfp647 and any other KRAB
ZFPs across the linker. However, as the antibody raised in sheep
was unable to detect the Zfp647 epitope in cells by
immunofluorescence (data not shown), we also analysed affinity-
purified (α-Zfp647) antibody raised in rabbit. This antibody worked
in immunofluorescence and was also able to detect Zfp647 by
western blot in extracts from wild-type, but not mutant, animals
(Fig. 2B). However, this antibody also recognises a smaller band
(~40 kDa), which is non-specific (present in –/–). Subcellular
fractionation of NIH3T3 cells reveals that this non-specific band is
cytoplasmic, whereas Zfp647 is in the nuclear fraction (Fig. 2B),
and therefore it does not interfere with our analysis of Zfp647
staining in the nucleus. Protein loading of the samples for Fig. 2A,B
is shown in Fig. 2C, which also confirms the subcellular
fractionation of NIH3T3 cells as histones are detected only in the
total and nuclear samples, not the cytoplasmic fraction.
Endogenous Zfp647 does not associate with pericentric
heterochromatin
We examined the subcellular distribution of endogenous Zfp647
during ES cell differentiation using our rabbit α-Zfp647 antibody.
In undifferentiated ES cells (–RA in Fig. 3A), endogenous Zfp647
is dispersed in the nucleoplasm with no obvious overlap with KAP1
staining. In a proportion of ES cells differentiated with RA (+RA),
Fig. 2. Detection of endogenous Zfp647 in cell extracts. (A) Western blot with
antibody raised in sheep against Zfp647 on extracts from embryos wild-type
(+/+) or homozygous mutant (–/–) for the gene-trap into Zfp647. (B) Western
blot with antibody raised in rabbit against Zfp647 on extracts from embryos
wild-type (+/+) or homozygous mutant (–/–) for the gene-trap into Zfp647, and
in whole cell (T), cytoplasmic (C) and nuclear (N) extracts of mouse NIH3T3
cells. (C) GelCode Blue-stained gel of identical amounts of protein samples as












Zfp647 relocalised, but unlike the gene-trapped protein, this
relocalisation was never to domains of pericentric constitutive
heterochromatin (DAPI-bright foci indicated by double arrowheads
in Fig. 3A). This may be due to epitope masking of the endogenous
protein when it associates with heterochromatin, although we think
this is unlikely as α-Zfp647 can detect the same epitope on Zfp647-
βgal at heterochromatin in ES492 cells (supplementary material Fig.
S1). Instead, in differentiated cells we observed that Zfp647 was
recruited to multiple foci (arrowed in Fig. 3A). These are reminiscent
of the foci detected with GFP-Zfp647 in transiently transfected cells
(Fig. 1C). In the cells in which they appeared, the number of distinct
foci of Zfp647 varied from 5 to 40 (average of 14).
Colocalisation of KRAB-ZFPs and KAP1 defines a new
nuclear body
Co-staining of ES cells, with antibody that recognises KAP1,
showed the relocalisation of KAP1 to sites of constitutive
heterochromatin upon differentiation (Fig. 3A, double arrowheads),
as has previously been seen by ourselves (Fig. 1B) and others
(Cammas et al., 2002). While Cammas et al. (Cammas et al., 2002)
found KAP1 to re-localise in a maximum of ~50% cells, and that
this was transient in F9 cells, in ES cells we find KAP1 at pericentric
heterochromatin increases during differentiation and reaching >90%
cells by 7 days of differentiation (Fig. 3B). However, we also
detected small nucleoplasmic foci of KAP1, not associated with
pericentric heterochromatin, that were coincident with the foci
detected by α-Zfp647 (arrowed in Fig. 3A). In deconvolved single
image planes, taken at 0.25 μm steps through the z-axis of ES cells,
both Zfp647 and KAP1 are in fine nuclear speckles in
undifferentiated cells that show no obvious overlap (–RA in Fig.
3C). In differentiated cells (+RA), it was apparent that one or more
foci of KAP1 may be juxtaposed to, or associated with, each focus
of Zfp647. The foci of Zfp647 foci (and their association with
KAP1) first appeared around day 4 of ES cell differentiation and
are present in a maximum of 44% of cells at day 6 (Fig. 3D). At
each time point, in the majority of cells containing Zfp647 foci,
they are also associated with KAP1.
We tested whether similar foci exist in other cell types. Non-
heterochromatic foci containing both Zfp647 and KAP1 were also
seen in the nuclei of primary mouse embryonic fibroblasts (MEFs)
from 12.5 dpc embryos (Fig. 4A) and in NIH3T3 cells (data not
shown). To determine whether these foci are specific to Zfp647, or
whether they might also contain concentrations of other KRAB-
ZFPs, we analysed the sub-nuclear localisation of NT2, one of the
few other KRAB-ZFPs for which an antibody to the endogenous
protein is available (Tanaka et al., 2002). In undifferentiated ES
cells, NT2 showed a nucleoplasmic distribution of fine speckles,
although a stronger patch of staining was also observed in most
cells; we have not identified what this structure is. Upon
differentiation with RA, NT2, like Zfp647, relocalised to
nucleoplasmic foci that were associated with KAP1 in a subset of
cells (arrowed in Fig. 4B) and not to pericentric heterochromatin
(Fig. 4B, double arrowheads). Unfortunately, as both antibodies
were raised in rabbit we were not able to co-stain with Zfp647 and
NT2 to determine whether these two proteins were present in the
same foci. We conclude that multiple KRAB-ZFPs can form foci
that associate with non-heterochromatic foci of KAP1 in
differentiated cells. We propose that these constitute a novel sub-
nuclear compartment that we refer to as KRAB and KAP1
associated (KAKA) foci.
KAKA foci also contain concentrations of HP1
KAP1 interacts, through its PxVxL motif, with HP1 proteins
(Nielsen et al., 1999; Ryan et al., 1999) and this is an integral part
Journal of Cell Science 122 (7)
Fig. 3. Detection of endogenous Zfp647 in cells.
(A) Immunofluorescence on undifferentiated (–RA) and day 6
differentiated (+RA) OS25 cells with antibodies that recognise
Zfp647 (red in merge) and KAP1 (green in merge). DNA was
counterstained with DAPI (blue in merge). Double
arrowheads indicate KAP1 concentrated at domains of
constitutive heterochromatin. Arrows indicate nucleoplasmic
foci of Zfp647 and KAP1 that overlap. Scale bars: 5 μm.
(B) Percentage of cells with KAP1 localised at the constitutive
pericentric heterochromatin with days of differentiation of
OS25 ES cells. (C) Deconvolved images from single optical
sections of immunofluorescence on undifferentiated (–RA)
and day 6 differentiated (+RA) OS25 cells using antibodies
that recognise Zfp647 (red) and KAP1 (green). DNA was
counterstained with DAPI (blue). Associated nucleoplasmic
foci of Zfp647 and KAP1 are shown enlarged in insets. Scale
bars: 5 μm. (D) Percentage of cells that show foci of Zfp647
(white bars) and Zfp647 foci associated with KAP1 foci
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of the mechanism of transcriptional silencing mediated by KRAB-
ZFPs/KAP1(Ayyanathan et al., 2003; Sripathy et al., 2006). HP1α
and β are concentrated at the domains of heterochromatin where
KAP1 is also colocalised (Gilbert et al., 2003); indeed, HP1 has
been shown to be required for the localisation of KAP1 to sites of
constitutive heterochromatin during differentiation (Cammas et al.,
2002). Interestingly, recent FRET data suggest differential
interaction between KAP1 and different HP1 isoforms (Cammas
et al., 2007).
However, as well as being located at domains of constitutive
heterochromatin (Fig. 5A, double arrowheads), we noticed small
nucleoplasmic foci of HP1 staining with antibodies that detect HP1α
and β. These are associated with the foci demarked by Zfp647
(arrowed in Fig. 5A). Closer examination of the morphology of
Zfp647 foci with respect to HP1α and β shows that, similar to
KAP1, they are often juxtaposed and also that multiple foci may
be linked (Fig. 5A,B, insets). Fig. 5A shows deconvolved single
optical sections of differentiated ES cells, but the association of
Zfp647 and HP1α in punctate foci was also confirmed in NIH3T3
cells by confocal microscopy (Fig. 5B). We also co-stained Zfp647
with HP1γ in differentiated ES cells, but as HP1γ stained the
euchromatic compartment so strongly, we were unable to detect
whether it is specifically in KAKA foci (data not shown).
Another protein that can interact with KAP1 and contribute to
KRAB-ZFP-mediated transcriptional repression is the H3K9 histone
methyltransferase (HMTase) SETDB1 (Ayyanathan et al., 2003;
Schultz et al., 2002; Sripathy et al., 2006). By immunofluorescence,
we observed that, although in some cells SETDB1 co-localises with
KAP1 at pericentric heterochromatin (~40% of cells in day 10
differentiated ES cells, data not shown), most of the protein appears
to be located in foci in the nucleoplasm (Fig. 5C). Occasionally,
we could detect SETDB1 foci that overlapped with, or were
associated with, the KAKA foci detected by immunostaining for
KAP1 (Fig. 5C, inset). However, this was not observed with all
KAKA foci, suggesting that SETDB1 may not always be present,
or that the resident concentration of SETDB1 is not high. Co-
Fig. 4. Colocalisation of NT2 and KAP1 in nucleoplasmic foci.
(A) Immunofluorescence on 12.5 dpc primary mouse embryonic fibroblasts
(MEFs) with antibodies that recognise Zfp647 (green in merge) and KAP1
(red in merge). DNA was counterstained with DAPI (blue in merge). Double
arrowheads indicate KAP1 concentrated at domains of constitutive
heterochromatin. Arrows indicate nucleoplasmic foci of Zfp647 and KAP1
that overlap, and others are shown enlarged in inset. Scale bar: 5 μm.
(B) Immunofluorescence on undifferentiated (–RA) and day 8 differentiated
(+RA) OS25 cells with antibodies that recognise the KRAB-Zfp NT2 (green in
merge) and KAP1 (red in merge). DNA was counterstained with DAPI (blue in
merge). Double arrowheads indicates KAP1 concentrated at domains of
constitutive heterochromatin. Arrows indicate nucleoplasmic foci of KAP1
and NT2, and are shown enlarged in the inset. Scale bars: 5 μm.
Fig. 5. HP1s concentrate at KAKA foci. (A) Deconvolved images from single
optical sections of immunofluorescence on day 6 differentiated OS25 cells
with antibodies that recognise Zfp647 (red in merge) and either HP1α or β
(green in merge). DNA was counterstained with DAPI (blue in merge).
Double arrowheads indicate HP1 concentrated at domains of constitutive
heterochromatin. Arrows indicate nucleoplasmic foci of ZFP647 with HP1,
and are shown enlarged in insets. (B) Immunofluorescence as in A but in
NIH3T3 cells and examined by confocal microscopy. Double arrowhead
indicates HP1 concentrated at a domain of constitutive heterochromatin.
Arrows indicate nucleoplasmic foci of Zfp647 with HP1, and are shown
enlarged in insets. (C) Deconvolved image from single optical section of
immunofluorescence on differentiated OS25 cells with antibodies that that
recognise SETDB1 (red in merge) and KAP1 (green in merge). DNA was
counterstained with DAPI (blue in merge). Nucleoplasmic foci of Zfp647 and












staining with antibodies that detect SETDB1 together with Zfp647
was not possible as both antibodies were raised in rabbit. We suggest
that KAKA foci contain complexes of KAP1 with HP1s associated
with KRAB-ZFPs, and that SETDB1 may be present.
KAKA foci are often adjacent to PML nuclear bodies
Our data suggest that KRAB-ZFPs and the KAP1/HP1 repression
machinery colocalise together at multiple nucleoplasmic foci that
we have termed KAKA foci. To determine whether these foci
represent a novel nuclear sub-compartment, we analysed their spatial
relationship to other nuclear bodies that have a superficial
resemblance in size and number.
First, co-staining with CREST antisera, which recognise
centromere components, revealed that KAKA foci are distinct from
centromeres/kinetochores (Fig. 6A). As KAP1 has been found to
colocalise with numerous damage response factors at DNA legions
(White et al., 2006), we tested whether foci demarcated by Zfp647
were in fact damage foci using an antibody against γ-H2AX.
Although we could not co-stain γ-H2AX with Zfp647 because both
antibodies were raised in rabbit, in parallel experiments the foci
detected with each antibody were different in appearance and
number. Moreover, when we induced DNA damage with UV-C,
whereas the number of γ-H2AX foci increased as expected, no
change in Zfp647 foci was observed (data not shown).
HP1s, together with MacroH2A, have been found to accumulate
in senescence-associated heterochromatin foci (SAHF) (Zhang et
al., 2005), but no SAHF bodies were detected with an antibody that
recognises MacroH2A during our ES cell differentiation (data not
shown).
KAP1 is a member of the TRIM/RBCC (tripartite motif/Ring
finger, B-box, coiled-coil) family of proteins, many of which have
been described as localised to discrete cellular subcompartments
(Meroni and ez-Roux, 2005; Reymond et al., 2001). A prominent
such example of an RBCC protein is PML – the principal component
and the organiser of PML nuclear bodies (PML-NBs). Co-staining
of differentiated ES cells with α-ZFP-647, and with antibody that
recognises PML and decorates PML-NBs, revealed that KAKA foci
are not coincident with PML-NBs. However, KAKA foci show a
spatial relationship with PML-NBs in the majority of the cells in
which they are present (arrowed in Fig. 6B). A proportion of Zfp647-
containing KAKA foci are in closely apposed pairs with PML-NBs
in ~77% of cells in which KAKA foci were detected (varying between
74 and 81% on days 4 to 10 of OS25 ES cell differentiation).
PML was one of the first substrates identified that is subject to
modification by the small ubiquitin-like modifier (SUMO)
(Sternsdorf et al., 1997) and both SUMOs, and the machinery
involved in both the addition and removal of SUMO from substrates,
are found concentrated in PML-NBs (Boddy et al., 1996)
(http://npd.hgu.mrc.ac.uk/index.html). Indeed, we observed that
KAKA foci were also indeed juxtaposed to PML-NBs detected by
antibodies that recognise either SUMO1 or SUMO2/3 (Fig. 6C,D).
Targeting of KAP1 to pericentric heterochromatin, but not to
KAKA foci, is dependent on Suv39h HMTases
To understand the factors that contribute to the differential targeting
of KAP1, HP1 and KRAB-ZFPs to pericentric heterochromatin or
to KAKA foci, we took advantage of mouse ES cells that lack the
factors responsible for epigenetic marks characteristic of
heterochromatin. The highest concentration of methylated CpGs in
mouse cells is at pericentric heterochromatin, and the DNA
methyltransferases (DNMTs) Dnmt3a and Dnmt3b also concentrate
there (Bachman et al., 2001). In the absence of these DNMTs, and
with the consequent loss of DNA methylation, there is an altered
nuclear organisation and histone modification profile at pericentric
heterochromatin (Gilbert et al., 2007). Transgene studies have also
implicated DNA methylation and recruitment to domains of
pericentric heterochromatin in the KRAB-mediated repression
mechanism (Ayyanathan et al., 2003). However, in late passage
Dnmt3a/b–/– cells, which we have previously shown have no
detectable remaining CpG methylation (Gilbert et al., 2007), we
found that KAP1 was still concentrated at heterochromatin (data
not shown). Therefore, DNA methylation at pericentromeric
heterochromatin is not needed to sequester KAP1 there.
Another chromatin mark characteristic of pericentric
heterochromatin is tri-methylated H3-K9 (H3K9me3) laid down by
the Suv39h family of HMTases. In mouse cells null for both Suv39h1
and Suv39h2 (Suv39h dn), the absence of H3K9me3 leads to a
delocalisation of HP1α and HP1β from pericentromeric
heterochromatin (Lehnertz et al., 2003) (Fig. 7A). We also found that
KAP1 localisation to pericentric heterochromatin was lost in Suv39h
dn cells (Fig. 7B), indicating that KAP1 concentration at these nuclear
domains may be driven through its interactions with HP1s. However,
discrete KAKA foci containing KAP1, HP1 and ZFP647 were still
present in the nuclei of Suv39h dn cells (Fig. 7). This suggests that
formation of KAKA foci is independent of the activity of the Suvar39h
HMTases and that the two nuclear sites of accumulation of KAP1
are fundamentally different from one another.
Sumoylation of KAP1 corresponds to the appearance of KAKA
foci
We also observed that both SUMO1 and SUMO2/3 could be found
concentrated at pericentric heterochromatin in some differentiated
Journal of Cell Science 122 (7)
Fig. 6. Association of KAKA foci with PML-NBs. Deconvolved images from
two optical sections of day 6 differentiated OS25 cells, separated by 0.5 μm in
the z-axis, after immunofluorescence with antibody that recognises Zfp647
(red) and, in green, either CREST anti-serum (A), antibody that recognises
PML (B), SUMO1 (C) or SUMO2/3 (D). DNA was counterstained with DAPI
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ES cells (SUMO1 shown in Fig. 8A). As KAP1 itself can be
sumoylated (Ivanov et al., 2007; Lee et al., 2007; Li et al., 2007;
Mascle et al., 2007), we thought it possible that the SUMO we
observe at pericentric heterochromatin is actually modified KAP1.
However, at day 10 of differentiation, the percentage of cells in
which SUMO1 and SUMO2/3 is at pericentric heterochromatin
(19% and 46%, respectively) is far below that in which KAP1 is
at these sites (96%). Interestingly, in Suv39h dn cells, pericentric
localisation was no longer seen for either SUMO (SUMO1 shown
in Fig. 8A), suggesting the localisation of a major sumoylated target
or of SUMO itself to this site is dependent on this HMTase or
H3K9me3. By contrast, the juxtaposition of KAKA foci and
SUMO-containing PML NBs persists in the absence of the Suv39h
HMTases (arrowed in Fig. 8A).
The appearance of KAKA foci during ES cell differentiation,
and their proximity to SUMO-containing PML-NBs, prompted us
to address whether sumoylation of KAP1 is also regulated during
differentiation. By western blot with a KAP1 antibody, we analysed
total cell extracts, prepared in the presence of N-ethylmaleimide
(NEM) to preserve SUMO modification, from both undifferentiated
(–RA) and day 10 differentiated (+RA) wild-type ES cells (wt41).
We found that the major unmodified form of KAP1 (Fig. 8B, single
arrow) was downregulated during ES cell differentiation, as
previously described for F9 cells (Cammas et al., 2004). However,
interestingly, a higher molecular weight form, corresponding to
SUMOylated KAP1 (double arrow), was increased with
differentiation. This was also seen in extracts from Suv39 dn ES
cells. This suggests that the sumoylated form of KAP1, which is
the form active in transcriptional repression (Ivanov et al., 2007;
Lee et al., 2007; Li et al., 2007; Mascle et al., 2007), is resident in
the euchromatic compartment, perhaps in KAKA foci, and not at
the constitutive heterochromatin, as KAP1 is delocalised from
pericentric heterochromatin in Suv39 dn ES cells (Fig. 7B).
Discussion
KRAB ZFPs have a dynamic nuclear localisation
The initial studies of transgenes silenced by the KRAB-KAP1
repression mechanism (Ayyanathan et al., 2003), the KAP1
localisation studies during ES and EC cell differentiation (Cammas
et al., 2002; Cammas et al., 2004), and the subnuclear localisation
of epitope-tagged KRAB-ZFPs (Matsuda et al., 2001; Payen et al.,
1998; Sutherland et al., 2001) (Fig. 1) had all pointed towards a
link between the KAP1/KRAB-ZFP repression pathway and
domains of pericentric heterochromatin in the nucleus. In this paper,
we present the first detailed study of the subnuclear distribution of
endogenous KRAB-ZFPs. We show that these proteins do have a
Fig. 7. KRAB-ZFP, HP1 and KAP1 localisation in Suvar39h knockout cells.
(A) Immunofluorescence on day 8 differentiated ES cells null for both
Suv39h1 and h2 (Suv39h dn), and on the wild-type parental controls for these
cells (wt41) with antibodies that detect Zfp647 (green in merge) and HP1β
(red in merge). DNA was counterstained with DAPI (blue in merge). Arrows
indicate nucleoplasmic foci of Zfp647 and HP1β, and some are shown
enlarged in inset. Double arrowheads indicate HP1β concentrated at domains
of constitutive heterochromatin in wild-type cells, but delocalised in Suv39h
dn cells. Scale bars: 5 μm. (B) As in A but with antibodies that recognise
Zfp647 (green in merge) and KAP1 (red in merge). Arrows indicate
nucleoplasmic foci of Zfp647 and KAP1. Double arrowheads indicate KAP1
concentrated at domains of constitutive heterochromatin in wild-type cells, but
delocalised in Suv39h dn cells. Scale bars: 5 μm.
Fig. 8. KAP1 and sumoylation. (A) Immunofluorescence on day 8
differentiated ES cells null for both Suv39h1 and h2 (Suv39h), and on the
wild-type parental controls for these cells (wt41) with antibodies that detect
KAP1 (green in merge) and SUMO1 (red in merge). Double arrowhead
indicates concentration of SUMO1 with domains of constitutive
heterochromatin in wild-type cells, but delocalised in Suv39h dn cells. Arrows
indicate SUMO1 in PML-NBs that are juxtaposed to KAKA foci. Scale bars:
5 μm. (B) Western blot with antibody that detects KAP1 in extracts prepared
from undifferentiated (–RA) and day 10 differentiated (+RA) ES cells null for
both Suv39h1 and h2 (Sv39dn), and on the wild-type parental controls for
these cells (wt41). Arrow indicates the unmodified form of KAP1 and double
arrow indicates sumoylated KAP1. The panel below shows the GelCode Blue-












dynamic nuclear localisation during cell differentiation, but that they
are not seen concentrated at the visible domains of constitutive
heterochromatin in differentiated mouse cells, even in cells where
KAP1 is concentrated there (Figs 3 and 4).
What is the explanation for the differential localisation of
endogenous and ectopically expressed KRAB-ZFPs? Ectopic
expression of GFP-tagged Zfp647 deletion constructs show that it
is the KRAB domain itself that is required for localisation to
heterochromatin (Fig. 2). This is probably due to the specific
interaction of the KRAB domain with KAP1 (Friedman et al., 1996)
and is supported by previous findings where other tagged KRAB-
ZFPs, with mutations in the KRAB domain that are unable to bind
KAP1, can no longer localise to centromeric foci (Matsuda et al.,
2001). It seems most likely that the ZFs or linker regions of KRAB
ZFPs, such as Zfp647, provide the DNA-binding specificity to direct
the protein to its correct target loci. We suggest that in the absence
of these regions (deletion constructs or gene-trapped proteins), the
KRAB-KAP1 interaction dominates and results in a mis-localisation
of the KRAB protein at heterochromatin. Ectopic expression of
epitope tagged full-length KRAB-ZFPs may saturate specific target
binding sites in the genome and so also result in the accumulation
of the tagged protein at heterochromatin.
Thus, caution must be exercised in interpreting the mechanism
of transcriptional repression when using ectopically expressed
KRAB-ZFPs; it remains unclear what the function of KAP1 is, if
any, at constitutive heterochromatin. Some KRAB proteins do
consist of only a KRAB domain, e.g. MIF1 (Nikulina et al., 2006),
and some are alternatively spliced to generate a KRAB-box only
protein, e.g. KRAB-O from the Zfp208 locus (Oh et al., 2005).
Therefore, it is possible that localisation at pericentric
heterochromatin is relevant to the function of a subset of KRAB
box-containing proteins. However, our finding that, in Suv39h dn
ES cells, KAP1 is completely delocalised from pericentric
heterochromatin, presumably as a consequence of HP1
delocalisation (Fig. 7), suggests that the major role of KAP1 is
not at pericentric heterochromatin. This is supported by the fact
that the phenotype of the mice null for both Suv39h HMTases is
quite mild, with all animals developing normally until 12.5 dpc
and many mice surviving to adulthood (Peters et al., 2001). A
null deletion of KAP1 itself, however, results in complete
embryonic lethality just after implantation (Cammas et al., 2000).
Ivanov et al. (Ivanov et al., 2007) have reported that a sumoylation-
deficient mutant of KAP1 (K6R) still localised to pericentric
heterochromatin and suggest that loss of repression conferred by
this mutant was not due to a defect in subnuclear targeting. This
would also be consistent with our suggestion that pericentric
heterochromatin is not the site of KRAB ZFP-mediated gene
repression.
KRAB ZFPs characterise a novel nuclear body
In differentiated mouse cells, we found that two endogenous
KRAB-ZFPs (Zfp647 and NT2) were concentrated in nucleoplasmic
foci that are not associated with pericentric heterochromatin, but
are tightly associated with foci of KAP1 (Figs 3 and 4). We have
termed these KRAB- and KAP1-associated (KAKA) foci. We
consider it likely that the KAP1-containing nucleoplasmic foci
reported with the GFP-tagged KRAB ZFP PAROT are also KAKA
foci (Fleischer et al., 2006).
KAKA foci also contain the known KAP1-interacting proteins
HP1α and HP1β (Nielsen et al., 1999; Ryan et al., 1999). We also
show that another component of the KAP1-mediated repression
machinery, SETDB1 (Schultz et al., 2002), is present in
nucleoplasmic foci that we observe occasionally overlapping with
KAKA foci (Fig. 5C). The KAP1-HP1-KRAB-ZFP complexes in
KAKA foci may only be transiently interacting with SETDB1, or
they may be interacting mainly with other chromatin modifiers at
these sites. In this regard, it is noteworthy that only 25% of the
KAP1 binding sites identified in the genome of Ntera2 cells are
also marked by the presence of H3K9me3 – the histone modification
catalysed by SETDB1 (O’Geen et al., 2007).
KAKA foci – twin of PML NBs?
We have shown that KAKA foci are often juxtaposed to PML
nuclear bodies (Fig. 6B). This is reminiscent of the relationship
between gems, Cajal bodies and cleavage bodies, all structures
involved in steps of pre-mRNA processing. These bodies can occur
as separate nuclear structures, but can be also be twinned or
colocalised in some situations (Li et al., 2006).
Intriguingly, given the spatial juxtaposition of KAKA foci and
PML-NBs, both KAP1 and PML are proteins of the RBCC family.
Modification of PML by sumoylation is known to be important for
the formation of PML-NBs (Zhong et al., 2000) and SUMOs are
concentrated in PML-NBs (Bernardi and Pandolfi, 2007) (Fig.
6C,D). As we have found that the appearance of high molecular
weight forms of KAP1 during differentiation, consistent with its
sumoylation (Fig. 8), is coincident with the cytological appearance
of KAKA foci (Figs 3 and 4), we speculate that, similar to PML-
NBs, sumoylation of KAP1 is involved in the formation of KAKA
foci. Consistent with a link between KAKA foci and sumoylation,
KRAB-ZFPs themselves have also been shown to be sumoylated
in a proteomics analysis of proteins modified by SUMO1 and
SUMO2/3 (Vertegaal et al., 2006).
It has been suggested that PML itself might be a SUMO E3 ligase,
modifying both itself and other targets (Bernardi and Pandolfi, 2007;
Quimby et al., 2006). Similarly, KAP1 has also been shown to be
an intra-molecular SUMO E3 ligase (Ivanov et al., 2007). As it is
the SUMOylated form of KAP1 that recruits the downstream
effectors such as SETDB1 and NURD, this suggests that KAKA
foci might be sites for modification and/or assembly of the
components of KRAB-ZFP-mediated transcriptional repression
(Ivanov et al., 2007; Li et al., 2007; Mascle et al., 2007).
It remains for bone fide target genes of KRAB-ZFPs, such as
Zfp647, to be identified in order to address whether target genes
are recruited to KAKA foci for their silencing or whether KAKA
foci are storage, processing or assembly sites for the proteins
involved in KRAB-ZFP-mediated silencing.
Materials and Methods
Cell culture and differentiation
Undifferentiated E14 wt, gene-trapped, Dnmt3ab–/– (Okano et al., 1999), Suv39h1/h2–/–
(Peters et al., 2001) and OS25 (Billon et al., 2002) ES cells were maintained on 0.1%
gelatin-coated dishes in Glasgow’s modified Eagle’s medium (GMEM) containing
10% foetal calf serum (FCS), non-essential amino acids, 1 mM sodium pyruvate, 0.3
mg/ml L-glutamine, 0.1 mM 2-mercaptoethanol and 1000 U/ml human recombinant
LIF. Mouse NIH3T3 fibroblasts were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% FCS.
100 μg/ml hygromycin B was used to select for undifferentiated (Oct4-expressing)
OS25 cells. To induce their differentiation, 5105 OS25 cells were plated in 25 cm2
flasks (Costar) without LIF or hygromycin B for 1 day. The cells were maintained
in medium with 510–6 M RA for the next 4 days. For the remaining length of
differentiation (up to day 10), 2.5 μM gancyclovir was also added to RA-containing
medium to select against undifferentiated (Oct4-expressing) cells (Billon et al., 2002).
Media was changed every second day and cells were replated or seeded onto 410
cm2 gelatinised slides as necessary. All other cell lines maintained and differentiated
as above with RA, but with no selection.
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DNA sequence analysis of ES492/Zfp647
5 RACE was used to obtain ~800 bp of sequence information for the ES492 gene-
trap as previously described (Sutherland et al., 2001). Mouse genomic and EST
databases were searched for sequence matches using the BLAST algorithm
(http://www.ncbi.nih.gov/BLAST/ or http://www.ensembl.org/). This revealed 94%
nucleotide identity with hypothetical mouse mRNA (NM_172817), which encodes
Zfp647 (NP_766405), the 535 amino acid KRAB-ZFP.
We subcloned and sequenced the full-length Zfp647 cDNA from EST BI656339
(IMAGE clone 5326813). Domains of the trapped proteins were examined using
InterProScan (http://www.ebi.ac.uk/InterProScan/) and the Simple Modular
Architecture Research Tool (SMART) (http://smart.embl-heidelberg.de/). The KRAB
box is of the A+B family (Shannon et al., 2003), and a linker region of 96 amino
acids separates the KRAB domain from the 13 C2H2 zinc fingers (ZFs). The
gene trap is inserted into the final ZF-encoding exon (after amino acid 147)
and uses a cryptic splice donor (http://npd.hgu.mrc.ac.uk/search.php?action=
builddetails&geneid=1NP01271).
Cell transfection
Full-length Zfp647 cDNA, and versions lacking the ZFs, or the KRAB box, were
cloned from PCR products in frame into pEGFP-C1 or -N1 vectors (Clontech). Zfp647
lacking the ZFs (GFP-Zfp647ΔZF) consisted of GFP fused to amino acids 1 to 186
of Zfp647. Zfp647 without the KRAB box consisted of GFP fused to amino acids
187 to 535 (Fig. 1C). NIH3T3 cells were transfected with Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions. Cells were incubated for
24 hours, fixed and visualised for GFP expression.
Bacterial fusion proteins and antibody production
Products encoding amino acids 90-174 of Zfp647, covering most of the linker region,
were PCR amplified from IMAGE clone 5326813 using the primers 5ACTG -
AATTCGGAAGTGACCACTCAGAATGC3 and 5TGAGCGGCCGCATAGGG -
TCTCTCAACAGTGGG3. The PCR product was subcloned into pGex-4T-1
(Amersham Biosciences), sequenced and transformed into E. coli BL21-CodonPlus
(DE3)RP cells (Stratagene). Bacterial GST-ZFP647 linker fusion protein was induced
with IPTG and purified on glutathione-agarose (Sigma) before injection into rabbits
and sheep (Diagnostic Scotland). The same PCR product was cloned into pET32a
(Novagen); the His-tagged fusion protein was purified on a Ni-agarose column (HIS-
Select Nickel Affinity Gel, Sigma) and an affinity column was made by binding it
to CNBr-activated sepharose 4B (Amersham Biosciences). Antibodies recognising
Zfp647 (α-Zfp647) were affinity purified against the Zfp647 linker affinity column
and specificity was confirmed by western blotting against His-tagged Zfp647 protein
expressed in E. coli (data not shown).
Subcellular fractionation and western blotting
Protein extracts from 12.5 dpc embryos were prepared by homogenisation of
dissected limbs (where Zfp647 is expressed) in 2SDS loading buffer and boiling
samples before loading. Whole-cell protein extracts were made by overlaying cells
with PBS, adding an equal volume of 2SDS protein loading buffer and boiling
before loading. NEM was added to the loading at a final concentration of 20 mM in
the protein samples in which it was used. For nuclear extracts, cells were washed in
PBS and resuspended on ice in nuclei extraction Buffer A [NBA, 5.5% sucrose (w/v
in dH2O), 10 mM Tris-HCl (pH 8), 85 mM KCl, 0.5 mM spermidine, 250 μM PMSF
(phenyl methyl sulfonyl fluoride), 0.2 mM EDTA]. An equal volume of NBA + 0.1%
NP-40 [v/v] was then added prior to pelleting at 500 g for 3 minutes at 4°C. Nuclei
were washed with NBA and their concentration determined from the A260. An equal
volume of 2SDS protein loading buffer was added to the sample and boiled before
loading on SDS-PAGE gels. Total cell, cytoplasmic and nuclear NIH3T3 fractions
were prepared as previously described (Sutherland et al., 2004).
For western blotting, protein extracts were fractionated by 10-12% SDS-PAGE
and transferred to a nylon membrane by wet blotting (GENIE blotter, Idea Scientific).
The membranes were incubated with primary antibodies and detected by horseradish
peroxidase (HRP)-conjugated donkey anti-rabbit or anti-mouse whole molecule IgG
(Sigma, 1:10,000) and chemiluminescence (SuperSignal 1:2000). Primary antibody
dilutions were as follows: 1:1000 sheep α-647 (3.2 mg/ml), 1:1500 rabbit α-647
(4.75 mg/ml) and 1:2500 rabbit α-KAP1 (Bethyl Laboratories, A300-274A). For
loading controls, protein extracts were stained with GelCode Blue stain reagent
(ThermoScientific) after fractionation. For histone loading controls, protein extracts
were fractionated by 17% SDS-PAGE before GelCode Blue staining.
Immunofluorescence
Cells were grown as monolayers on slides and fixed for 20 minutes in 3%
paraformaldehyde (pFa)/PBS containing 1.5 mM MgCl2 and 1 mM CaCl2. Fix was
quenched in 50 mM NH4Cl/PBS for 10 minutes and cells were permeabilised in
0.25% Triton X-100/ PBS for 12 minutes. Cells were incubated overnight with primary
antibodies: 1:150 dilution of rabbit α-647 (this paper); undiluted mAb supernatant
recognising KAP1 (gift of F. J. Rauscher III and D. Schultz) or a 1:1200 dilution of
a mAb against KAP1 (gift of P. Chambon); 1:500 dilutions of mouse mAb α-HP1α,
β and γ (Chemicon); 1:200 dilution mouse mAb α-SSEA-1 (DSHB); 1:2000 dilution
of rabbit α-β-gal (Europa) or a mAb against β-gal (Promega); 1:1000 dilution of
mouse mAb α-PML (Chemicon); 1:300 dilution of CREST sera (Gilchrist et al., 2004);
1:150 dilution of sheep α-SUMO1 and 1:50 dilution of α-SUMO2/3 (gifts of Ron
Hay); 1:200 dilution of MacroH2A1 (Upstate); and 1:500 dilution of α-phospho-
H2AX [Ser139] (Upstate). After washing off non-specifically bound antibody, the
slides were then incubated for 1 hour with 1:200 dilutions of FITC- or TexasRed-
labelled secondary antibodies (Jackson and Vector Laboratories) or 1:1000 dilutions
of Alexa Fluor 488 or Alexa Fluor 594 secondary antibodies (Invitrogen).
For treatment with UV, cells were irradiated with 200 J/m2 of UV-C at 254 nm
(UV Stratalinker 1800, Stratagene), returned to media and incubated for 30 minutes
before fixation and immunofluorescence as described above. For immunofluorescence
combined with detection of bromodeoxyuridine (BrdU) incorporation, 0.01 M BrdU
(Roche) was added to cells in culture 30 minutes before fixation in 3% pFa for 20
minutes. Cells were incubated with primary antibody and subsequently fixed in 10%
formalin (v/v)/PBS for 10 minutes and permeabilised with 0.1% Triton X-100/PBS
for 12 minutes. DNA was denatured with a 30-minute 2 M HCl treatment to allow
for α-BrdU antibody access. Cells were washed in PBS, blocked for 10 minutes in
5% BSA (w/v) before incubating with 1:100 dilution of a rabbit antibody recognising
BrdU (Harlan SeraLab) for 1 hour, followed by incubation with secondary antibodies.
Slides were counterstained with 0.5 μg/ml DAPI in Vectashield, and examined on
a Zeiss Axioplan epifluorescence microscope equipped with a triple band-pass filter
(Chroma #83000) and imaged with cooled CCD camera using IPLAB software v.
3.6 (Scanlytics, USA). For optical sectioning, the microscope objective was fitted
with a Pifoc motor to allow optical sectioning in the z-axis and the images were
subject to deconvolution to remove out of focus blur using Hazebuster deconvolution
software. A Zeiss LSM510 laser-scanning confocal microscope was also used for
examining some slides.
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